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ABSTRACT
The term conjugated linoleic acid (CLA) refers to a range of geometric and
positional isomers of linoleic acid. Recent research suggests a variety of
potential health benefits with consumption of dietary CLA. These include a
reduction in body fat deposition that has been demonstrated in a number of
monogastric species including the mouse, rat, hamster and pig. This thesis
describes the effects of CLA on lipid metabolism in sheep, where CLA may be
useful in reducing carcass fat and improving fatty acid profile. The results are
contrasted with those in the hamster, a model monogastric species, previously
shown to respond to CLA.
Ovine adipose tissue metabolism was studied in explants maintained in culture
and incubated with a mixture of CLA isomers and individual isomers. Total
lipogenesis, and the formation of saturated and monounsaturated fatty acids
were examined. Results show no effect of CLA (mixed or individual isomers)
on total lipogenesis or desaturation of fatty acids. Furthermore, there was no
effect on mRNA concentration for acetyl coenzyme A carboxylase (ACC) or
stearoyl coenzyme A desaturase (SCD). The effect of feeding CLA (protected
from rumen degradation) to sheep, on lipogenic gene expression was then
investigated. While there was no evidence of a decrease in total fat deposition,
there was a decrease in the proportion of monounsaturated fatty acids in the
tissues. As there was no effect on SCD mRNA levels, it appears likely that
CLA inhibits SCD activity rather than affecting gene expression.
A further feeding study was undertaken in Golden Syrian hamsters. As in the
sheep, CLA feeding reduced the monounsaturated fatty acid content of the
tissues but did not change the SCD mRNA concentration in adipose tissue or
liver. This further supports the suggestion that CLA directly inhibits SCD
activity. Unlike the sheep, there was an overall decrease, of approximately
10%, in total carcass fat. However, paradoxically, there was an increase in
adipose tissue ACC and fatty acid synthase (FAS) mRNA concentrations.
Thus, suppression of lipogenic enzyme expression does not appear to be the
mechanism by which CLA reduces fat deposition.
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11. INTRODUCTION
1.1. ANIMAL FAT AND HUMAN HEALTH
An increase in the number of people suffering from chronic diseases such as
obesity, diabetes and cardiovascular disease is putting a huge financial strain
on the National Health Service. In the western world, incidences of obesity and
diabetes are on the increase, and cardiovascular disease is still the greatest
cause of premature death. Obesity is caused when consumption of energy
exceeds energy expenditure. Excess energy is stored as fat, primarily in
adipose tissue depots and can accrue to comprise over 50% of body weight
(Vernon, 1986). Obese people are generally less healthy and are at a higher risk
of developing other diseases such as diabetes and cardiovascular diseases.
Diabetes is a disease state where glucose is poorly handled by the body as a
result of impaired insulin production or resistance to insulin. Insulin dependent
diabetes mellitus (IDDM) results in high blood glucose concentrations due to
the lack of insulin synthesis by the pancreas. Patients normally display
symptoms in childhood and must be treated by daily insulin administration to
correct the blood glucose concentration. Non-insulin dependent diabetes
mellitus (NIDDM) is the most common form of diabetes, and is seen in older,
usually obese patients who are producing high levels of insulin to overcome
effects of insulin resistance induced by obesity. NIDDM occurs when the level
of insulin production by the pancreas cannot be sustained, resulting in high
blood glucose levels which cannot be corrected by insulin administration
(Mangiapane & Salter, 1999). Cardiovascular disease is a chronic disease state,
caused by arterial obstruction. Coronary heart disease (CHD) is caused by
obstruction of the coronary arteries, and is usually preceded by the
development of fatty deposits in coronary arteries which harden and increase in
size. This results in a narrowing of blood vessels, increases the risk of blood
clots and impairs blood flow to the heart, resulting in death of heart muscle and
possible heart attack (Mangiapane & Salter, 1999). All of these diseases are
associated with diet and the over-consumption of energy, leading to obesity,
which can result in NIDDM and cardiovascular disease. The latest data on fat
consumption indicates that in the UK, over 38% of total energy is supplied by
fat (Defra, 2000). Fat is energy dense; 1g of fat contains 2.3 times the amount
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of energy as 1g of glycogen, the form in which carbohydrate is stored in the
body (McDonald et al, 1995). Therefore consumption of a small amount of fat
supplies a large amount of energy, but no feeling of satiety, therefore there is a
tendency to over-eat in terms of energy balance. It has been long established
that the type of fat consumed has a major impact on the incidence of CHD. An
increase in blood cholesterol has been shown to increase the risk of CHD, and
saturated fatty acid intake increases blood cholesterol. In contrast,
polyunsaturated fatty acids lower blood cholesterol and therefore the risk of
developing CHD. In the UK an average of 15% of total energy is supplied from
saturated fatty acids, with only 6.9% from polyunsaturated fatty acids (Defra,
2000). Consequently, government recommendations are to reduce consumption
of saturated fats to no more than 10% and for the percentage of total energy
from fat to be below 35% (Department of Health, 1994). 22% of total fat intake
is accounted for by consumption of meat, poultry and meat products, while
dairy products account for a further 15% (Department of Health, 1994). Thus
there is a significant contribution of ruminant products to total fat intake and
implementation of these recommendations has had an effect on meat
consumption. This has implications for meat producers.
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1.2. DIETARY FAT AND ANIMAL PRODUCTS
Animal products are a major source of dietary fat, with the majority of fatty
acids coming from dairy products and meat. Consumption of meat has fallen in
the U.K. over the last 30 years, and the last decade has seen a number of health
and related scares involving meat products, including outbreaks of salmonella
and Escherichia coli 0157, bovine spongiform encephalopathy (BSE) and foot
and mouth disease. All these cases have weakened public confidence in the
livestock industry and have resulted in reductions in sales of meat and meat
products. In addition to these factors, government recommendations advise
against the consumption of high levels of saturated fat, advising that only 10%
of food energy from total fat should be derived from saturated fats (Department
of Health, 1994). Dairy products and meat from ruminants are particularly high
in saturated fats in comparison to meats from pigs or poultry (Table 1.1). This
is due to the structure of the ruminant digestive tract and process by which their
food is digested and absorbed, which will be discussed later. There is a
perception that it is unhealthy due to the type and amount of fat it contains, so
consumption of these meats has reduced (Figure 1.1). In addition red meat is
more expensive than chicken or turkey, and therefore consumption of the latter
is increasing at the expense of red meat. Clearly the continuation of such trends
is worrying for the livestock industry, and the decline in meat consumption
seen over previous years needs to be addressed. However the discovery of
conjugated linoleic acid (CLA) in samples of ground beef (Pariza et al, 1987),
and the fact that ruminant meat is particularly high in CLA suggests that
ruminant meat is not all bad. A number of beneficial effects have been
attributed to CLA, including its potential as an anti-carcinogen and reductions
in fat deposition seen in animals fed diets supplemented with CLA. Thus the
advantages of CLA in ruminant meat could be twofold; increased consumption
of CLA contained in ruminant tissues could confer increased health benefits on
consumers, and the feeding of CLA to animals may have favourable effects on
the amount and type of fat associated with the meat. This is discussed in more
detail in Sections 1.6 and 1.7. The Government has set up public bodies to
monitor food standards and production in response to public concern regarding
food safety, and organisations such as the Food Standards Agency have a role
to play by advising consumers on aspects of food safety. Meat industry bodies
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such as the Meat and Livestock Commission aim to promote meat and meat
products, through campaigns, liaison with producers and advice on the
production of a better product, more suited to consumers’ needs. As previously
mentioned, consumption of beef and lamb has fallen over the last 30 years,
while poultry consumption has risen. If these trends continue they will have a
devastating effect on the ruminant meat industry. A major problem is the fat
content of ruminant tissues, and any attempt to meet consumers’ requirements
for beef and lamb needs to focus on changing the amount and type of fat
present in the carcass. The rise in poultry consumption indicates that
consumers prefer lean meat with little associated fat. Although poultry contains
similar amounts of fat to ruminant meats, this fat is largely unsaturated and is
usually removed from the meat prior to consumption. There are a number of
ways that the amount and type of fat in ruminant meat could be changed, chief
of which is to change the carcass composition, to raise the lean percentage and
reduce associated fat. To do this effectively the process of fat deposition during
the growth of ruminants and the effects on both the digestive and fat deposition
processes in response to different dietary fats needs to be understood.
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Table 1.1 Fatty acid composition of meat and dairy products
Fatty acid Beef
a
Lamb
a
Pork
a
Dairy products
b,c
C4:0 NR NR NR 4.20
C6:0 NR NR NR 2.37
C8:0 NR NR NR 1.33
C10:0 NR NR NR 2.97
C12:0 0.08 0.31 0.12 3.40
C14:0 2.66 3.30 1.33 11.18
C16:0 25.0 22.2 23.2 26.56
C16:1 4.54 2.20 2.71 2.17
C18:0 13.4 18.1 12.2 11.13
C18:1 n-9 36.1 32.5 32.8 21.31
C18:2 2.42 2.70 14.2 2.19
C18:3 n-3 0.70 1.37 0.95 1.21
Data from
a
Enser et al, 1996;
b
Jensen, 1992 expressed as % weight of total fatty acids.
c
Dairy
products are an average of fatty acid composition for milk and butter. NR = not reported.
Sources: Enser et al, 1996; Jensen, 1992
Figure 1.1 Meat consumption from 1970 - 2000
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1.3. LIPIDS
The term ‘lipid’ is a collective term for a number of compounds which are
insoluble in water. This group of compounds includes fats, oils, phospholipids
and sterols. They have many different functions, but a large number of fats and
oils are the major forms of stored energy in many organisms, while
phospholipids and sterols are the major constituents of biological membranes.
Fats and oils are principally composed of fatty acids and their derivatives.
1.3.1. The structure and naming of fatty acids
Fatty acids are made up of a carboxyl (COOH) group bound to a hydrocarbon
chain. This hydrocarbon chain can be of any length, but is usually even
numbered in eukaryotes; short chain fatty acids are usually between 2 and 14
carbons long; and long chain fatty acids over 14 carbons in length. Fatty acids
vary in their degrees of saturation, that is, how many double bonds and
therefore hydrogen atoms are associated with them. A fatty acid is said to be
saturated if it does not contain any double bonds and therefore has the
maximum number of hydrogen atoms possible bound to each carbon atom.
Unsaturated fatty acids contain one or more double bonds and therefore have
less hydrogen atoms bound to them. The conversion of an unsaturated fatty
acid to a saturated one requires the addition of hydrogen, and so saturated fatty
acids are said to be hydrogenated. In fatty acids containing double bonds, there
are two different configurations, cis and trans. These refer to the position of the
remaining hydrogen atoms in relation to the fatty acid chain. The cis
configuration has both remaining hydrogen atoms on the same side of the fatty
acid chain, while the trans configuration has them on opposite sides (Figure
1.2). Changes in configuration produce geometric isomers of fatty acids, while
changes in the position of double bonds produce positional isomers. The
naming of fatty acids is done according to structural features, namely chain
length and number of double bonds. The number of carbons in the chain is
written first, followed by a colon, after which the number of double bonds
contained within the carbon chain is written. For example, myristic acid, a
saturated fatty acid with 14 carbons and no double bonds is written as 14:0,
while palmitoleic acid, a monounsaturated fatty acid with 16 carbons and 1
double bond is written as 16:1. However, this system has its limitations when
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dealing with a number of forms or isomers of the same molecule. Sometimes it
is important to know not only the number of double bonds, but their
configuration and location in the molecule. Numbering of the location of
double bonds is usually done from the carboxyl end of the fatty acid, so
palmitoleic acid is referred to as cis-9 hexadecadienoic acid, indicating that the
double bond is between the ninth and tenth carbons from the carboxyl end of
the fatty acid chain, and it is in the cis configuration. Fatty acids also have
systematic names (Table 1.2) by which they are more commonly referred to.
The biosynthesis of fatty acids means that most naturally occurring fatty acids
are even numbered.
Figure 1.2 Representation of cis and trans fatty acids
H H H R
C C C C
R R R H
cis fatty acid trans fatty acid
R denotes the fatty acid chain
Source: Adapted from Gurr, Harwoood & Frayn (2002)
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Table 1.2 Common saturated, monounsaturated and polyunsaturated
fatty acids found in animal tissues and their systematic names
No. of carbon atoms
and double bonds
Systematic name Common name
2:0 n-Ethanoic Acetic
3:0 n-Propanoic Propionic
4:0 n-Butanoic Butyric
6:0 n-Hexanoic Caproic
8:0 n-Octanoic Caprylic
10:0 n-Decanoic Capric
12:0 n-Dodecanoic Lauric
14:0 n-Tetradecanoic Myristic
16:0 n-Hexadecanoic Palmitic
16:1 cis-9-Hexadecanoic Palmitoleic
18:0 n-Octadecanoic Stearic
18:1 trans-9-Octadecenoic Elaidic
18:1 trans-11-Octadecenoic trans-Vaccenic
18:1 cis-9-Octadecenoic Oleic
18:1 cis-11-Octadecenoic Vaccenic
20:0 n-Eicosanoic Arachidic
22:0 n-Docosanoic Behenic
Source: Adapted from Gurr, Harwood & Frayn (2002)
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1.3.2. Saturated fatty acids
Saturated fatty acids contain no double bonds, and the naturally occurring ones
in animal tissues are up to 22 carbons in length. In these compounds, the atoms
in the carbon-carbon bond are able to freely rotate, resulting in a very flexible
fatty acid chain. The most stable conformation is a straight extended chain, due
to the lack of interactions between atoms within a single bond.
1.3.3. Unsaturated fatty acids
Unsaturated fatty acids have at least one double bond in their hydrocarbon
chain. Monounsaturated fatty acids have a single double bond and are generally
between 16 and 22 carbons in length. The degree of saturation has an effect on
the alignment of the fatty acid chain, as the introduction of double bonds and
the associated restriction of rotation in the acyl chain motion at that point, due
to inter-atomic forces, causes the chain to kink or to be extended (Gurr,
Harwood & Frayn, 2002). Polyunsaturated fatty acids originate from their
monounsaturated counterparts; thus linoleic acid (18:2) is produced by
desaturation of oleic acid (18:1), however this only happens in plants. Animals
cannot synthesise linoleic acid and therefore it is an essential fatty acid which
must be supplied in the diet.
1.3.4. Storage of lipids in animal tissues
Storage occurs when dietary energy intake exceeds that required by the body.
Most lipids are stored as triacylglycerols, which are esters of glycerol and
consist of three fatty acids in ester linkage with glycerol (Figure 1.3).
Triacylglycerols are hydrophobic, like all lipids, and because of this do not
carry associated water. Fat oxidation yields much more energy than that of
carbohydrates (Lehninger, 2000). Triacylglycerols are stored primarily in
adipose tissue in animals, which has the advantage of being able to expand
greatly to accommodate vast stores of energy.
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Figure 1.3 Triacylglycerol structure
CH2OH + R1-COOH CH2OOC R1
CH2OH + R2-COOH CH2OOC R2
CH2OH + R3-COOH CH2OOC R3
Glycerol + Fatty acid Triacylglycerol
R represents the fatty acid chain
1.3.5. Growth and fattening
Animals consist of four major types of tissue; nervous, bone, adipose and lean.
These tissues are in turn made up of different cells. For the purpose of this
thesis, adipose and lean tissues are discussed. Adipose tissue is mainly made up
of adipocytes, whose primary function is to esterify and store fat. Lean tissue is
made up of a number of different cell types, forming muscle proteins organised
into muscle fibres; and water. In the immature animal, the rate of growth is
very rapid. Initially protein or lean tissue deposition rate is greater than that of
fat, but as the animal reaches its mature weight, the rate of fat deposition
increases to exceed that of protein (Figure 1.4). If fat growth is not restricted,
fat depots can expand massively to comprise over 50% of total body weight.
Lean tissue is still being produced but the amount present in the body remains
approximately constant due to the turnover of constituent proteins, where those
which are old or damaged are degraded and new ones are synthesised.
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Figure 1.4 Composition of gains in empty body weight for castrate cattle
of a medium-sized breed
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1.4. LIPID METABOLISM
Lipid metabolism in ruminants and monogastrics is different, in that ruminants
have four stomachs instead of one. The largest of them is the rumen, which is
colonised by micro-organisms which help to digest the plant matter which
forms a large part of ruminant diets. Ruminants also have a true stomach, or
abomasum, which contains stomach acid and enzymes as in the monogastric.
In the non-lactating ruminant, the major site of fatty acid synthesis is adipose
tissue and little occurs in liver. In humans and birds the liver is the major site
of fatty acid synthesis (Vernon, 1980), but mice, rats and rabbits synthesise
fatty acids in both tissues (Jansen et al, 1966; Leveille, 1966; Leung &
Bauman, 1976). The differences in diet and digestion strategy in these two
types of animals results in differing pathways of lipid metabolism, and
therefore are considered separately in this section.
1.4.1. Lipid metabolism in the monogastric
The monogastric animal has a simpler approach to digestion and absorption of
fats relative to the ruminant. It has only one stomach, the equivalent of the
abomasum in ruminants, which secretes acid and pepsinogen to hydrolyse
proteins. The stomach then gives way to the small intestine, where digesta
entering is mixed with bile salts, secretions from the pancreas and alkaline
fluid from the duodenum. Pancreatic lipase acts on fats to produce non-
esterified fatty acids and glycerol. The small intestine of the monogastric
processes much more triglyceride than the ruminant, as fat passes through the
stomach and enters the small intestine as large globules, which are difficult to
hydrolyse quickly. Bile salts emulsify fats, allowing hydrolysis to occur more
effectively. Fats are then solubilized into micelles, which are absorbed due to
the action of bile salts. After absorption, as in the ruminant, triacylglycerols are
resynthesised and packaged into lipid droplets called chylomicrons, which then
enter the circulation for distribution to the rest of the body.
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1.4.2. Dietary fat
Fat present in the body comes from two sources; dietary fat or endogenously
synthesised fat. Dietary fat is hydrolysed during digestion then re-esterified or
oxidised on reaching the tissues depending on the energy state of the animal;
endogenously synthesised fat is made by lipogenesis. Adipose tissue contains
stored or esterified fat. This is an energy store which can be mobilised when
bodily energy requirements exceed energy intake. Fat is hydrolysed to form
glycerol and non-esterified fatty acids, which can then be used to meet the
energy requirements of the animal. Dietary fats affect lipogenesis. In humans
consuming a high fat diet with 40% energy as fat, de novo lipogenesis (fatty
acid and triacylglycerol (TAG) synthesis from glucose and amino acids) is not
a major contributor to fat storage. In animals consuming a high carbohydrate
diet, lipogenesis is much more important and contributes significantly more to
fat deposition. Lipogenesis is particularly important in the ruminant, which
consumes a low fat diet and must synthesise fatty acids and TAG from the
products of digestion which are discussed in Section 1.4.5.
1.4.3. Lipogenesis
Fatty acid synthesis occurs via a process known as lipogenesis, which is the
formation of acetyl-coenzyme A from acetate, glucose or lactate. Acetate is the
major precursor in adult ruminants, with glucose and lactate contributing more
to lipogenesis in foetal, pre-ruminant animals and monogastrics (Vernon,
1986). Glucose is largely produced by gluconeogenesis in the ruminant
(Ballard et al, 1969), due to the lack of glucose in the diet. Little is available
for fatty acid synthesis, as much of it is diverted to tissues that cannot use fatty
acids, such as the brain. The process of lipogenesis is initiated by the
conversion of acetate to acetyl-coenzyme A by acetyl-CoA synthetase (Figure
1.6). This occurs in the cytosol of the cell (Ballard, 1972; Knowles et al, 1974).
Acetyl-CoA carboxylase (ACC), another enzyme present in the cytosol,
converts acetyl-coenzyme A to malonyl-coenzyme A. This enzyme is
hormonally regulated, and exists in active and inactive states depending on
phosphorylation of serine residues. This is the first committed step in fatty acid
synthesis and a key regulatory point of the process (Vernon, 1992). Malonyl-
coenzyme A goes through a series of reactions which elongate the fatty acid
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chain by 2 carbons. These reactions are catalysed by fatty acid synthase (FAS)
which consists of seven polypeptides that are associated in a complex. Each of
these acts on the fatty acid chain, and extends it by 2 carbons. This is repeated
seven times until palmitic acid is formed and leaves the cycle. Palmitic acid is
the precursor for a number of long chain fatty acids; the chain may be
lengthened by addition of acetyl groups by elongases present in the
endoplasmic reticulum and mitochondria (Figure 1.6); or a double bond
introduced to form monounsaturated fatty acids by the action of stearoyl-CoA
desaturase (SCD). Palmitoleic and oleic acids are the most common
monounsaturated fatty acids present in animal tissues. Further desaturation to
linoleic and linolenic acids is not possible in animals, so these fatty acids are
essential in the diet of animals for synthesis of long chain polyunsaturated fatty
acids (Lehninger, 2000).
Figure 1.5 Fatty acid metabolism
Acetate, pyruvate or lactate Exogenous fatty acids
Fatty acids
Fatty acyl-CoA
Glycerol-3-phosphate
1 acyl glycerophosphate
Esterification Fatty acyl-CoA
1,2 acyl glycerophosphate
Esterification
1,2 diacylglycerol
Esterification Fatty acyl-CoA
Triacylglycerol
Lipolysis
Glycerol Fatty acids
Adapted from Vernon (1981)
Fatty acid synthesis
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1.4.3.1. Acetyl-CoA carboxylase (ACC)
This enzyme is the first enzyme in the catalysis of fatty acid and ultimately
lipid synthesis. ACC is a heterotetrameric protein, with a molecular weight of
approximately 265kDa (Salati & Goodridge, 1996) present in the cytosol.
Although its actions are usually described as a single step, in reality there are
two steps. ACC contains a biotin prosthetic group, which acts as a carrier of
CO2, which is then transferred to acetyl-CoA, forming malonyl-CoA
(Lehninger, 2000). The biotin prosthetic group must be able to interact with the
biotin carboxylase and the carboxytransferase sites for the enzyme to be active
(Gurr, Harwood & Frayn, 2002). Regulation is by phosphorylation in response
to hormones.
1.4.3.2. Fatty acid synthase (FAS)
Animal fatty acid synthase is a dimeric enzyme, which contains seven catalytic
domains, each of which needs to be active for the enzyme to be completely
active. FAS in mammalian and avian liver has a molecular weight of
approximately 270kDa (Gurr, Harwood & Frayn, 2002). The major product is
palmitic acid, although in mammary gland C4:0-C16:0 can be formed. FAS is
regulated by dietary fat and level of nutrition (Salati & Goodridge, 1996).
1.4.3.3. Stearoyl-CoA desaturase (SCD)
This enzyme complex consists of three proteins: NADH-cytochrome b5
reductase, cytochrome b5 and a desaturase component, all of which are cyanide
sensitive. The complex has a molecular weight of approximately 112kDa
(Cook, 1996). The enzyme catalyses the removal of hydrogen from saturated
fatty acyl chains. SCD always introduces a double bond between carbons 9 and
10, hence its other name, delta-9 desaturase.
Chapter 1: Introduction
16
Figure 1.6 Fatty acid synthesis
Acetate
Cytosol Acetyl-CoA synthetase
Acetyl-CoA
Cytosol Acetyl-CoA carboxylase (ACC)
Malonyl-CoA
Cytosol Fatty acid synthase (FAS)
Palmitic acid (C16:0)
Endoplasmic reticulum Fatty acid elongase
Stearic acid (C18:0)
Endoplasmic reticulum Stearoyl CoA desaturase (SCD)
Oleic acid (C18:1)
From Lehninger (2000)
1.4.4. Lipolysis
Lipolysis is the hydrolysis of triacylglycerol to form three free fatty acids and
glycerol. Studies in non-ruminants show that hormone sensitive lipase acts on
the triacylglycerol to form a diacylglycerol which is further hydrolysed to form
free fatty acids and glycerol (Shapiro, 1977; Vaugham & Steinberg 1965).
Lipolysis in the ruminant is postulated to occur in the same way (Vernon,
1981).
1.4.4.1. Lipoprotein lipase (LPL)
Lipoprotein lipase is a key enzyme in lipolysis of triacylglycerols and acts at
the capillary endothelium of muscle and adipose tissues, on triacylglycerol-rich
lipoproteins. LPL is constituted of 448 amino acids (Fielding & Fielding, 1996)
and is similar to pancreatic lipase. LPL action produces unesterified fatty acids
and glycerol, as a result of the serine hydrolase action of the enzyme. This
results in the uptake of fatty acids into tissues for oxidation (eg. muscle) or re-
esterification (eg. adipose tissue).
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1.4.5. Lipid metabolism in the ruminant
Ruminants consume an inherently low-fat diet (1-2% fat), in contrast to
monogastrics, with lipids being provided in forage crops and supplements or
concentrates made up of crushed cereal grains with oil seeds or their extracts
added (Harfoot and Hazlewood 1988). Ruminant lipid metabolism is different
to that in animals with single stomachs, due to the colonization of the rumen by
micro-organisms. Ruminant diets cannot contain high amounts of fat,
especially unsaturated fatty acids, as these are potent inhibitors of microbial
fatty acid metabolism in the rumen (Jenkins, 1993). Consequently de novo
lipogenesis is very important in the ruminant animal. The action of rumen
micro-organisms on dietary fat is an important part of lipid metabolism. In an
animal consuming pasture, the major fatty acid being supplied to the rumen is
linolenic acid, whereas in an animal consuming a dietary supplement, or a
concentrate diet, quantities of linoleic acid as triglyceride enter the rumen
(Harfoot, 1981). Therefore there are two different pathways by which linoleic
and linolenic acids are hydrogenated.
1.4.5.1. Lipid metabolism in the rumen
Lipids entering the rumen are acted on initially by microbial lipases, which
hydrolyse ester linkages to form free or non-esterified fatty acids. Unsaturated
fatty acids may then be acted on by other rumen bacteria in a process known as
biohydrogenation (Figure 1.7), the product of which is ultimately stearic acid
(C18:0). The initial lipolysis step is essential for isomerisation to occur as a
free carboxyl (COOH) group is required for the isomerase to be active (Kepler
et al, 1970). The final hydrogenation step is rate limiting, and conversion of
trans-11 vaccenic acid to stearic acid can be affected by conditions within the
rumen; excessive amounts of linoleic acid irreversibly inhibit this step (Harfoot
et al 1973), while feed particles and cell-free ruminal fluid stimulate
conversion to stearic acid (Kellens et al, 1986). This final step can be slow
compared to the preceding ones, leading to a build up of 18:1 trans-11 in the
rumen, some of which can pass out into the tissues through the rumen wall,
incompletely biohydrogenated. This has implications for further lipid
metabolism in the tissues and is a route by which unsaturated fat is stored by
the ruminant. In addition to biohydrogenation, the microbes are also able to
carry out de novo fatty acid synthesis, usually forming stearic and palmitic
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acids (Knight et al, 1978). When microbes pass out of the rumen, into the
abomasum or true stomach, the fatty acids contained within them are available
for absorption by the animal. Fermentation processes occurring in the rumen
act on carbohydrates and proteins, and produce short chain or volatile fatty
acids, with fatty acid chains between two and five carbons in length. The three
major ones are butyric, propionic and acetic acids. These can pass through the
rumen wall and supply the ruminant animal with a considerable proportion of
the total energy available. Of these, acetic acid is the most abundant, although
the production of individual acids can be changed by feeding different diets
and altering fermentation patterns in the rumen. The ruminant therefore uses
acetic acid as acetate for the precursor for de novo lipogenesis, not glucose.
Much of the glucose produced from breakdown of dietary carbohydrate is used
by the rumen micro-organisms and is not available to the animal, hence the low
contribution of glucose to lipogenesis. The hydrogenation of most of the fatty
acids fed and the limitations in the amount of fat that can be fed means that
changing carcass fat is extremely difficult in the ruminant animal.
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Figure 1.7 Biohydrogenation of lipids in the rumen
Linoleic acid D-linolenic acid
cis-9, cis-12 C18:2 cis-9, cis-12, cis-15 C18:3
isomerisation
Conjugated linoleic acid cis-9, trans-11, cis-15
cis-9, trans-11 C18:2 C18:3
hydrogenation
trans-11, cis-15-octadecadienoic acid
C18:2
hydrogenation
Vaccenic acid
trans-11 C18:1
hydrogenation
Stearic acid
C18:0
Source: Adapted from Christie (1981)
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1.4.5.2. Post-ruminal lipid metabolism
Passage of digesta through the omasum and abomasum in the ruminant is swift
due to its uniform consistency after ruminal digestion. The composition of
digesta does not change appreciably, but micro-organisms passing through are
subjected to acid digestion and are broken down to release their fatty acids for
absorption by the small intestine. Although most of the fatty acids in the small
intestine of the ruminant are present in the non-esterified form, they are still
associated with particles of feed and must be separated before absorption can
take place. This is done by pancreatic and biliary secretions which form
micelles in a similar way to that in monogastric animals. Studies have shown
that in animals where bile production is limited, fatty acid absorption from the
small intestine fell to 17% of the amount seen in the normal animal (Heath &
Hill, 1969). Bile addition helps to transfer unesterified fatty acids into solution
(Polonovski & Bourrillon, 1952) to be absorbed and therefore it is hardly
surprising that in the absence of bile there is reduced fatty acid absorption.
Fatty acids entering the duodenum as unhydrolysed triglycerides, such as those
protected against rumen degradation are acted upon by pancreatic lipases and
broken down to form non-esterified fatty acids and glycerol and then absorbed
through mucosal cells. The main fatty acid available for absorption is stearic
acid, much of which is converted to oleic acid by desaturases prior to
resynthesis of triglycerides for storage or use in other parts of the body.
1.4.5.3. Triacylglycerol synthesis
95% of the fatty acids synthesised by the pathway described above are
esterified; however this does not mean that they are incorporated into
triacylglycerol stores, because there is a certain amount of lipolysis occurring,
liberating glycerol and free fatty acids. The glycerol-3-phosphate pathway is
assumed to be the route by which triacylglycerol is synthesised in ruminant
adipose tissue (Vernon, 1981), but this requires glucose from the blood, as
adipose tissue has virtually no glycerol kinase activity, ruling out the use of
glycerol liberated by lipolysis (Vernon, 1980). Triacylglycerols are supplied to
adipose tissue via the blood, contained in the centre of large lipoproteins called
chylomicrons. On arrival at the adipose tissue, the enzyme lipoprotein lipase
(LPL) is secreted by the adipocytes and attached to the cell membrane of
endothelial capillary cells where it catalyses the hydrolysis of triacyglcerols
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subsequent to their re-esterification within adipocytes (Vernon, 1992,
Lehninger, 2000). Studies suggest that dietary fatty acids are more readily
incorporated into adipose tissue (Vernon, 1992), and this is supported by a
reduction in the contribution of fatty acids synthesised de novo to esterification
and storage in the adipose tissue of cows when exogenous fatty acids were
added (Baldwin et al, 1973).
1.4.6. Transcription factors and receptors involved in lipid
metabolism
In recent years a number of transcription factors have been identified and
studied. Transcription factors are regulatory proteins which bind to DNA
(Lehninger, 2000), and activate transcription, the production of RNA from
DNA. To synthesise the proteins which make up the various enzymes involved
in lipid metabolism, an RNA template is needed, therefore the process of
transcription is the first response to a signal for increased fatty acid synthesis or
lipolysis for example. In addition to transcription factors, specific receptors are
also capable of activating gene expression and work in conjunction with certain
transcription factors. Two such systems which play an important role in lipid
metabolism are described here.
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1.4.6.1.1. Sterol regulatory element-binding proteins (SREBPs)
Sterol regulatory element-binding proteins (SREBPs) are synthesised as
precursors bound to the membrane of the endoplasmic reticulum. The protein
forms a loop, with both amino and carboxyl ends protruding into the cytoplasm
(Osborne, 2000). There are 3 forms of SREBP: 1a, 1c and 2. The latter is
activated in response to a drop in cellular cholesterol (Latchman, 1998) and
controls cholesterol biosynthesis, but SREBP 1a and 1c regulate fatty acid
metabolism (Gurr, Harwood & Frayn, 2002). The precursor is cleaved and the
active form of the protein enters the nucleus and binds to the sterol regulatory
element. This is present in all of the genes which SREBP controls and activates
the expression of cholesterol biosynthetic genes (Figure 1.8). SREBP-1c is
activated in response to high insulin levels (Gurr, Harwood & Frayn, 2002),
which are known to increase fatty acid synthesis. Increased SREBP-1c
activation then increases gene transcription in the nucleus of enzymes involved
in fatty acid synthesis. Table 1.3 shows some of the genes which SREBPs
affect. Clearly SREBPs are key regulators of lipid metabolism, and substances
that have been postulated to have a direct effect on certain genes (eg. insulin on
ACC) may be acting through SREBP. The SREBPs are a major control point in
the system and manipulation of their activation status has the potential to
change many different factors in the lipid metabolism pathway, with far
reaching effects on the biological system.
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Figure 1.8 Activation of SREBP
Source: Latchman (1998)
When cholesterol is present in the cell, the SREBP transcription factor remains anchored in the
endoplasmic reticulum membrane and is prevented from passing into the nucleus. When levels
of cellular cholesterol drop, the SREBP precursor is cleaved. This releases the active form of
the protein which enters the nucleus and activates transcription of genes involved in cholesterol
biosynthesis such as ACC and FAS.
With cholesterol
(normal state)
Drop in cholesterol
concentration
ER
Cytoplasm
NucleusSREBP
ER
Cytoplasm
NucleusSREBP
Gene
transcription
Table 1.3 Genes affected by activation of SREBPs
Gene Controlling isoform Function Reference
Acetyl-CoA carboxylase 1c De novo fatty acid synthesis
Fatty acid synthase 1c De novo fatty acid synthesis
Lipoprotein lipase 1c Import of lipoprotein-triacylglycerol fatty acids
Stearoyl-CoA desaturase 1c Synthesis of oleate
Kim & Spiegelman, 1996; Lopez et
al, 1996; Magana & Osborne, 1996;
Shimano et al, 1996; Tontonoz et al,
1993
Glycerol 3-phosphate acyltransferase 1c Triacylglycerol and phospholipid synthesis Sul & Wang, 1998
HMG-CoA synthase 2 De novo cholesterol synthesis Goldstein & Brown, 1990
PPAR-J 1c Induction of adipocyte differentiation Kliewer et al, 1995
Squalene synthase 2 De novo cholesterol synthesis Guan et al, 1996
LDL receptor 2 Import of LDL particles Hussain et al, 1999
HMG-CoA reductase 2 Inhibition of cholesterol biosynthesis Brown & Goldstein, 1986; Sabine, 1983
Adapted from Gurr et al, 2002
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1.4.6.1.2. Peroxisome proliferator-activated receptors (PPARs)
PPARs are nuclear hormone receptors responsible for the regulation of fatty
acid metabolism (Kersten, 2001). There are three different isoforms: D, E (G)
and J. PPARD is mainly expressed in the liver, while PPARJ is primarily
present in adipose tissue (Gurr, Harwood & Frayn, 2002). PPARJ has an
important role in adipogenesis, which is the differentiation of pre-adipocytes
into mature adipocytes, and the sensitivity of tissues to insulin (Auwerx, 1999).
Expression of PPARJ is increased by high levels of fat and reduced by either
fasting or low levels of fat (Vidal-Puig et al, 1996). Insulin also causes
increased gene expression of PPARJ (Rieusset et al, 1999). Fatty acid
derivatives are ligands for PPARs, and PPARs interact with peroxisome
proliferator response elements, which are present in the sequences of genes
involved in lipid metabolism (Gurr, Harwood & Frayn, 2002). This activation
of PPARJ results in increased adipogenesis and fatty acid storage. PPARD
increases high density lipoprotein production and fatty acid oxidation in the
liver, which provides glycerol 3-phosphate for triacylglycerol synthesis, so the
two isoforms work co-ordinately (Figure 1.9). There is evidence that SREBP-
1c, expressed in adipocytes causes increased fatty acid synthesis, increasing
concentrations of ligands for PPARJ (Auwerx, 1999). The most potent ligands
for PPARJ are eicosanoids and unsaturated fatty acids (Kliewer et al, 1997;
Krey et al, 1997); fatty acids that have been shown to bind are linolenic (18:3),
eicosapentaenoic (20:5) and docosahexaenoic (22:6). Any factor which has an
effect on fatty acid availability will affect the PPARs and therefore the actions
that they have.
S
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Figure 1.9 Actions of PPARs D and J in liver and adipose tissue
fat oxidation
LIVER
PPARD activation
Dietary fatty acids
PPARJ activation
ADIPOSE TISSUE adipocyte differentiation
fat storage
Source: Gurr, Harwood & Frayn (2002)
1.4.7. Regulation of lipid metabolism
There are a number of factors regulating lipid metabolism in animals, and as
such these can all be manipulated to have different effects on metabolism. The
substrates for lipogenesis, namely glucose and acetate, have stimulatory effects
on fatty acid synthesis and esterification, while growth hormone has inhibitory
effects on fatty acid synthesis and stimulatory effects on lipolysis (Vernon,
1982). Insulin has stimulatory effects on fatty acid synthesis but inhibits
lipolysis, and on the other hand glucagon has the opposite effects to insulin.
Dexamethasone, a synthetic glucocorticoid has an inhibitory effect on fatty
acid synthesis (Faulconnier et al, 1994; Vernon et al, 1991). Fatty acids, whose
effects on lipid metabolism are the subject of this thesis, have inhibitory effects
on both fatty acid synthesis and lipolysis, but stimulate esterification (Vernon,
1981).
1.4.7.1. Hormonal regulation - Insulin and glucocorticoids
A body system can be in a state of anabolism or catabolism. In the former, the
effects of the hormone insulin are manifested, while in the latter the
glucocorticoids (eg. glucagon) and the catacholamines (eg. adrenaline) are in
control. It has been demonstrated by a number of researchers that insulin
increases lipogenesis in ruminant and non-ruminant animals. Vernon (1979)
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showed that ovine adipose tissue was metabolically active for 3 days in culture
and that including insulin in the culture medium resulted in an increase in the
rate of fatty acid synthesis as measured by [1-
14
C] acetate incorporation. [U-
14
C] glucose incorporation was also measured, but rates of fatty acid synthesis
from this were much lower than from acetate and representative of lipogenesis
in the ruminant, where 95% of the carbon for fatty acid synthesis is derived
from acetate (Smith & Prior, 1986, Vernon, 1979). Faulconnier et al (1997)
investigated the effects of insulin and dexamethasone (a synthetic
glucocorticoid) on lactate production by bovine and ovine adipose tissue. The
major products of glucose metabolism are carbon dioxide and lactate, and
although acetate is the predominant source of carbon for fatty acid synthesis,
ruminant adipose tissue uses glucose to produce NADPH via the pentose
phosphate pathway, which then is involved in the production of ribose-5-
phosphate for nucleic acid synthesis. Faulconnier et al (1997) showed that
insulin increased the ratio of lactate production to glucose utilization,
dexamethasone reduced it and that dexamethasone when added to insulin
supplemented media could not reduce this ratio. Chilliard & Faulconnier
(1995) studied the effects on acetate and glucose utilization of insulin and/or
dexamethasone treatment on ovine and bovine adipose tissue explants cultured
for seven days. This study showed differences between ovine and bovine
tissue, but the stimulatory effects of insulin, both with and without
dexamethasone were still present in both species, and the inhibitory effects of
dexamethasone were evident. Again, the acetate utilization was greater than
that of glucose, consistent with the former being the major carbon source for
ruminant lipogenesis (Smith & Prior, 1986, Vernon, 1979). Vernon et al (1991)
cultured ovine adipose tissue for 48 hours with insulin and dexamethasone and
showed that insulin increased the rate of fatty acid synthesis and
dexamethasone decreased it. Additionally, and as shown in the current results,
insulin and dexamethasone acted together to increase fatty acid synthetic rate.
Miller et al (1991) showed that insulin significantly increased lipogenesis in
bovine adipose tissue explants treated with insulin both short term (2h) and
long term (48h). Tissue was still capable of responding to insulin treatment
after 48h, but levels of acetate relative to total lipid were reduced compared to
explants cultured for 2h. This has been demonstrated previously (Miller et al,
1989; Etherton & Evock, 1986). The effect of insulin on lipogenesis is not
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confined to ruminant animals; Walton and Etherton (1986) demonstrated an
increase in glucose incorporated into porcine adipose tissue maintained in
culture with insulin, compared to controls. Glucagon and the catacholamines,
namely adrenaline, reduce lipogenesis and stimulate lipolysis, while insulin
reduces lipolysis and stimulates lipogenesis. Insulin is produced by the
pancreas in response to an increase in blood glucose levels and stimulates
lipogenesis and inhibits lipolysis. Glucagon is produced by the pancreas in
response to a decrease in blood glucose levels and stimulates lipolysis and
inhibits lipogenesis. Adrenaline, produced by the adrenal gland, also acts on
the liver to promote glycogen breakdown and increase blood glucose levels
(Frayn, 2003).
1.4.7.2. Dietary fat
Fatty acids have been shown to have effects on lipid metabolism. High fat diets
inhibit lipogenesis in both liver and adipose tissue (Herzberg, 1983) and long
term feeding of polyunsaturated fatty acids (PUFAs) suppresses hepatic
lipogenic enzyme synthesis (Shillabeer et al, 1990). Lipogenesis is the
synthesis of fatty acids from precursors, so any increase in these precursors
will translate into an increase in lipogenesis. When high carbohydrate diets are
fed, animals show increased lipogenesis. When levels of fat in the diet are
reduced, as seen in ruminants and other animals consuming a low fat diet, TAG
must be synthesised from other dietary components. Treatment of cultured rat
hepatocytes with PUFAs in response to treatment with insulin, dexamethasone
and triiodothyronine (T3) caused a reduction in ACC and FAS mRNA levels
(Fukuda et al, 1992; Armstrong et al, 1991). It has since been shown that the
inhibitory effect on lipogenic enzyme synthesis seems to be specific to liver
(Girard et al, 1994), with no changes in FAS mRNA levels in adipose tissue of
rats fed high levels of polyunsaturated fat (Shillabeer et al 1990) or in cultured
rat adipocytes treated with linoleate and stimulated with insulin and
dexamethasone (Girard et al, 1994). There is no effect of saturated or
monounsaturated fatty acids on lipogenic enzymes in liver or adipose tissue
(Ntambi, 2001; Shillabeer, 1990). The length of time that diets are fed for can
have marked effects. Short term feeding or treatment of cells (48h to 2 weeks)
results in small changes in lipogenic enzyme activity, but over time could have
significant influence on the type of fatty acids and composition of fat stored in
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adipose tissue (Shillabeer et al, 1990). Feeding saturated fatty acids over an
extended period of time (12-18 months) does not reduce lipogenesis as
effectively as a PUFA diet (Dupont et al, 1978), indicating that PUFAs are able
to interact with the processes of lipid metabolism. PUFAs reduce hepatic
lipogenesis by suppressing lipogenic genes expressed in liver; ACC, FAS and
SCD (Xu et al, 1999; Jump et al, 1994), and stimulating fatty acid oxidation
(Clarke, 2001). However the latter pathway is not as sensitive to PUFA
regulation, so PUFAs seem to have their effects largely on lipid synthesis
(Clarke, 2001). The key features that fatty acids seem to need to possess are a
chain containing at least 18 carbons, and at least two double bonds in the 9 and
12 positions (Clarke & Jump, 1993). PUFA directly increase the amount of
peroxisome proliferator-activated receptor D (PPARD), by acting as ligands
(Clarke, 2001). Up-regulation of this receptor induces transcription of genes
involved in fatty acid oxidation (Xu et al, 1999), one of which is responsible
for the production of malonyl-CoA. The drop in malonyl-CoA concentration
results in increased fatty acid entry into the mitochondria and peroxisomes
which leads to increased fatty acid oxidation (Zammit, 1999). n-3 PUFAs are
more potent than n-6, but metabolites of PUFAs are the most potent (Clarke,
2001). As previously mentioned, high levels of PUFAs are the most effective at
suppressing fatty acid synthesis and stimulating fatty acid oxidation, but
studies in porcine stromal-vascular adipocytes indicated that high levels of
fatty acids (>100PM) may have a cytotoxic effect, with many cells treated with
long chain PUFAs being lost from the plates (Ding & Mersmann, 2001). The
researchers put forward several possible explanations for this: 1) PUFA may be
more effective detergents and cause a loss of cell integrity; 2) Large amounts
of certain PUFAs may be incorporated into cell membranes, changing function
and attachment to the plate; 3) Oxidation products of PUFA may have adverse
effects on the cells; 4) A metabolite of the PUFA; possibly an eicosanoid may
be the trigger for cell loss; 5) Apoptosis may be stimulated (Ding & Mersmann,
2001). In support of this it has been noted that PUFA metabolites, eicosanoids
and oxidised fatty acids are more potent transcriptional activators than PUFAs
(Clarke, 2001). Clearly the feeding of PUFAs will result in greater absorption
from the digestive tract, resulting in higher plasma non-esterified fatty acid
(NEFA) levels. This results in an increase in the activity of LPL (Peterson et al,
1990), which is able to bind the fatty acids, but in doing so, its affinity for lipid
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droplets is reduced (Posner & DeSanctis 1987; Bengtsson & Olivecrona,
1980). Albumin can reverse this, by binding to the fatty acids (Bengtsson-
Olivecrona & Olivecrona, 1987; Posner & DeSanctis 1987; Bengtsson &
Olivecrona, 1980; Scow & Olivecrona, 1977). In contrast to the PUFAs, oleic
acid has been shown to have a stimulatory effect on LPL during the
differentiation of porcine adipocytes in culture. Expression levels of LPL are
indicative of the lipogenic condition of the cell (Ding & Mersmann, 2001). As
concentrations of oleic acid increased, LPL mRNA levels rose, as did
differentiation of the cells. There is a peroxisome proliferator-response element
(PPRE) in the promoter area of the LPL gene, and this in conjunction with the
concomitant rise in PPARJ mRNA suggests that the effects of oleic acid on
LPL mRNA concentrations are mediated through PPARJ (Ding & Mersmann,
2001). The effect of oleic acid was acute (mRNA level increases seen at 1-5d
and no change thereafter), suggesting that the fatty acid affects transcription,
rather than acting through membrane compositional change. SCD mRNA
levels also increase during the differentiation of 3T3-L1 preadipoctyes
(Ntambi, 1995), and it is likely that PPARJ is involved. Inhibition of hepatic
SCD1 by 50, 55 and 95% respectively was seen in rats fed trilinolein,
trilinolenin and triarachidonin, compared with fat free controls (Ntambi, 1992).
PUFAs with longer chain lengths seem to be most potent. There was no
difference in SCD1 mRNA levels between rats fed saturated and
monounsaturated fat. This was demonstrated in adipose tissue of rats fed
linoleic acid, where a 75% decrease in SCD1 mRNA levels was seen (Jones et
al, 1996). SCD1 mRNA levels decreased dose-dependently, and were
accompanied by reduced levels of palmitoleic acid, the product of SCD1
activity. A reduction in SCD1 activity was also seen in the liver of rats fed
linoleic acid (Jeffcoat & James, 1978), providing a further mechanism for fatty
acid effects. Ntambi (1992) observed that PUFAs act at the level of gene
transcription to reduce induction of hepatic SCD1. It remains to be seen
whether this is true for adipose tissue as well, or if there are effects on enzyme
activity rather than transcription. Studies in 3T3-L1 pre-adipocytes treated with
arachidonic acid showed a dose dependent inhibitory effect on both SCD
enzyme activity and mRNA levels (Sessler et al, 1996) Treatment with linoleic
and linolenic acid also reduced SCD1 mRNA levels but stearic and oleic acids
had no effect. By comparing enzyme activity with mRNA levels, Sessler et al
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(1996) suggested that the fatty acids were affecting mRNA stability as the
reductions in the activity and mRNA were not equal. Transcriptional run-on
assays confirmed that the mRNA half-life was reduced. The discovery of
SREBPs and their effects on many of the genes involved in lipid metabolism
allowed the effects of fatty acids to be seen from a different perspective. A
number of studies have shown that suppression of the SREBP-1 gene is
accompanied by low expression of lipogenic genes (Xu et al, 1999; Yahagi et
al, 1999), and that SREBP mRNA levels are suppressed by PUFAs, but not
saturated fatty acids (SFAs) or monounsaturated fatty acids (MUFAs) (Xu et
al, 1999; Yahagi et al, 1999). Evidence for the action of SREBP as a “master
switch” for lipogenic genes came from the study of FAS, which was shown to
contain DNA binding sites for SREBP-1 (Magana & Osborne, 1996). It has
been suggested that the effects of PUFAs on SREBP and subsequently
lipogenic genes is mediated by an impairment of the proteolytic release of
SREBP (see Section 1.4.6.1.1.) by inhibition of transcription factors involved
in insulinemic and carbohydrate control of lipogenesis, thereby reducing the
nuclear content of mature SREBP (Xu et al, 1999). This would result in an
increased rate of SREBP mRNA degradation as seen in SCD (Sessler et al,
1996) and ACC (Katsurada et al, 1990) which would result in a lowering of
precursor SREBP anchored in the endoplasmic reticulum. However, there are
links between PPARs and SREBP. Activation of SREBP-1c results in
increased FAS mRNA in adipose tissue, leading to increased fatty acid
synthesis and generation of ligands for PPARJ (Gurr, Harwood & Frayn,
2002). However, it is clear that the existence of PPARs and SREBPs cannot
explain all the effects of fatty acids on lipid metabolism, as PPARD-/- mice fed
PUFAs still showed reduced mRNA levels for lipogenic enzymes, so clearly
PUFAs can have their effects either through a different transcription factor or
directly on the genes themselves.
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1.5. CONJUGATED LINOLEIC ACID
Conjugated linoleic acid is a collective term for a number of positional and
geometric isomers of linoleic acid, an 18 carbon fatty acid with two double
bonds. They are referred to as conjugated because the double bonds are
separated by 2 carbon atoms between which is a single bond. The two most
abundant isomers are cis-9, trans-11 and trans-10, cis-12 CLA (Figure 1.10).
These are positional isomers, because the double bonds are between different
carbon atoms in each isomer. Double bonds are also possible between different
carbons in the fatty acid chain; cis-cis, trans-trans, cis-trans and trans-cis
combinations for double bonds at C7, 8, 9, 10, 11, 12, 13 have been reported
(Lavillonniere et al, 1998; Sehat et al, 1998; Yurawecz et al, 1998; Parodi,
1977). The conjugated double bond structure is thought to be responsible for
the many biological effects of CLA that have been reported.
Figure 1.10 Structures of the two major isomers of CLA and linoleic acid
trans-10, cis-12 CLA
cis-9, trans-11 CLA
cis-9, cis-12 LA
Source: Steinhart (1996)
Chapter 1: Introduction
33
1.6. PRODUCTION OF CLA
1.6.1. Ruminal CLA production
In ruminants, there are two methods by which CLA can be synthesised. The
first is by biohydrogenation of dietary linoleic acid by rumen bacteria. The
initial step is isomerisation (Section 1.4.5.1) by linoleate isomerase to form cis-
9, trans-11 CLA. This is then converted to trans-11 18:1. The latter happens
very quickly, so consequently concentrations of cis-9, trans-11 CLA do not
build up in the rumen (Kellens et al, 1986). A study comparing levels of CLA
in meat from ruminants and non-ruminants (Chin et al, 1992) found that levels
of CLA were higher in the former, and that the major isomer present was cis-9,
trans-11 Chin et al (1992) concluded that since linoleate isomerase produces
cis-9, trans-11 CLA, rumen microbial activity must be the source of this
isomer. The accumulation of CLA in the tissues due to incomplete
biohydrogenation of CLA was also reported by Kelly et al (1998). But it
became clear that the presence of CLA in the tissues could not be explained by
this mechanism of CLA production alone. There was a shortfall between
amounts of CLA produced in the rumen and measured in the tissue, and it was
clear that there was something else producing the CLA in the tissues (Griinari
& Bauman, 1999). Although trans-11 18:1 can pass out of the rumen and be
absorbed in the gastrointestinal tract, because CLA is so quickly hydrogenated,
little is available for absorption in the gastrointestinal tract and therefore CLA
produced in this way is not the only contributor to tissue concentrations of
CLA.
1.6.2. Endogenous CLA production
The discrepancy between amounts of ruminally produced CLA and tissue
concentrations led to a number of suggestions for the presence of CLA in
ruminant tissues. It was known that cultured rat hepatocytes were capable of
desaturating trans-11 18:1 to cis-9, trans-11 CLA (Mahfouz et al, 1980) and
this led to hypotheses that this was happening in ruminant tissue (Griinari et al,
1997). This seemed more likely, after the discovery that the desaturase enzyme
SCD was present in mammary gland (Kinsella, 1972) combined with the fact
that desaturation occurs readily in adipose tissue, with preference given to fatty
acids synthesised de novo (Pothoven et al, 1974). As mentioned in Section
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1.4.3, SCD acts on palmitic and stearic acids to form C16:1 and trans-11 C18:1
respectively, but Griinari et al (2000) demonstrated that it was also able to
form cis-9, trans-11 CLA from trans-11 18:1 (Figure 1.11). An experiment
inhibiting SCD in tissues by abomasal infusion of sterculic oil demonstrated
that as levels of trans-11 18:1 reduced, there was a concomitant reduction in
tissue CLA concentrations (Griinari, 2000). A number of other studies have
also demonstrated a close relationship between CLA and trans-11 18:1, and
that this is applicable over a large range of trans-11 18:1 concentrations
(Griinari & Bauman, 1999).
Figure 1.11 CLA biosynthesis in ruminants
cis-9, cis-12 18:2 cis-9, cis-12 18:2
(linoleic acid) (linoleic acid)
cis-9, trans-11 18:2 cis-9, trans-11 18:2
(CLA) (CLA)
trans-11 18:1 trans-11 18:1
(vaccenic acid) (vaccenic acid)
C18:0 C18:0 cis-9 C18:1
(stearic acid) (stearic acid) (oleic acid)
RUMEN TISSUES
Adapted from Griinari & Bauman (1999)
However, there is another major isomer of CLA to consider, which is also
found in the milk and tissues of ruminants and other animals. The trans-10, cis-
12 isomer has been identified in cow milk (Griinari & Bauman, 1999), and
feeding a low fibre diet resulted in the trans-10 isomer being the most
abundant in milk fat (Griinari, 1998). There is no evidence to suggest that
mammals possess a delta-12 desaturase (Pariza et al, 2001), to act on trans-10
18:1 and convert it to trans-10, cis-12 by the insertion of a double bond at
position 12 in the fatty acid chain. This would suggest that its origins are in the
rumen, and formation by biohydrogenation, followed by absorption from the
gastrointestinal tract, however this merits further research to fully elucidate the
mechanism by which trans-10, cis-12 CLA is incorporated into the tissues.
SCD
SCD
Chapter 1: Introduction
35
1.6.3. Desaturase indices
Fatty acid composition of tissues provides an indication of enzyme activity.
The '9 desaturase index provides an estimate of SCD enzyme activity (Corl et
al, 2001), and examines the ratio of the substrate for SCD and product of SCD
action. The ratio can be calculated as: C18:1 cis-9 / C18:0 or C16:1 cis-9 /
C16:0. Although these fatty acids are found in the tissues normally, changes in
the indices are a sign of changes in SCD enzyme activity.
1.7. EFFECTS OF CLA
1.7.1. CLA as an anti-carcinogen
Ha et al (1987) first isolated CLA from grilled minced beef. It was of particular
interest at that time because it was found to inhibit carcinogenesis. Ip et al
(1991) showed that dietary CLA fed at 0.5, 1 and 1.5% could prevent
mammary carcinogenesis in rats exposed to 7,12-dimethylbenz(a)anthracene at
50d of age. This anti-carcinogenic effect was dose dependent, but feeding
greater than 1% CLA did not further reduce tumour incidence appreciably.
Subsequent studies have determined that the anti-carcinogenic effects of CLA
are seen at 0.1%, indicating high potency. The majority of studies examining
carcinogenesis in response to CLA treatment have been done using mammary
tumour models, but effects have been seen in 5 different tissues and in several
strains of both mice and rats (Scimeca, 1999). A further dose-response study
showed conclusively that CLA is effective at low concentrations in the diet,
with chronic feeding of CLA at levels of 0.05-0.5% in the diet dose
dependently inhibiting rat mammary tumours induced by 7,12
dimethylbenz(a)anthracene (Ip et al, 1994) Chronic feeding is more effective
than acute feeding, as rats fed for 4 weeks subsequent to carcinogen treatment
with 1% CLA showed no reduction in tumour incidence. CLA feeding for 8
and 20 weeks delayed appearance of tumours by 2-3 weeks and significantly
reduced tumour appearance respectively (Ip et al, 1997). It is possible that
there may be a concentration which must be attained before CLA is effective in
preventing development of cancerous cells, supported by the emergence of
evidence that for CLA to be effective in blocking malignant tumours it must be
present in the organ affected. CLA is primarily incorporated into
triacylglycerols, which are neutral lipids (Banni et al, 2001) and a major
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constituent of the mammary gland. This explains the high level of
incorporation of CLA seen in mammary gland in response to CLA feeding
(Corl et al, 2003; Ip et al, 1997). Clearly the conjugated diene structure of CLA
is important in the mechanism of effect in carcinogenesis, as linoleic acid-
supplemented diets have been shown to increase tumours when compared to
those supplemented with CLA (Cesano et al, 1998) and when high levels of
linoleic acid were fed to female Sprague-Dawley rats during growth of
mammary tissue they developed significantly more tumours than rats fed low
levels (Lu et al, 1995). The differentiation and maturation period for the
mammary gland appears to be a critical point in the process of carcinogenesis.
Ip et al (1994) suggested that changes in gland development and
morphogenesis could be a mechanism by which CLA exerts its effects. This is
supported by work done on rat mammary epithelial cells in primary culture
where cells were treated with a mixture of CLA isomers (Ip et al, 1999). Cells
treated with CLA at increasing concentrations showed a dose-dependent
reduced growth of mammary epithelial cell organoids (MEO), with 32ȝM
inhibiting growth by 50%. An equi-molar concentration of linoleic acid had no
effect, indicating that the conjugated diene structure of CLA has distinct
biological effects. There is evidence of maintenance of this structure through in
vivo elongation and desaturation of CLA; Banni et al (1995) detected
conjugated dienes (CD) C18:3 and C20:3 in the livers of rats fed 0.04% CLA
for 1 week. CD 20:4 may compete with arachidonic acid for cyclooxygenase
(COX) and lipooxygenase (LOX), which control the synthesis of eicosanoids,
including prostaglandins, thromboxanes and leukotrienes. In adipose tissue, it
is conceivable that CLA or a metabolite of CLA may be released from the
triacylglycerol pool contained in the adipocyte (Ip et al, 1997) and change
eicosanoid synthesis in a similar way. It is possible that CLA may through the
actions of its metabolites, indirectly modulate this process. It is clear that CLA
feeding during maturation of mammary gland is most effective in reducing
carcinogenesis. CLA was shown to inhibit DNA synthesis in cultured
mammary epithelial cells when culture proliferation rate was high (Ip et al,
1999). There was also evidence that CLA induced apoptosis in differentiated
mammary cell organoid cell cultures. It appears that CLA has a direct effect
prior to initiation on development by limiting growth and proliferation of
normal mammary epithelium, and that it does this by reducing DNA synthesis
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and triggering apoptosis of mammary epithelial organoids (Ip et al, 1999; Ip et
al, 1994). Another suggestion is that CLA could activate peroxisome
proliferator activated receptors (PPARs) which are capable of altering
epithelial growth either directly or indirectly (Houseknecht et al, 1998).
Dietary CLA has been shown to be incorporated into mammary gland neutral
lipids, with levels increasing while CLA feeding is occurring. Upon withdrawal
of CLA a rapid reduction (return to basal levels in 4 weeks) in tissue CLA was
seen and this correlated extremely well with tumour incidence (Ip et al, 1997),
suggesting that the presence of CLA is needed to prevent tumour appearance.
CLA incorporation into the phospholipids of mammary gland was noted to be
much lower (0.5% of total fatty acids) than that of neutral lipids (3% of total
fatty acids) and take much longer for withdrawal to have an effect. This reflects
the resistance to compositional change in phospholipids, which are a major
constituent of biological membranes (Ip et al, 1997). The observation that CLA
is incorporated into phospholipids provides another possible mechanism for
action of CLA. Any change in fatty acid composition will affect membrane
fluidity and as such, will affect receptor activation, and affinities of factors for
their respective receptors (Ip et al, 1999). As explained previously, CLA is a
mixture of many different isomers, and there is evidence that they may have
different effects due to their different shapes (Figure 1.10). Until recently,
synthesis and isolation of pure isomers was extremely difficult, so effects seen
with the mixtures of CLA used in experiments could not be attributed to one
isomer, however this is now not the case and it has been possible to show that
the cis-9, trans-11 isomer is responsible for the anti-carcinogenic effects. This
is demonstrated in rats with chemically induced mammary tumours fed a
sunflower oil (LA rich) diet, a CLA mix or purified cis-9, trans-11 CLA. The
two CLA treatments reduced tumour incidence by 44 and 45% respectively,
when compared to sunflower oil (Lavilloniere et al, 2003), but it is of note that
other studies have shown that linoleic acid promotes tumour development (Ip
et al, 1997), so inhibitory effects of CLA on tumour development may have
been exaggerated when expressed relative to linoleic acid. The formation of
cis-9, trans-11 CLA from C18:1 trans-11 by SCD in the tissues is well
documented (Section 1.6), and as such, a number of studies have examined the
effects of feeding other fatty acids on tissue CLA concentration and tumour
incidence. Rats fed 1, 2 and 3% vaccenic acid showed proportionately
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increased concentrations of CLA and its metabolites in liver and mammary
gland up to 2%, after which levels remained constant (Banni et al, 2001).
Levels of CLA in mammary gland with 2% vaccenic acid feeding were
equivalent to those which had been previously shown to inhibit tumour
incidence. A second linked study fed 2% vaccenic acid to rats treated with
carcinogens, and demonstrated that there was a correlation between vaccenic
acid feeding and the number of pre-malignant mammary lesions. This strongly
suggests that vaccenic acid feeding could be used as an anticancer drug, and
has its effects by being the precursor for cis-9, trans-11 CLA synthesis
endogenously by SCD. A similar study examined the additive effects of
feeding both vaccenic acid and cis-9, trans-11 CLA in rats with chemically
induced mammary carcinomas. There was an additive effect of CLA and
vaccenic acid on reduction of tumours, as well as a dose response effect of both
fatty acids. The effect of CLA was not as significant as that of vaccenic acid,
due to concentrations of the former being at the low end of the dose response
curve (Corl et al, 2003). Feeding vaccenic acid and CLA gives a further
inhibitory effect on tumour incidence due to the action of SCD. Clearly there
are a number of ways by which CLA and its associated metabolites and
precursors could be utilised to treat cancer. In conclusion, CLA is a potent anti-
carcinogen, efficacious at dietary concentrations close to those consumed by
humans (Ip et al, 1994). In addition, although it seems that trans-10, cis-12
CLA may cause hyperinsulinemia and insulin resistance (Roche et al, 2002;
Clement et al, 2002), there have been no such serious effects seen in animals
fed cis-9, trans-11 CLA. Dietary manipulation seems to be the most economic
way to deliver the favourable effects of CLA through vaccenic acid/CLA cis-9,
trans-11 and there is no doubt that endogenous production of cis-9, trans-11
CLA by SCD is an important route for treatment and prevention of cancer.
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1.7.2. Effects on fat and lean repartitioning
The first evidence for an effect of CLA on body composition was shown in
mice (Park et al, 1997), where body fat mass in male and female mice fed 0.5%
mixed isomer CLA was reduced by 57 and 60% respectively. In addition to
this, lean mass was significantly elevated, by 5 and 14% in male and female
mice respectively. Further studies in mice (West et al, 1998) showed a
reduction in fat pad weights and body weight in mice fed high and low fat
diets, both with and without CLA. This effect was also shown in other rodents;
in rats fed 3% CLA and subjected to a diet that increased fat store mobilization,
body fat reduced and body protein increased compared to rats fed sunflower oil
(Stangl, 2000), and in sheep fed CLA prior to weaning body lipid was reduced
(Mir et al, 2000). The increase in mRNA for uncoupling proteins (UCP) 2 and
3 during starvation, which parallels increased fat breakdown, may be the mode
of action for CLA repartitioning in this case. Similarly, rats fed 2% CLA
showed reduced TAG content in white adipose tissue (Yamasaki et al, 1999)
suggesting that CLA may inhibit lipid filling of adipocytes. It is of note that the
reduction in fat pad weight occurred despite an increase in food intake in rats
fed CLA compared to controls. This is indicative of a specific effect on lipid
metabolism, and may be due to an increase in energy expenditure. Increased
levels of UCP-2 mRNA were seen in adipose tissue from mice fed CLA
(Tsuboyama-Kasaoka et al, 2000), and this may have resulted in apoptosis of
adipocytes due to decreased efficiency of ATP synthesis due to metabolic
uncoupling. From the rodent studies that have been done, it is evident that mice
respond much more dramatically to CLA feeding than rats in terms of fat
reduction; in rats fed 0.5% CLA the reduction in fat pad weight was 15-25%, in
mice it was 50-80% (Yamasaki et al, 1999). Some studies have shown a
reduction in food intake (West et al, 1998), which seems consistent with
reduced body fat mass; however this cannot be entirely responsible, because an
increase in energy expenditure was also seen (West et al, 1998; Park et al,
1997) measured by changes in metabolic rate and an increase in muscle
carnitine palmitoyl transferase-1 (CPT-1) activity respectively. Park et al
(1997) suggested that the effects of CLA were manifested in a reduction of fat
deposition, combined with increased lipolysis in adipocytes and potentially an
increase in fatty acid oxidation in muscle and adipocytes. The same group have
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shown that the trans-10, cis-12 isomer is responsible for the repartitioning
effect seen in CLA feeding studies (Park et al, 1999). There was no effect of
the cis-9, trans-11 isomer, but a mixture of isomers and trans-10, cis-12 CLA
reduced body fat. Possible mechanisms for this were suggested as a result of
work in cultured adipocytes (fat storage) and skeletal muscle cells (major site
of fat oxidation). To support these mechanisms, reductions in intracellular
TAG and glycerol were seen, together with enhanced glycerol release into the
culture media and reduced LPL activity indicating less fatty acid uptake and a
reduction in TAG synthesis. In rats fed 1% trans-10, cis-12 CLA and a CLA
mix, an increase in adipose tissue CPT-1 enzyme activity was seen (Martin et
al, 2000). This indicated that beta oxidation was increased, but there was no
evidence that peroxisome proliferation was happening. This is in agreement
with recent research findings (Moya-Camarena et al, 1999), and contradicts
earlier findings which indicated that peroxisome proliferation was seen with
increased beta oxidation (Belury et al, 1997). No evidence for a reduction in
TAG synthesis was seen when phosphatidate phosphohydrolase (the rate
limiting enzyme in de novo TAG synthesis in adipocytes) enzyme activity was
measured (Martin et al, 2000). The increase in beta oxidation may result in
lower levels of trans-10, cis-12 in tissue lipids, as seen in hamsters fed CLA
(de Deckere et al, 1999), due to the geometric and positional differences
between the major two conjugated isomers which favour oxidation of trans-10,
cis-12 CLA over cis-9, trans-11 CLA (Martin et al, 2000). Lower amounts of
trans-10, cis-12 CLA, linoleic and linolenic acids in the liver of hamsters fed
trans-10, cis-12 CLA and a CLA mix, indicate that the trans-10, cis-12 isomer
is responsible for an increase in oxidation of 18 carbon PUFAs (de Deckere et
al, 1999). Another characteristic seen in animals fed CLA is the increase in
liver weight (Tsuboyama-Kasaoka et al, 2000; de Deckere et al, 1999; West et
al, 1998), often combined with a reduction in adipose tissue weight. Several
researchers have suggested that this is due to lipid filling (Tsuboyama-Kasaoka
et al, 2000; de Deckere et al, 1999; West et al, 1998). Reports that trans-10,
cis-12 CLA and a mixture of isomers induces peroxisome proliferation in mice
and therefore liver hypertrophy (Belury et al, 1997) have been contradicted by
a study which found no effect of CLA on palmitoyl CoA peroxidase and
carnitine acetyl transferase, markers of peroxisome proliferation (de Deckere et
al, 1999). It seems that the increase in liver weight is due primarily to
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hypertrophy. There have also been a number of studies done in the 3T3-L1
preadipocyte cell line to study the effects of CLA on cell differentiation during
adipogenesis, and after confluence on mature adipocytes. Post confluent 3T3-
L1 adipocytes treated with 100PM CLA for up to 96 hours had more apoptotic
cells than BSA and linoleic acid treated cultures (Evans et al, 2000). This
supports the study reported previously (Tsuboyama-Kasaoka et al 2000), which
suggested that CLA stimulated apoptosis of adipocytes. Preadipocyte
proliferation was inhibited by CLA, indicating a mechanism by which
adipogenesis was reduced, which could be active in reducing fat pad weights.
Adipogenic differentiation factor PPARJ2 mRNA was reduced with CLA
treatment (Brodie et al, 1999), indicating a clear effect on differentiation. In
addition, CLA may have effects on mature cells; post-confluent cultures treated
with 50-200PM CLA had less TAG and smaller cell sizes compared to cultures
treated with linoleic acid. Treatment of cells with trans-10, cis-12 CLA
reduced TAG content significantly when compared to a mixture of CLA
isomers (Evans et al, 2000); this is further evidence that the trans-10, cis-12
CLA isomer is responsible for effects on lipid metabolism. The effects of CLA
on differentiation are unprecedented, as fatty acids stimulate adipogenesis
(Amri et al, 1991), so CLA has potential for altering lipid metabolism in terms
of reducing fat synthesis. CLA has been shown to have marked effects on fatty
acid composition of tissues; sheep fed CLA had reduced levels of oleic acid in
adipose tissue (Mir et al, 2000), and liver microsomes from mice fed CLA
supplemented diets had reduced levels of MUFAs than those from mice fed 5%
corn oil (Lee et al, 1998). There was also a decrease in the desaturase index
(see Section 1.6.3), likely to reflect a decrease in the enzyme activity; this has
also been seen in pigs where CLA feeding increased SFAs and reduced
MUFAs in TAG (Dugan et al, 2000). 100PM trans-10, cis-12 CLA reduced
mouse liver microsomal SCD activity, in contrast to cis-9, trans-11 CLA where
activity was not different to control levels (Park et al, 2000). Trans-10, cis-12
CLA reduced hepatic SCD activity in rat liver microsomes dose dependently
(Bretillon et al, 1999), but there was no effect of cis-9, trans-11 CLA. Taken
together, these studies suggest that trans-10, cis-12 CLA is responsible for the
reduction in MUFAs and increase in SFAs seen in animals fed a mixture of
CLA isomers. In mice, CLA feeding reduced levels of hepatic SCD mRNA
relative to beta actin, levels of which were unchanged with CLA (Lee et al,
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1998), increased levels of SFAs and reduced those of MUFAs. This was a clear
link between enzyme activity and gene expression and indicates that down
regulation of the SCD gene is accompanied by a reduction in protein levels and
enzyme activity, resulting in a drop in the levels of palmitoleic and oleic acids.
Choi et al (2000) demonstrated a reduction in SCD1 gene expression in 3T3-
L1 adipocytes treated with trans-10, cis-12 CLA. Based on the observation that
CLA had been shown to reduce MUFAs (Lee et al, 1995), they hypothesised
that trans-10, cis-12 CLA reduced fat (Evans et al, 2000) by lowering levels of
MUFA in TAG, which leads to small lipid droplets and smaller cells, as oleic
and palmitoleic acids make up 58% of the fatty acids in the lipid droplets of
these cells (Lee et al, 1995). Effects of trans-10, cis-12 CLA on 3T3-L1
preadipocyte differentiation are likely to be through inhibition of the SCD
gene, as no effects of CLA on PPARJ2 were seen (Choi et al, 2000). However,
in light of previous studies where inhibitory effects of CLA on PPARJ2 were
seen (Brodie et al, 1999; Satory & Smith, 1999), this is still unclear. The
identification of a PUFA response element in the SCD gene, along with other
lipogenic genes (Clarke & Jump, 1993) suggests that CLA may act by reducing
SCD1 mRNA stability and/or gene transcription. Notably, CLA treatment has
been shown to consistently reduce MUFAs and increase SFAs by an as yet
undiscovered mechanism. CLA has also been implicated in the reduction of
milk fat observed in dairy cows fed certain diets. Abomasal infusion of CLA
decreased milk fat (Chouinard et al, 1999; Bauman et al, 1998; Loor &
Herbein, 1998), and this effect was most pronounced on de novo fatty acid
synthesis and desaturation. The former was manifested in a reduction in short
and medium chain fatty acids that are synthesised by the mammary epithelial
cells (Bauman et al, 1998). Ratios of the SFA:MUFA increased dose
dependently, indicating inhibition of SCD (Chouinard et al, 1999), and there is
evidence that FAS and SCD activity are inversely related to CLA uptake
(Jayan et al, 1998). Abomasal infusion of individual CLA isomers
demonstrated that only trans-10, cis-12 CLA was able to reduce milk fat
(Baumgard et al, 2000), and that this isomer was responsible for increasing the
ratio of 18:0:18:1, and therefore reducing the activity of SCD. There was a
greater reduction in fatty acids from de novo synthesis than pre-formed fatty
acids, in line with Bauman et al (1998), indicating an effect on fatty acid
synthesis. Indications that CLA may work by reducing the activities and
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expression of key lipogenic genes came from work done in cows fed milk-fat
depressing diets. Loor & Herbein (1998) had already suggested that CLA may
reduce ACC, and in cows fed milk fat depressing diets, ACC and FAS activity
decreased by 61 and 44% respectively, and ACC mRNA levels were
comparatively reduced (Piperova et al, 2000). This is consistent with a
reduction in mammary de novo fatty acid synthesis mediated through down-
regulation of ACC, leading to reduced ACC and FAS enzyme activity. Trans-
10, cis-12 CLA has been shown to depress milk fat, and the mechanism by
which ACC and FAS was affected in response to a non-CLA-containing but
milk fat depressing diet is likely to be the mode of action for this CLA isomer.
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1.8. PROJECT HYPOTHESES
1) The fat reducing effect of CLA is due to decreased lipogenesis in
adipose tissue
2) The fat reducing effects seen in rodents and other monogastric animals
will occur in ruminants provided that sufficient CLA reaches the
tissues
1.8.1. Experimental objectives
The first series of experiments examined lipogenesis, fatty acid formation and
expression of key lipogenic enzymes in sheep adipose tissue explants treated
with cis-9, trans-11 and trans-10 cis-12 CLA, both together and as individual
isomers over a range of different concentrations. The effect of CLA on mRNA
levels for ACC and SCD in sheep was investigated further in an in vivo trial,
together with fatty acid composition of tissues. The final experiment examined
potential mechanisms of CLA action on lipid metabolism in the hamster, a
small monogastric animal model that has been shown to respond to CLA
treatment, by examining carcass and fatty acid composition and mRNA levels
of lipogenic genes in response to different supplementation levels of CLA.
It is important to determine how CLA has its fat reducing effects to ascertain
any possible adverse effects on lipid metabolism such as an increase in the
saturated fatty acid profile or hepatosteatosis as a result of supplementing diets
with CLA. The effects of the individual isomers need to be determined, as
some of the effects attributed to CLA may be as a result of feeding different
purities of CLA isomers, containing many different forms of CLA, which may
have differing effects on lipid metabolism. This thesis describes the effects of
CLA on adipose tissue lipid metabolism in the sheep, through direct treatment
of tissue with CLA and dietary supplementation. The effects of dietary CLA
supplementation on lipid metabolism in the hamster are also described. This
thesis provides new evidence that CLA follows different routes of action in
ruminant and monogastric animals.
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2. MATERIALSAND METHODS
2.1. REAGENT SOURCES
Applied Biosystems
Amplitaq Gold with 10X PCR Gold buffer and MgCl2 solution.
BDH Laboratory Supplies, Merck Ltd., Lutterworth, Leicestershire
Mercaptoethanol.
Fisher Scientific, Loughborough, Leicestershire
Chloroform, EDTA, Ethanol, Glacial acetic acid, Hexane, Isopropanol,
Methanol, Phenol, Sodium acetate, Sodium chloride, Sodium hydroxide,
Sodium methoxide, Toluene, Whatman filter paper.
Natural Lipids, Norway
Conjugated linoleic acid isomers cis-9, trans-11 and trans-10, cis-12,
Tonalin.
Promega UK Ltd., Chilworth Research Centre, Southampton, Hampshire
Blue/orange 6X loading dye, NTPs (ATP, CTP, GTP and UTP), Random
hexamers, Reverse transcriptase, RNAse, DNAse with 10x buffer, 100 and 25
base pair DNA ladders.
Rhone Merieux, Harlow, Essex
Sodium pentabarbitone – 60mg/ml Sagatal.
Special Diet Services, Witham, Essex
RM 1: 2% fat maintenance ration rodent chow .
Sigma Chemical Company, Poole, Dorset
Bovine serum albumin, Boron tri-fluoride, Chloroform-iso-amyl alcohol,
Conjugated linoleic acid (1:1 cis-9, trans-11:trans-10, cis-12), Dexamethasone,
Diethyl pyrocarbonate, Gentamycin, Guanidinium thiocyanate, HEPES, Insulin
from bovine pancreas, Linoleic acid, Medium 199, Oleic acid, Penicillin G,
Phenol:chloroform:isoamyl alcohol, Phosphate buffered saline, Potassium
chloride, Sodium hydrogen carbonate, streptomycin sulphate, Water
(Ribonuclease free).
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2.2. ANIMALS AND TRIALS
2.2.1. Explant culture of ovine subcutaneous adipose tissue
The aim of this project was to examine the effects of fatty acids, particularly
the isomers of conjugated linoleic acid on fatty acid metabolism in animals,
and specifically their effects on lipogenesis in adipose tissue and liver.
2.2.1.1. Animals
Sheep approximately 12 months old were used for the explant experiments, and
were housed in individual pens in the metabolism unit on the University farm.
The sheep were Mule x Charolais ewes and were fed a pelleted diet containing
225g barley, 450g oats, 225g grass meal and 100g Nutramol 30 (molassed feed
meal) per kg. Body weight was recorded immediately prior to slaughter and
animals were killed by stunning and exsanguination. Samples of adipose tissue
were removed from the subcutaneous depot (above the base of the tail) for
culture.
2.2.2. Effect of protected CLA feeding in sheep on lipid metabolism
The aim of this trial was to examine the effects of feeding CLA to sheep on
ACC and SCD RNA levels in adipose tissue depots and liver in order to
investigate whether CLA affects lipogenic gene expression in vivo. The
cooperation of Dr. Richard Wynn in conducting the animal feeding trial is
gratefully acknowledged. Full details of this trial and the results obtained are
described in Wynn (2003), particularly the effects of protected CLA on the
rates of fat deposition in the sheep.
2.2.2.1. Animals
36 weaned ewe lambs were used for this study with an initial weight of
approximately 28kg. Lambs were individually penned with free access to water
and mineral licks. Prior to feeding trial diets, lambs were given basal diet
(Tables 2.1 and 2.2) for 2 weeks to allow them to acclimatise to diet and
accommodation. Animals were also wormed during this time (Nilverm Gold,
Schering Plough Animal Health).
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Table 2.1 Composition of basal lamb fattener diet
Diet component
Amount in diet
(g/kg fed weight)
Barley 550
Oats 350
Molassed feed meal 50
Extracted soybean meal 25
Sheep vitamins & minerals (Frank Wright Ltd.) 25
Table 2.2 Analysis of basal lamb fattener diet
Crude Protein
(g/kg dry matter)
Gross energy
(MJ/kg dry
matter)
Estimated
metabolisable
energy
(MJ/kg dry
matter)
Lipid
(g/kg)
Dry matter
(g/kg)
109 18.42 12.54 29 874.2
2.2.2.2. Experimental diets
Lambs were fed a lamb fattener diet as ground meal, the composition of which
is displayed in Table 2.1, to grow at approximately 180g per day.
Supplementation of ruminally protected CLA-80 (80% CLA; Natural ASA,
Hovdebygda, Norway), or Megalac (Volac International Ltd., Royston,
Hertfordshire) was added by hand to diets 1-6 in differing amounts (Table 2.3).
Although exact details of the protection method are not in the public domain,
protection of the CLA-80 from rumen biohydrogenation was understood to be
achieved by coating it with specific hydrogenated fatty acids, which pass
virtually unchanged through the rumen (Trouw Nutrition UK, Wincham,
Northwich, Cheshire). Megalac is a commercially available lipid source
containing fatty acids bound as calcium salts which are protected against
rumen breakdown but dissociate in the acidic conditions of the abomasum,
releasing the fatty acids for absorption. The protected CLA (PCLA) contained
67.7% (w/w) lipid. Of the lipid component (as free fatty acid equivalents)
12.5% was the cis-9, trans-11 isomer and 12.5% was the trans-10, cis-12
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isomer of conjugated linoleic acid, 58% was C18:0 and 10% was C16:0. The
protection against rumen degradation was assessed by Dr. Richard Wynn (see
Wynn, 2003) by feeding the material to sheep fitted with rumen and proximal
duodenal cannula and assessing the flow of CLA to the proximal duodenum.
The dual phase marker technique of Faichney (1975) was used to assess the
flow of digesta to the duodenum. The material was found to be 65.8%
protected against rumen biohydrogenation while the unprotected CLA fed in
the same experiment was only 8.5% protected.
2.2.2.3. Animals and treatments
Thirty-six female Mule x Charollais lambs (age 72 ± 3d, live weight 27.9 ±
1.4kg), which had been with their mothers at grass, were individually housed in
an environmentally controlled metabolism unit with continuous access to water
and a mineral block. During a three week adaptation period all animals were
fed a concentrate diet (Tables 2.1, 2.2) as a meal to achieve a growth rate of
approximately 180g/d. After the adaptation period animals were randomly
assigned to one of seven treatment groups and fed the same concentrate diet to
grow at 180g/d plus one of the following: 25g PCLA/kg DM (Low PCLA), 50g
PCLA/kg DM (Medium PCLA), 100g PCLA/kg DM (High PCLA), 21.7g
Megalac/kg DM (Low Megalac), 43.3g Megalac/kg DM (Medium Megalac),
86.6g Megalac/kg DM (High Megalac) (all n = 5) or no added supplement
(Control; n = 6). Megalac (Volac Ltd., Royston, Herts, U.K.) was used to
control for the total lipid content of the PCLA and both supplements were
balanced for energy content at each intake level and provided extra energy
above that of the basal ration (Table 2.3). The gross energy content of the
PCLA was 28.73MJ/kg fed weight and that of the Megalac 33.17MJ/kg fed
weight. The chemical composition of the PCLA has been described above. The
Megalac however contained 812mg lipid/g and the major fatty acids were
palmitic (C16:0; 48.8%) and oleic acid (C18:1; 34.4%). Diets were fed for 10
weeks and all the animals were weighed twice weekly to monitor growth rate
and adjust feed intakes accordingly. Levels of feed were calculated according
to the Ministry of Agriculture, Fisheries and Food (1975) and were adjusted
once a week according to the mean weight of the treatment group. Throughout
the trial all animals were fed once daily at 08.00h and feed refusals were noted.
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Table 2.3 Supplement inclusion with crude protein (CP) and gross
energy (GE) in treatment diets
Diet
Supplement
addition
(g/kg diet)
CLA
(c9,t11 &
t10,c12) (g
in dry diet
as fed/kg
basal diet
fed)
Estimated
GE
(MJ/kg
dry diet
fed/day)
Crude protein
(g in dry diet
as fed/kg
basal diet
fed)
1. Low PCLA 25.0 4.23 19.14 109
2. Medium PCLA 50.0 8.46 19.86 109
3. High PCLA 100.0 16.9 21.30 109
4. Low Megalac 21.7 - 19.14 109
5. Medium Megalac 43.3 - 19.86 109
6. High Megalac 86.6 - 21.30 109
7. Control Nil - 19.14 109
Lambs were fed for 8 weeks, reaching a final body weight of approximately
45kg.
2.2.2.4. Slaughter and collection of samples
Animals were randomly slaughtered within 36h by stunning and
exsanguination, and samples collected. Small amounts of subcutaneous,
perirenal and omental adipose tissue were taken and snap frozen in liquid
nitrogen and stored at -80qC for RNA extraction and fatty acid composition
analysis as described in Sections 2.3.9 and 2.3.10. A sample of liver was also
taken and snap frozen for the same purpose. RNA was extracted from tissue
and used to make complementary strand DNA, amounts of which were
quantified by Taqman RT-PCR as described in Sections 2.3.11 and 2.3.14.
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2.2.3. CLA feeding trial in hamsters
The aim of this experiment was to examine the effects of a 90% pure CLA
mixture, consisting of a 50:50 mix of cis-9, trans-11 and trans-10, cis-12 CLA
on body weight and composition, plasma cholesterol and triglyceride levels,
adipose tissue depot weights, liver weight, fatty acid composition of these
tissues and mRNA levels for key lipogenic genes.
2.2.3.1. Animals
40 male 6 week old weanling Golden Syrian hamsters were purchased from
Harlan and individually housed in shoebox cages with free access to water and
powdered diet, supplied in powder hoppers to minimise spillage. Hamsters
were weighed before being assigned to their treatment groups, to ensure that
the initial average weight was the same across groups. Animals were fed
control diet for 1 week before their assignation to a treatment group and
introduction to the treatment diets.
2.2.3.2. Experimental diets
A 2% standard rat chow (RM 1, SDS, Witham, Essex) with 2% added fat as
rapeseed oil (food grade, J Sainsbury plc, London) was fed. The 2% added fat
was replaced with CLA in the treatment diets, which were fed for 11 weeks.
The treatment diets consisted of the following:
Control diet (2% fat standard rodent chow + 2% added fat as rapeseed oil)
0.5% CLA diet (2% standard rodent chow + 1.5% rapeseed oil and 0.5% CLA)
1.0% CLA diet (2% standard rodent chow + 1.0% rapeseed oil and 1.0% CLA)
2.0% CLA diet (2% standard rodent chow + 0% rapeseed oil and 2.0% CLA)
Hamsters were weighed weekly to monitor growth rate and well-being and any
hamster losing more than 10% of total body weight during this period was
withdrawn from the trial. Feed refusals were weighed three times weekly and
fresh diet supplied.
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2.2.3.3. Sacrifice and collection of samples
Hamsters were terminally anaesthetised with 15mg Sagatal, administered
intraperitoneally. Body weight was measured prior to blood sampling by
cardiac puncture. Blood was collected into EDTA blood tubes and placed on
ice for plasma recovery. The entire liver was removed and weighed, and snap
samples were taken and rapidly frozen in liquid nitrogen for RNA extraction
and fatty acid composition analysis. Epididymal, perirenal and intrascapular fat
pads were dissected out in their entirety, weighed and frozen in liquid nitrogen
for analysis as described for the liver. The carcasses were retained at -20ºC for
total body composition analysis.
2.2.3.4. Plasma recovery from blood samples
Blood was spun at 3000rpm for 20 minutes at 4ºC and the plasma layer
removed using a Pasteur pipette into a clean LP4 tube. 200µl of plasma was
stored in microtubes at -20ºC for triglyceride and cholesterol measurement.
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2.3. ROUTINE MATERIALS ANDMETHODS
2.3.1. Preparation of adipose tissue explants
Adipose tissue was aseptically removed from a sheep immediately following
slaughter, placed in warm buffer and rapidly transferred to the laboratory.
Blood vessels and connective tissue were dissected out and the tissue was
chopped into small (10-15mg) pieces. The pieces were then washed with
culture media before incubation for 24 hours at 5% CO2, 39qC in media with
no treatment. This was to allow the tissue to recover and re-synthesise any
damaged hormone receptors.
2.3.2. Culture media
Medium 199 containing Earle’s salts and L-glutamine was made up with the
following additions: HEPES: 5.2g/l (cell culture grade), NaHCO3: 2.2g/l and
anhydrous sodium acetate: 0.3602g/l, gassed with 95% O2 / 5% CO2 (Air
Products) and the pH was adjusted to 7.4 using 5M NaOH. The media was then
sterile filtered by means of a 0.22Pm bottle top filter (Fahrenheit) and stored at
4qC until use. On the day of use, the following were also added to the media:
Penicillin G: 0.044g/l, streptomycin sulphate: 0.05g/l, gentamycin sulphate:
0.044g/l and 0.5g/l of 50mg/ml BSA solution.
2.3.3. Explant culture
Following the 24 hour pre-incubation period, treatment culture media was
made up as before, but treatments of oleic acid and conjugated linoleic acid cis-
9, trans-11 and trans-10, cis-12 isomers, complexed to BSA (as described in
Section 2.3.4) were added to the plates at 10PM concentrations for a further 24
hours. The media was refreshed after 24 hours, and left for a further 24 hours,
prior to lipogenesis measurements being made.
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2.3.4. Reagent preparation
2.3.4.1. 24% bovine serum albumin solution
12g of essentially fatty acid free BSA was added to 35ml 150mM NaCl in
small amounts over a 5 hour period, using a magnetic stirrer to ensure that it
was completely dissolved. The pH of the solution was then adjusted to 7.4
using 5M NaOH and the final volume made up to 50ml using 150mM NaCl.
Aliquots were stored at -20qC until required.
2.3.4.2. Bovine serum albumin – linoleic acid / CLA / oleic acid complex
The complex was prepared according to Bruce (1996). 84mg of CLA isomers
cis-9, trans-11 or trans-10, cis-12 was mixed well with 2ml ethanol and 100Pl
5M sodium hydroxide. The ethanol was removed under a stream of nitrogen
and 10ml of 150mM sodium chloride was added to the dried sodium salt of the
fatty acid. The solution was heated for 3-5 minutes on a Dri-Block, and then
transferred to a magnetic stirrer at room temperature. While the solution was
still warm 12.5ml of ice cold 24% bovine serum albumin was added and the
solution stirred for 10 minutes. The final volume was adjusted to 25ml with
150mM sodium chloride to give a concentration of 12mM and aliquots were
frozen at -40qC until required. For oleic acid and linoleic acid, 97mg and 96mg
of their sodium salts respectively were heated in 10ml of 150mM sodium
chloride, and then prepared in the same way as conjugated linoleic acid to give
concentrations of 12.7 and 14.3mM respectively.
2.3.5. Measurement of lipogenesis using radio-labelled acetic acid
Culture media was prepared as before, with treatments of oleic acid and CLA
isomers cis-9, trans-11 and trans-10, cis-12 complexed to BSA added to
individual flasks. Lipogenesis was measured by looking at the incorporation of
radio-labelled acetate into the adipose tissue explants as previously done in this
laboratory (Daniel et al, 2004; Dawson et al, 1999). [1-
14
C] acetate
(Amersham) was added to the culture media at 0.27Pl/ml media, giving a
specific activity of 0.1MBq/ml. Each flask contained 5ml of culture media. The
tissue was transferred to the flasks, which were gassed with 95% O2 / 5% CO2
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(Air Products), stoppered, and incubated in a shaking water bath at 39qC for 2
hours. T0 flasks, which measured the incorporation of acetate in the instant that
tissue was added to the media, were placed on ice before tissue addition, and
then placed back in the ice bath immediately after tissue was added. After 4
hours, the flasks were removed from the water bath and placed in an ice bath to
kill the tissue. The total weight of the explants was recorded and these were
stored in plastic scintillation vial inserts at -40qC for extraction of lipid. The
media in each flask was then collected for glycerol assay and stored at -40qC in
plastic scintillation vial inserts.
2.3.6. Folch lipid extraction
Lipid was extracted from tissue using the method of Folch et al (1957).
Approximately 200mg of the frozen tissue from the lipogenesis step was
weighed out into a 50ml conical Sarstedt tube to which 5ml of methanol was
added. The sample was then homogenized using a Polytron homogenizer for
30 seconds. 10ml of chloroform was added to the homogenate and the sample
was homogenized further for 30 seconds. The tubes were vortexed and left to
stand for 10 minutes. A Folch wash was then performed by adding 3.75ml
0.88% potassium chloride solution to the tubes and mixing thoroughly. The
tubes were centrifuged at 3000rpm and 25qC for 10 minutes to enable the
phases to separate. The lower organic phase (the chloroform) was collected
using a short form Pasteur pipette into an oven dried, desiccated and weighed
scintillation vial and dried under a stream of nitrogen to complete dryness. The
vials were then placed in an oven at 80qC for 3-4 hours to dry off further and
then desiccated and weighed to determine the weight of lipid extracted.
2.3.6.1. Measurement of acetate incorporated into lipid
8ml of Emulsifier-Safe scintillant (Packard) was added to each vial, and the
vials warmed for 2 minutes in the oven at 80qC to dissolve the lipid. The vials
were then vortexed until a clear solution was obtained and placed in a
scintillation counter for 12 hours prior to counting for
14
C. Each vial was
counted for a minute to give disintegrations per minute (dpm) of the carbon-14
present in the [1-
14
C] acetate.
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2.3.6.2. Measurement of fatty acid formation
In the measurement of the above it was necessary to distinguish between the
different types of fatty acid present and to preserve them in their different
forms they were stored under nitrogen and not dried in an oven after extraction
of lipid. This helped to prevent oxidation of the lipid so that the different types
of fatty acids could be separated out. To get a measure for percentage lipid
recovered from the tissue, 3 samples of tissue were extracted then dried in an
oven as described above. The average percentage from these samples was then
used to determine the weight of lipid extracted from the rest of the samples.
2.3.7. Acid-base methylation of lipid
Lipid extracted from adipose tissue and PCLA and Megalac supplements was
methylated according to Kramer et al (1997) and Christie (1999). Briefly, a
25mg sample of lipid was dissolved in 1ml toluene in a 15ml methylating tube
to which 2ml of 0.5M sodium methoxide in methanol was added. The tube was
capped and the contents mixed prior to methylation at 60qC for 20 minutes,
shaking halfway through. 2ml of 14% boron trifluoride was added and mixed
and the tubes were returned to the oven for a further 20 minutes at 60qC. After
cooling, 5ml of deionised water was added and the tubes were vortexed before
addition of 2 x 2ml hexane to extract the fatty acid methyl esters. The hexane
was drawn off, transferred to a clean tube and dried under nitrogen to leave the
fatty acid methyl esters, which were then redissolved in 1ml hexane.
2.3.8. Argentiation thin layer chromatography
Plastic backed, silica coated TLC plates (Merck, 20cm x 20cm, silica gel 60)
were soaked in a 4% silver nitrate solution made up in 9:1 water:methanol for
30 minutes to allow the silver ions to impregnate the plate. The plate was dried
in a fan oven for 20 minutes at 80qC and cooled before loading the fatty acid
methyl esters in hexane using a hairdryer. 2-5mg of lipid was loaded onto each
column of the plate. The plate was run to separate the fatty acid methyl esters
using an equilibrated TLC tank of 90:10 petroleum ether:diethyl ether to within
1cm of the top of the plate. The fatty acid bands were visualised by spraying
the dried plate with 0.1% 2,7 dichlorofluorescein in methanol, and marked
immediately. The highlighted bands on the TLC plate were cut out and placed
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in glass scintillation vials to which 15ml Emulsifier Safe scintillation fluid was
added. The vials were transferred to a scintillation counter where they were left
for 2 hours prior to counting the
14
C present for 10 minutes.
2.3.9. Analysis of fatty acid methyl esters by gas chromatography
Gas chromatographical analysis was performed by Dr. R. Wynn, using a Perkin
Elmer Autosystem fitted with an autosampler and flame ionization detector in
conjunction with Turbochrom 4 software (Perkin Elmer, Beaconsfield,
Buckinghamshire) and using a 100m column. Samples were placed in 2ml vials
or 100Pl inserts, which were sealed using a crimped aluminium cap. Sample
fatty acids were identified by reference to standards and were expressed as a
percentage of total fatty acid methyl esters present. The calibration standard
used contained 19 fatty acid methyl esters (Sigma 189-20) from C8:0 to C22:1.
A methylated sample of Tonalin CLA-90 (Natural Lipids, Hovdebygda,
Norway) was added as well as more C18:1 trans isomers: C18:1 trans-6, C18:1
trans-9, C18:1, trans-11, C18:1, trans-12 (Sigma Aldrich Chemical Company
Ltd., Poole, Dorset).
2.3.10. Ribonucleic acid extraction
2.3.10.1.Acid-guanidinium-thiocyanate-phenol-chloroform extraction
Tissue previously snap frozen in liquid nitrogen was prepared by wrapping in
foil, and smashing into smaller pieces using a hammer, and then grinding to a
powder using a pestle and mortar filled with liquid nitrogen. This had to be
done very rapidly to prevent the tissue thawing and the RNA degrading. The
ground tissue was transferred into 50ml polypropylene screw-topped tubes
(Sarstedt) and stored at -80qC. Approximately 2g of the frozen ground adipose
tissue was placed into 10ml of denaturing solution in a 50ml polypropylene
conical tube (Fahrenheit). The sample was homogenised using a Polytron
homogeniser, rinsing the probe between samples. The samples were then
frozen in the tubes and allowed to thaw in order to shear the DNA. 10ml of
chloroform was added to the tube and mixed well to extract the fat from the
samples. The phases were separated out by centrifugation at 3000rpm for 10
minutes at 4qC. The chloroform layer was pipetted off and the extraction
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repeated. 1ml of 2M sodium acetate at pH4 was added, followed by 10ml of
water saturated phenol and 2ml of chloroform-isoamyl alcohol 49:1. The
samples were vortexed between additions, transferred into plastic 30ml tubes
and centrifuged at 10000rpm for 30 minutes at 4qC. This left the RNA in the
top aqueous phase, DNA and proteins in the interphase and phenol and
chloroform in the bottom phase. 30ml glass tubes with 10ml isopropanol in
were prepared and the top phase from the previous spin was transferred to
these. The tops were covered with foil and left at -20qC overnight to precipitate
the RNA. The tubes were spun at 10000rpm for 30 minutes at 4qC and the
isopropanol poured off, leaving the precipitated RNA at the bottom of the tube.
This was dissolved in 3ml of denaturing solution and vortexed until it dissolved
completely. 3ml of isopropanol was added to the denaturing solution and the
tubes were covered and left at -20qC overnight. The tubes were then spun at
10000rpm under the same conditions as before. The liquid was then poured off,
the pellet washed with 4ml of 75% ethanol and centrifuged again. The ethanol
was poured off and the tubes left to dry. When dry, the RNA was redissolved
in 2ml of ribonuclease-free water for quantification. For liver an additional step
to remove glycogen was carried out where the RNA pellet was dissolved in
2.4ml ribonuclease free water and vortexed before addition of 7.5ml of 4M
sodium acetate at pH 7. The tubes were then left at 0qC overnight to aid
precipitation. Following precipitation, tubes were centrifuged at 10000 rpm for
30 minutes at 4qC. The resulting pellet was washed with 4ml of 75% ethanol
and dissolved in 2ml of ribonuclease free water, pending measurement of the
RNA.
2.3.10.2.Quantification of RNA
1ml aliquots of RNA were transferred into a quartz cuvette and their
absorbance measured at 260 and 280nm on a spectrophotometer (Pharmacia
LKB Ultrospex III). One absorbance unit at 260nm is equivalent to 40Pg of
RNA per Pl and from this information the RNA content of the samples could
be calculated. The absorbance at 280nm measures protein present in the
sample. To check that the RNA was of good quality and not contaminated with
protein the ratio of the 260:280 readings was calculated. Ideally this ratio
Chapter 2: Materials and Methods
58
should be between 1.7 and 2.0, and samples below 1.5 should not be used. The
RNA yield per gram of starting tissue was then calculated. Aliquots of 10Pg or
20Pg of RNA were stored as a precipitate in 1.5ml microtubes with 8 volumes
of ethanol and 0.1 volumes of 3M sodium acetate at pH 5.5. The samples were
stored at -80qC for further analysis. To check that the RNA was intact, a small
amount of each sample was run on a 1% agarose gel, and the presence of the
18S and 28S bands verified.
2.3.10.3.Trizol extraction
This method extracts RNA from small amounts of tissue so is suitable for
smaller samples such as those obtained from rodents. Tissue was prepared as in
section 2.3.10.1 and the resulting powder stored in 1.5ml microtubes at -80ºC.
Approximately 100mg of tissue was weighed into autoclaved 15ml glass tubes
and 1ml Trizol reagent was added. Tissue was homogenized using a
Polytron homogeniser. The homogenate was poured into autoclaved 1.5ml
microtubes and freeze thawed at -80ºC to shear DNA. Tubes were thawed and
centrifuged at 12000g for 10 minutes at 4ºC. Excess fat was removed from the
top and the supernatant was transferred to a clean tube. Tubes were left at room
temperature for 10 minutes, and then 200µl of choloroform was added.
Samples were shaken for 15 seconds to mix the tube contents and left at room
temperature for 2-3 minutes, then centrifuged at 12000g for 15 minutes at 4ºC.
The clear aqueous top phase contains the RNA, with DNA and protein in the
interphase, and phenol and chloroform in the lower organic phase. The top
phase was transferred into a clean tube and the RNA was precipitated. For
adipose tissue samples 500µl of isopropanol was added to precipitate the RNA,
but in the case of liver, which contains glycogen, a glycogen removal step is
necessary; therefore to precipitate the RNA from liver samples 250µl of 0.8M
sodium citrate and 1.2M sodium chloride solution and 250µl of isopropanol
were added. For both adipose tissue and liver samples, tubes were left at room
temperature for 10 minutes and centrifuged at 12000g for 10 minutes at 4ºC.
The resulting supernatant was poured off and 1ml 75% ethanol was added to
the RNA pellet, vortexed and centrifuged at 7500g for 5 minutes at 4ºC. The
resulting supernatant was poured off and the pellet air dried for 5-10 minutes,
before being redissolved in RNAse-free water for quantification.
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2.3.10.4.Quantification of RNA extracted using Trizol
A sample (usually 10µl) of the total volume was dissolved in 45µl of RNAse-
free water for quantification using a Gene-Quant spectrophotometer, which
uses a 50µl volume and measures at 230nm, 260nm, 280nm and 320nm to
ensure clean, pure RNA as previously described in section 2.3.10.2. The
concentration of the stock solution was calculated and diluted to 0.75µg/µl for
DNAse treatment.
2.3.10.4.1. DNAse treatment
RNA was treated with DNAse to ensure that any remaining DNA
contamination which could affect results during Taqman analysis was
removed. 40µl of sample RNA at a concentration of 0.75µg/µl was pipetted
into a 1.5ml microtube. 5µl of 10x DNAse buffer and 5µl of DNAse were
pipetted into the tube and the contents mixed. The tubes were incubated in a
37ºC waterbath for 30 minutes, then 200µl of RNAse-free water and 150µl of
phenol:chloroform:isoamyl alcohol were added. Samples were vortexed and
spun at 12000g for 5 minutes to allow phase separation. 150µl of the aqueous
top phase which contained the RNA were pipetted into 1.5ml microtubes
containing 375µl 100% ethanol and 15µl 3M pH 5.5 sodium acetate and stored
at -80ºC. RNA was precipitated and quantified as described previously in
Section 2.3.10 and diluted to 0.1µg/µl ready for synthesis of complementary
strand DNA (cDNA) as described in Section 2.3.11.
2.3.11. Reverse transcriptase polymerase chain reaction (RT-PCR)
This technique was used as an alternative to the ribonuclease protection assay
to detect the presence of stearoyl CoA desaturase (SCD) and acetyl CoA
carboxylase (ACC) messenger RNA in RNA samples extracted from adipose
tissue and liver of sheep used in the CLA feeding trial, and levels of ACC,
FAS, LPL and SCD mRNA in adipose tissue and liver of hamsters fed CLA.
This was done as a two step method so that both the reverse transcriptase and
the polymerase chain reaction could be optimised independently.
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2.3.11.1.Reverse transcriptase reaction
The reverse transcriptase (RT) reaction synthesises complementary strand
DNA. Clean and precipitated RNA was used for the RT reaction at a
concentration of 0.1Pg/Pl. 5Pl of RNA was mixed with 1Pl of random
hexamers and 9Pl of RNAse free water. This was incubated for 5 minutes at
70qC to denature the secondary structure, and then put on ice while the
following reagents were added, in order (Table 2.4).
Table 2.4 Contents of reverse transcriptase reaction
Reagent Volume (µl) Final concentration
MMLV Reverse transcriptase buffer x5 5 --
Nucleotides at 10mM (dNTPs) 1.25 0.5mM
RNAse inhibitor 0.5 25U
MMLV Reverse transcriptase 1 200U
Water (RNAse/DNAse free) 2.25 --
The tubes were incubated for 10 minutes at room temperature and then 1 hour
at 42qC. The total volume of 25Pl containing the cDNA made by the reverse
transcriptase reaction was made up to 100Pl with DNAse and RNAse free
water and stored at -20qC prior to amplification by polymerase chain reaction
(PCR).
2.3.11.2.Polymerase chain reaction
This reaction uses the cDNA made during the reverse transcriptase step
(Section 2.3.11.1) in a process of amplification using the ABI 7700 ‘Taqman’
machine which takes 96 x 0.2ml well plates. This is a real time PCR system
which detects and quantifies fluorescence produced by a reporter present in the
well. The fluorescence of this reporter increases in proportion to the amount of
product formed during the course of a reaction. Two different reporters were
used, one of which was Sybr Green, which binds any double stranded DNA
present in the well. This can be a disadvantage, as apart from true PCR
product, the Sybr Green may bind primer dimers, or DNA present in the RNA
(especially likely if the sample has not been DNAsed) and the concentration of
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PCR product may be exaggerated. An alternative, more specific method
involves using a Taqman probe containing a fluorescent dye attached to the 3’
base and a quenching dye on the 5’ base. The probe sits on either of the two
DNA strands between the two primers. When it is irradiated the dye transfers
energy to the quenching molecule, so producing a non-fluorescent substrate.
PCR involves replication of the DNA to which the probe is bound and as the
polymerase enzyme moves along the strand, digesting bases, the 5’ end is lost
into solution. The reaction was set up on a 96 well 0.2ml plate, with samples
being run in triplicate. Table 2.5 shows the reagents in each well.
Table 2.5 Reagents and cDNA added to each well of the reaction plate
Reagent
Volume
+ probe
Volume
- probe
Concentration
2x Taqman Universal PCR MM* 12.5µl - -
2x SybrGreen PCR MM* - 12.5µl -
Forward primer (10pmol/Pl) 0.75µl 0.75µl 0.3PM
Reverse primer (10pmol/Pl) 0.75µl 0.75µl 0.3PM
Probe (10pmol/Pl) 0.5µl - 0.2µM
cDNA ({ 5ng total RNA/Pl) 2µl 2µl 10ng RNA
Water (molecular grade) 8.5µl 9.0µl -
*MM = mastermix
A mastermix was made up (Table 2.6), sufficient to run each sample in
triplicate. To ensure there was enough reagent, 2.2 times the reagent was made
up, leaving some spare.
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Table 2.6 Mastermix to be added to cDNA
Reagent Volume + probe Volume - probe
2x Taqman Universal PCR MM* 40Pl -
2x SYBR Green PCR MM* - 40Pl
Forward primer (10pmol/Pl) 2.4Pl 2.4Pl
Reverse primer (10pmol/Pl) 2.4Pl 2.4Pl
Probe (10pmol/Pl) 1.6Pl -
Water (molecular grade) 27.2Pl 28.8Pl
*MM = mastermix
24.5Pl of Mastermix (Table 2.6) was added to a labelled tube, followed by
2.1Pl of cDNA. The tube contents were mixed and briefly spun down to the
bottom of the tube. 25Pl was pipetted into a well on the 96 well reaction plate
in duplicate or triplicate for each sample run. The wells were capped with an
optically clear cap strip and the plate was placed into the machine for PCR.
2.3.12. Design of primers and probes for sheep and hamster genes
Primers and probes were designed for ovine ACC, SCD and beta actin and
hamster ACC, FAS, LPL, SCD and beta actin (see Section 2.4.6 and 2.4.7) by
entering the sequences into the Primer Express software. Primers were then
selected from the output. When primer-probe sets had been designed, the
primers were tested on sheep and hamster cDNA to verify that the correct
product was being formed. This product consisted of the region from which the
primers were taken and the sequence between the primers. In most cases the
product length was approximately 70-80 base pairs. Samples from the PCR and
a DNA ladder to identify band sizes were run on a 4% metaphor agarose gel at
100V for 1-2 hours, stained using ethidium bromide for 20 minutes and
visualised under UV light. The sheep primers and probes were designed with
Dr. Z. Daniel of the University of Nottingham and the sequences are displayed
in Table 2.7. However, in the case of the hamster, after several attempts to
design primers and probes for ACC, FAS, LPL and SCD (Sections 2.4.7 and
2.4.8) a paper which had used Taqman RT-PCR on hamster tissue reported
Chapter 2: Materials and Methods
63
primer and probe sequences for these genes (Guo et al, 2001). The exact
sequences for ACC, FAS, LPL and SCD together with the original genetic
sequences used to design the primers and probes were kindly supplied (Table
2.15; Qiu Guo, personal communication). These primers and probes were
synthesised and used in the subsequent RT-PCR analysis on the hamster tissue.
Table 2.7 Primers and probes used in measurement of ovine SCD, ACC
and beta actin mRNA levels
Sequence Tm (qC)
SCD
Forward primer CGAACC TAC AAAGCT GGGCT 65.4
Reverse primer TGGAACGCC ATGGTGTTG 67.0
Probe CCC CTACGGGTC TTC CTGACATCG 74.4
ACC
Forward primer CAT GTC TGGTTT GCACCT AGT CA 66.0
Reverse primer TCACTT TAT TCC CACCAAAACGA 66.1
Probe CGAGACCGAAAG AAAATAGAC TCA CAGCGA 75.0
Beta actin
Forward primer TGT GCGTG CAT CAAGGAGAA 66.8
Reverse primer CGC AGT GGCCT CTC CTG 68.3
Probe CTG CTACGT GGCCCT GGACTT CGA 75.6
2.3.12.1.1. Making and testing of PCR product
Complementary strand DNA was made from hamster RNA extracted from
adipose tissue and liver using a reverse transcriptase reaction as described in
Section 2.3.11.1. A PCR reaction was then done on the cDNA from the reverse
transcriptase reaction. For multiple reactions a mastermix was made up which
contained all the components except the template and the enzyme. Table 2.8
shows the components of the mastermix.
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Table 2.8 Mastermix for single PCR reaction
Reagent Volume (Pl)
Nucleotides at 10mM (dNTPs) 1.0Pl
Forward oligo at 10pmol/Pl 1.25Pl
Reverse oligo at 10pmol/Pl 1.25Pl
PCR buffer 5.0Pl
MgCl2 3.0Pl
RNAse/DNAse free water 28Pl
The mastermix was made up as in table 2.6, and 39.5Pl was added to 0.5ml
autoclaved microtubes containing 10Pl of cDNA and 0.5Pl of Amplitaq Gold
enzyme. Tubes were spun briefly to mix contents and concentrate at the bottom
of the tube, before adding to the PCR block for the run. The PCR block was
pre-programmed as shown in Table 2.9.
Table 2.9 PCR block programme
Step 1 95qC for 10 minutes
Step 2 94qC for 30 seconds
Step 3 Melting temperature of primer - 5qC
Step 4 72qC for 1 minute
Repeat steps 2-4 34 times
Step 5 72qC for 5 minutes
Step 6 Hold at 4qC
After PCR, products were stored at -20qC, prior to running on a gel.
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2.3.13. Casting and running of 4% metaphor agarose gel
4g of metaphor agarose was sprinkled into 100ml TAE buffer whilst rapidly
stirring to prevent clumps forming. The stirring bar was removed and the
agarose soaked in the buffer for 15 minutes before heating. The solution was
weighed and heated for 1 minute on medium in a microwave and left on a
bench for 15 minutes. The gel was heated for a further 2 minutes, removed and
gently swirled to resuspend settled powder and gel pieces. The gel was then
heated on high for 1-2 minutes or until the solution boiled, before being held at
boiling point for 1 minute, ensuring all particles had dissolved. Sufficient hot
distilled water was added to make the gel solution up to its initial weight. The
gel was allowed to cool to 50-60qC before casting. A gel former was prepared
by sealing at both ends using tape or a clamp, and set up with a comb to
accommodate all the samples to be run. The cooled gel was carefully poured in
to avoid bubbles forming and left to set at 4qC for an hour. Once set, the tape
or sealer was removed from the gel, and the gel former containing the gel was
set in an elecrophoresis tank. This was filled with enough TAE to cover the
surface of the gel. The comb was removed to allow the buffer to fill the wells
before sample loading. 10Pl of PCR product was run on the gel with 3Pl DNA
loading dye. The gel was run until the markers were approximately 60% of the
way down the gel and stained using ethidium bromide solution for 20 minutes.
2.3.14. Measurement of mRNA levels for hamster and sheep genes
Complementary strand DNA was synthesised as described in section 2.3.11.1
from RNA extracted from hamster liver, epididymal, perirenal and
intrascapular adipose tissue (section 2.3.10.3) using Trizol reagent. RNA was
extracted from sheep liver, subcutaneous, perirenal and omental adipose tissue
(section 2.3.10.1), using an acid-guanidinium-thiocyanate-phenol-chloroform
extraction. Samples from individual animals were run in duplicate on the plate
so that a single tissue and gene could be run on the same plate to reduce
variability. A 7 point standard curve was also run, using a pooled sample of 5Pl
of cDNA from each animal. The dilutions for the standard curve are expressed
in terms of RNA, because the cDNA is not quantified after synthesis. The
dilutions are detailed below (Table 2.10).
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Table 2.10 Standard curve dilutions for Taqman RT-PCR
Dilution factor Volume of stock (µl) Volume of water (Pl)
1 in 5: 0.2x stock 40 160
1 in 10: 0.1x stock 40 360
1 in 20: 0.05x stock 100 of 1 in 10 dilution 100
1 in 50: 0.02x stock 20 of 1 in 5 dilution 180
1 in 100: 0.01x stock 20 of 1 in 10 dilution 180
Two other solutions completed the standard curve – a stock solution, given the
name 1x stock and a 5x stock solution, where 5 times the normal volume of
stock was added to the mastermix. In addition to the standard curve, a no
template control (NTC) and a no amplification control (NAC) were also run in
duplicate. These consisted of water and RNA added in place of cDNA template
respectively. The NTC checked that there was no contamination on equipment
or in solutions and the NAC checked that there was no DNA present in the
RNA used to make the cDNA template, which could be being amplified in the
sample templates, and over-estimating the gene expression.
2.3.15. Fatty acid analysis of hamster adipose tissue, liver and
treatment diet lipids
Lipid was extracted from adipose tissue as previously described in Section
2.3.6, according to Folch et al (1957).
2.3.15.1.Extraction of hepatic lipids
A hepatic homogenate was prepared from 250mg of frozen liver to which 5ml
of cold Tris-NaCl buffer (50mM Tris/150mM NaCl) was added and
homogenised using a Polytron homogeniser. 1ml of this homogenate was
then taken and transferred into a 15ml graduated conical polypropylene tube on
ice. 3.75ml of cold freshly made chloroform:methanol (1:2v/v) was added to
the tube and the contents mixed well. At room temperature 1.25ml chloroform
was added to the tube and the contents vortexed, then 1.25ml distilled water
was added and the tube vortexed again. This gave a final extraction solvent
ratio of chloroform:methanol:water of 10:10:9 v/v. To complete phase
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separation, tubes were centrifuged at 1100rpm at 25qC for 5 minutes. The
lower organic chloroform phase, which contained the lipid, was collected into a
solvent resistant LP4 tube using a Pasteur pipette. The lipid was dried down
under a stream of nitrogen gas, rinsing the tubes down with choloroform to
ensure all lipids were extracted.
2.3.15.2.Extraction of diet lipids
Approximately 1g of each diet was weighed out in triplicate into a 50ml
graduated conical polypropylene tube. 5ml of chloroform:methanol (1:2 v/v)
was added and the tube contents vortexed thoroughly. To pellet the diet
particles, samples were centrifuged at 1100rpm and 25qC for 10 minutes. The
upper organic phase, which contained the extracted lipids, was collected using
a Pasteur pipette into a graduated conical polypropylene tube. This procedure
was repeated on the diet samples twice. The three extracted portions were
mixed and centrifuged at 1100rpm and 25qC for 10 minutes to pellet any
remaining diet particles. The organic phase was collected into a pre-weighed
15ml graduated conical polypropylene tube using a glass Pasteur pipette. The
lipid was dried down under nitrogen gas to complete dryness and the weight of
the capped tubes was recorded to determine lipid yield from the diet samples.
2.3.16. Methylation of lipid samples
Lipid samples were methylated and analysed by Dr. A.L. Lock, Cornell
University, Ithaca, N.Y.
2.3.17. Body composition analysis on hamsters
Hamster carcasses were frozen at -20qC immediately after removal of adipose
tissue and liver samples as described in Section 2.2.3.3. Once completely
frozen, carcass weights were recorded prior to commencement of freeze
drying. Carcasses were freeze dried to remove all water for 4-5 days and
weights recorded again on the 4
th
and 5
th
days to check that weight was
remaining constant. Carcasses were broken up and homogenised using a
blender to ensure that a representative sample could be taken for percentage fat
analysis. 1g of the homogenised carcass was taken and analysed using a rapid
Soxhlet extraction at a running temperature of 150qC, boiling time of 35
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minutes and extraction time of 50 minutes. The percentage fat in the carcass
was then calculated from the extract weight and starting sample weight.
2.3.18. Cholesterol and triglyceride assays
Cholesterol and triglyceride standards were made up from the solutions
supplied with the kit (Table 2.11).
Table 2.11 Preparation of standards for cholesterol and triglyceride
assays
Cholesterol conc mM Triglyceride conc mM µl standard µl water
0
0.517
1.030
0
0.339
0.678
0
100
200
1000
900
800
2.070 1.356 400 600
3.100 2.034 600 400
4.140 2.712 800 200
5.170 3.390 1000 0
10µl of blank (water), standard or sample was pipetted into wells on a 96 well
plate. 250µl of Trace Cholesterol or Triacylglycerol assay reagent was added,
and then the plate was incubated at 37ºC for 15 minutes to allow the assay
reaction to proceed. The plate was read at 550nm on a Dynatech MR5000
micro-plate reader.
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2.4. METHOD DEVELOPMENT
2.4.1. Development of explant culture conditions
The aim of these experiments was to investigate the effect of conjugated
linoleic acid upon lipogenesis in adipose tissue explants. A culture period of 24
hours was used, followed by a 2-hour incubation using 1-
14
C acetic acid as a
label. The starting point for the development of the explant culture technique
used in this thesis was provided by work done by Dawson et al (1993). Krebs
Ringer bicarbonate buffer solution at pH 7.4 was used as the culture medium
initially but it became clear that it was unable to support the tissue for a 24
hour period prior to lipogenesis measurement. No
14
C above that of
background levels was detected, so it was concluded that the tissue was dead.
Dawson et al (1993) had been using the culture medium only for the 2 hour
incubation immediately after slaughter, so this cast doubt on its suitability as a
long term culture medium. A different culture medium was tried – Medium
199 (Sigma); one which previous work in this laboratory had shown to be
successful in culturing explants for up to 48 hours post-slaughter. (Daniel
2002, Richards, 1997) There was discussion as to whether a pre-incubation
period in untreated media was required immediately post slaughter. It was
decided to include this and incubate the explants in media without treatment
substances in order to allow the tissue to recover after chopping. This improves
the quality of the explants because receptors that may have been damaged in
the preparation process can be re-synthesized. For the purposes of technique
development, a positive control was used to check that the experiment was
working using this procedure. Insulin is known to increase the rate of
lipogenesis of adipose tissue by activating the enzyme acetyl CoA carboxylase
(Vernon et al, 1999, Vernon, 1993), so the efficacy of the technique could be
established.
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2.4.1.1. Supply of fatty acids to adipocytes
Fatty acids are solubilized for transport in the circulatory system due to binding
to albumin. This blood protein has a high affinity for free fatty acids, although
it does carry other components, but their binding is weakened when
concentrations of free fatty acids are high. This is the route of supply of non-
esterified fatty acids to adipocytes, and therefore it is essential to bind fatty
acids to be supplied to the adipocytes to albumin to facilitate their uptake
(Noble, 1981). Work suggests that a molar ratio of 4:1 fatty acid:bovine serum
albumin is used (Peck et al, 1996). The ratio that was used in the explant
experiments was 7:1 but the amounts added were still below the toxicity level
of 100PM for BSA-bound fatty acids as reported by (Peck et al, 1992).
2.4.1.2. Measurement of lipogenesis using radio-labelled acetic acid
Lipogenesis is calculated by the measurement of radiolabelled
14
C taken up by
the explants from [1-
14
C] acetate supplied over an incubation period. From the
specific activity of the acetate, and its concentration, the amount of fatty acid
formed can be calculated. Previous work done in this laboratory had used
[1-
14
C] acetate with a specific activity of 0.02MBq per ml of media,
corresponding to 135Pl of acetate per 50ml of media (Daniel et al, 2004). This
produced some high counts and consequently it was decided to work with a
tenth of the amount, which brought the counts down significantly and gave a
specific activity of 27dpm/nmol acetate. Instead of performing a lipid
extraction on the tissue, a solubiliser was used instead to dissolve the adipose
tissue before addition to the scintillation fluid. This did not consistently
produce the results expected for the positive control, and it was considered
possible that acetate that was not incorporated into the lipid but adherent to the
associated connective tissue was being counted. The experiment was to look at
acetate incorporated into the lipid as a measure of lipogenesis, so a Folch lipid
extraction (Folch et al, 1957) was used. This removed the non-lipid fraction
and associated acetate so only the acetate bound to the lipid was counted for
14
C. The changes being investigated were so small that it was thought better to
use a lipid extraction to ensure that only the bound lipid was being analysed.
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2.4.2. Measurement of stearoyl CoA desaturase (SCD) activity
The focus of the project shifted from investigating the effects of CLA isomers
and other fatty acids on lipogenesis and lipolysis to looking at their effects on
the stearoyl CoA desaturase enzyme. Its activity can be measured by looking at
the type of fatty acids formed in adipose tissue incubated for a time period in
culture media containing
14
C acetate. The incubation with radio-labelled
acetate was carried out as previously described in section 2.3.5 and the lipid
was extracted from the explants, but instead of counting the total lipid formed
immediately, the individual fatty acids as fatty acid methyl esters were
separated according to their degree of saturation using a silver – impregnated
thin layer chromatography plate (sections 2.3.7 and 2.3.8). This was based on a
technique previously done in this laboratory using silver-impregnated florisil
columns (Daniel et al, 2004). At the start of using this technique very low
counts were being seen, possibly due to the low specific activity of the acetate
present so it was decided to raise this to 1360dpm/nmol acetate (0.32MBq per
flask)
2.4.2.1. Preparation of fatty acid methyl esters
Initially, 5% sulphuric acid in methanol was used to methylate the lipid at 90qC
for 2.5 hours. The fatty acid methyl esters (FAMEs) were extracted using 2x
2ml petroleum ether. During the methylation the lipid turned brown, and after
extraction of the FAMEs, the lipid would not dissolve in the petroleum ether.
The methylation being used is a strong one, especially with heating at 90qC for
2.5 hours, and it was suspected that the fatty acids were being oxidized.
Christie (1982) recommends using a further solvent to dissolve lipid in prior to
methylating because methanol, or reagents composed primarily of methanol
will not allow non-polar lipids such as triacylglycerols to dissolve in them and
will not react in a reasonable time. A milder base methylation (Christie, 1999,
2001) was used, which was much quicker and used 0.5M sodium methoxide in
methanol at 50qC for 10 minutes. The esters were extracted with hexane. This
was much more successful so this method was adopted.
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2.4.2.2. Separation of fatty acid methyl esters using silver ion thin layer
chromatography
Silver ion thin layer chromatography is effective at separating saturated fatty
acids from unsaturated ones due to the interaction of the silver with the double
bond of the unsaturated fatty acids. The monounsaturated fatty acid band is
approximately 1cm below the saturated fatty acid band due to the retardation of
the double bond by the silver. Previously, silica coated glass TLC plates have
been used, but with care it is possible to use plastic backed plates,
impregnating them with silver by immersion in a 4% silver nitrate solution in
9:1 water:methanol (Wood & Snyder, 1966). One of the limiting factors was
the amount of lipid that could be loaded onto the plate. It is not possible to load
all the lipid that is contained in the average flask of explants (approximately
100mg) because of the likelihood of smearing the sample up the plate and not
achieving a clean separation. The best separations are achieved by using
between 2 and 20mg of lipid – if too little is used, it is impossible to detect in
the bands, but if too much is used, a clean separation is not achieved. The
loading limit posed a problem, because the radiolabel being detected using
100mg of lipid was sufficient for the scintillation counter to detect and accurate
enough to calculate from, but if a twentieth of that amount was used it would
not be possible to distinguish between background counts and sample counts.
Due to the safety risk of using increased levels of radiation, TLC plates were
run using different amounts of lipid, to determine quality of separation and
detection of sample. Three amounts of lipid were investigated; 2.7mg, 13mg
and 27mg. The clearest separation was given with 2.7mg of lipid, while the
bands tended to run into each other using 13mg. The 27mg of lipid did not
separate at all and just smeared up the plate. Gas chromatography revealed that
no separation had taken place within the band. The 2.7mg of lipid had
separated into bands, with the unsaturated fats below the saturated fats, but
amounts were very low, so would be unlikely to contain sufficient
14
C to be
detected by the scintillation counter. The 13mg lipid band had separated, but
was less clear in that some of the bands had run into each other. It was obvious
that amounts of lipid in excess of 13mg could not be run successfully on the
TLC plate, and that 13mg of lipid gave a smeared separation, so it was decided
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to run amounts of 2mg and 5mg to check clarity of separation. It was possible
to get a clear separation using 5mg of lipid, so this was used for all future TLC
plates.
2.4.3. Retrieval of fatty acid methyl ester bands
Once the TLC plates had been run and the bands visualised, the next step was
to extract the fatty acid methyl esters from the plates. Initially this was done
using two hexane washes for 30 minutes each before centrifuging the solvent to
pellet any silica and drying it off. The analysis from the gas chromatograph
showed that there was very little unsaturated fatty acid present, even in the
monounsaturated band. There was very little oleic acid present which was
unusual for ovine adipose tissue. It was suspected that not all the fatty acids
were being removed from the silica, especially the monounsaturated ones. This
may be because hexane is not a polar enough solvent to lift the unsaturated
fatty acids off the silica. The fact that the silver retards the double bond of the
monounsaturated fatty acids is an indication that they are more firmly bound to
the adsorbent than saturated ones. Previous work in this laboratory (Richards,
1997) has shown that oleic acid may be eluted with 1:1 diethyl ether:
petroleum ether, and that 3% diethyl ether in petroleum ether elutes all
saturated fatty acid methyl esters. Thus it was decided to use different solvent
mixtures for each band to improve detection. This produced levels of
monounsaturates in excess of saturates in the correct band. These solvent
systems were used for all future extraction work.
2.4.4. Elution of the fatty acid methyl esters from the TLC plate
The individual bands on the TLC plate were cut up and placed in methylation
tubes to which 2ml of solvent was added. The tubes were vortexed and left for
30 minutes to allow the lipid to dissolve in the solvent. The solvent was then
transferred to an LP4 tube using a Pasteur pipette. This solvent wash was
repeated and the liquid transferred to the LP4 tube which was then centrifuged
at 3000rpm for 10 minutes in order to pellet the remaining silica at the bottom
of the tube. The solvent was transferred into another LP4 tube, leaving the
silica behind, and dried off to leave lipid. This was resuspended in 180Pl of
hexane prior to gas chromatograph analysis.
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2.4.5. Verification of fatty acid bands
Following the initial experiment, it was found that although the plates showed
a saturated fatty acid band and a monounsaturated fatty acid band, there was
another band close to the loading area. Upon exposure to film, it became clear
that there was no or little radioactivity in the monounsaturated band, but some
in the saturated or top band and the lower band. The lower band would be
expected to be polyunsaturated fatty acids, and it was unclear why there should
be no oleic acid being formed, when polyunsaturated fatty acids were present.
Standards of palmitic and oleic fatty acid methyl esters were run on a silver
TLC plate to verify that the oleic acid band did run to 1cm below the palmitic
acid band. This was found to be correct, so the next step was to add some
radiolabelled oleic and palmitic fatty acids to the standards and methylate them
before running on a silver TLC plate. This was done to check that the acetate
was not preventing the oleic acid from running up the plate to its usual
position. The plate was imaged to detect radiolabelled fatty acid methyl esters.
The oleic acid was 1cm below the palmitic acid band, so the radiolabel was
clearly not preventing upward travel of the oleic acid. Attention then turned to
the methylation being used. The base methylation is suitable for lipids present
as triacylglycerol, but does not work well for lipids present as free fatty acids
(FFAs). An acid-base methylation would methylate all lipids, whether present
as TAG or FFAs. It may be possible that the oleic acid formed during the
incubation is present as FFAs, due to the time taken for it to be formed.
Palmitic acid is formed relatively quickly, but lipid destined for oleic acid must
be elongated in the endoplasmic reticulum, desaturated and then re-esterified. It
may be that the incubation was not long enough for the process to be
completed. An experiment was done using an acid-base methylation in addition
to a base methylation and plates compared for oleic acid bands. Clear MUFA
bands were seen, containing radioactive acetate, and the lower band that was
previously visible, just above the loading point was absent. It was concluded
that this band seen under base methylation conditions had been composed of
unmethylated free fatty acids, and therefore base–acid methylation was used
thereafter.
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2.4.6. Design of primers and probes for hamster genes
Primer and probe sets were required for hamster ACC, beta actin, FAS, LPL
and SCD. Relatively little sequencing work has been done on the hamster
genome, so initially mouse and rat sequences were used which were likely to
be highly conserved across other rodent species and therefore suitable for use
with hamster DNA. Sequences for the above genes in rat and mouse were
found under the following accession numbers in the GenBank database: Rat
ACC: NM 053922; Rat beta actin: NM 031144; Rat FAS: NM 017332; Rat
LPL: NM 012598; Rat SCD1: NM 139192; Rat SCD2: NM 031841; Mouse
ACC: BC022940; Mouse beta actin: NM 007393; Mouse FAS: NM 007988;
Mouse LPL: NM 008509; Mouse SCD: NM 009127; Mouse SCD2: NM
009128. A BLAST search was done to check that the gene sequences for rat
and mouse were a good match and suitable to design the primers from. Primer-
probe sets for the genes of interest are shown in Table 2.12. It was not possible
to design a suitable primer-probe set for the individual SCD genes due to the
presence of 2 isoforms in rat and 4 in mouse. Finding a region of the sequence
that was not conserved across isoforms proved difficult and such regions did
not yield any primer-probe sets.
Table 2.12 Primers designed from mouse and rat sequences
Gene Forward primer Reverse primer
ACC CAGATCCGGAAATATCATGTTTCA TGATCAATACGCCCTATGTCACC
Beta actin CGTGAAAAGATGACCCAGATCA ACGTAGCCATCCAGGCTGTG
FAS TCCTGGAACGAGAACACGATCT CAAGTCCAGGAGTGACACGTCTC
LPL CAAGATTCACTTTTCTGGGACTGA TCTCTGTACGGCACAGTGGC
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2.4.7. PCR optimization
It was necessary to verify that the PCR products being formed with the primers
were the correct size to ensure that the desired region of sequence was being
amplified.
2.4.7.1. 1
st
design primers
RNA was extracted from hamster liver as described in Section 2.3.10.4 and
complementary DNA was synthesized from this template. A PCR reaction was
set up as previously explained in section 2.3.11 across a temperature gradient
to check at which temperature the primers worked best. Ideally the annealing
temperature should be 5 degrees below the melting temperature of the primers.
The Primer Express program is set up to design primers and probes with Tm
values of 60qC and 70qC respectively. With this in mind, I set up a temperature
gradient from 55qC to 65qC for all primers and amplified up cDNA from
hamster liver. The resulting PCR products were then run on a gel against a
DNA ladder to confirm size and check that the correct product was being
formed (Figure 2.1).
Figure 2.1 PCR using hamster LPL primers over a temperature gradient
Primer dimers Product
The LPL primers worked well across the temperature gradient, with the
clearest band being seen at 56qC. The product size calculated from the
75bp
50bp
25bp 55qC 56qC 58qC 61qC 63qC 65qC 25bp 25bp
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sequence is 78 base pairs, which indicated that the product band seen just
above the 75 base pair marker was likely to be the correct one. The bands seen
at 55 and 56qC just below the 50 base pair marker are probably primer dimers,
and disappear as the annealing temperature increases.
2.4.7.2. Verifying PCR product
To confirm that the PCR reaction is working successfully with the primers, one
clear sharp band needs to be seen on the gel. At temperature extremes, several
bands may be seen, with the main one not clear. As the ideal temperature is
approached, the main band will sharpen up and the others will become less
evident, eventually not being seen. This is the temperature at which the primers
will work best. Ideally the primers needed to work best at 60qC, because the
probe is designed to work with a differential of 10qC from the primers. If this
differential changes, the efficiency of the reaction is altered, so the annealing
temperatures for the probe and primers should be 70qC and 60qC respectively.
The temperature gradient for the PCR reaction is a way of checking if the
primers will successfully amplify up cDNA. If only one temperature setting is
used, it cannot be confirmed whether the primers really do not amplify or
whether they do not amplify at that particular temperature. If all of the primers
were to work and product bands to be seen and conditions had to be changed
for each gene, using a probe would not have been possible because primer-
probe annealing temperature differentials must be 10qC. In this case, using
Sybr Green, a dye that binds to double stranded DNA would be better to
measure amplification and therefore gene expression. In the case of LPL,
where the best annealing temperature is 56qC, using Sybr Green would be the
best approach unless it was possible to find another primer pair that would
work best at 60qC.
2.4.7.3. 2
nd
design primers
ACC, beta actin and FAS showed no bands on the gel, so these primers did not
produce products under the conditions of the PCR reaction. New primers were
designed and checked in the same way (Table 2.13).
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Table 2.13 Sequences for 2
nd
design primers
Gene Forward primer Reverse primer
ACC TGGATCCGCTTACAGAGACTTTT GCCGGAGCATCTCATTCG
Beta actin GGCGCTTTTGACTCAGGATT GGGATGTTTGCTCCAACCAA
FAS TCGTGATGAACGTGTACCGG CTTTGTAAACGTCCTCACCCG
cDNA was synthesized and a PCR reaction set up as in Section 2.3.11. A gel
was run to look at products and check sizes (Figure 2.2).
Figure 2.2 PCR products using FAS, ACC and beta actin primers
Primer dimers Product
This gel shows bands at 58 and 59qC for beta actin, approximately 100 base
pairs in size. The expected product was 70 base pairs, but it is possible to see a
second band at 59qC, which is likely to be the predicted fragment. The 2 bands
indicate that the primers are clearly not producing a single clean product so are
unlikely to be suitable for use in Taqman analysis. No product bands were
detected using FAS or ACC primer pairs. The FAS primers formed primer
dimers which can also be seen on the gel.
100bp
25bp
50bp
25bp 58 59 61 62 63 64 65 58 25bp 59
FAS ACC E actin
58 59 61 25bp
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2.4.8. Final primer and probe sequences
2.4.8.1. ACC, FAS and LPL primers
Similar work (Guo et al, 2001) has looked at gene expression using Taqman
analysis for a number of genes in Chinese hamsters, including ACC, FAS and
LPL. Sequences for these have been published on GenBank under the
following accession numbers: ACC: AF 356089; FAS: AF 356086 and LPL:
AF 356087. From this work I was able to obtain probe and primer sequences
for ACC, FAS, LPL and SCD (Guo, personal communication). Primer and
probe sequences were checked against the gene sequences from the database
and located in FAS and LPL. Primers for ACC were found, but the probe did
not match any of the sequence. Initially, only primers were ordered, to check
that they were able to amplify up hamster cDNA. Table 2.14 shows the primers
that were tested.
Table 2.14 Primers from Qiu Guo
Gene primers Primer Sequence Tm (qC)
ACC Forward primer CTGCTGGAGACCGAAAGCTT 65.7
ACC Reverse primer CAACATGGTGTCAGGACGTTCT 66.1
FAS Forward primer AAGGACCAGGTGGAGGATGC 67.5
FAS Reverse primer CCTGGACAAGGACTTTGCCA 67.4
LPL Forward primer TTTAACTACCCCCTGGACAATGTC 65.6
LPL Reverse primer ACCTTCTTGTTGGTCAGACTTCCT 65.1
SCD Forward primer CCGAGAGACTTCAGGGAACTTG 66.1
SCD Reverse primer GGTAGGCAGGTATGCTCCGA 66.2
Primers were tested to check that they amplified hamster cDNA and produced
the correct size products. These primers had been designed to work on the
Taqman, which uses an annealing temperature 10qC less than the probe at 70qC
so I expected these to work well with an annealing temperature of 60qC, so a
single temperature setting was used. The product sizes for ACC, FAS and LPL
were calculated to be 102bp, 70bp and 92bp respectively. Figure 2.3 shows the
product bands from the PCR using these primers.
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Figure 2.3 PCR products using primer pairs for ACC, FAS and LPL
Clear single bands were formed for each gene and for both liver and adipose
tissue cDNA. The markers indicated that the band sizes agreed with the
expected product. It is interesting to see that while the ACC bands from liver
and adipose tissue are of equal intensity, those from FAS and LPL in adipose
tissue and liver vary. The FAS product formed from liver cDNA is more
intense than that formed from adipose tissue cDNA. This is likely to reflect
relative proportions of the different genes in the 2 tissues. Similarly, the LPL
product from adipose tissue is more intense than that from liver. It is known
that LPL is more evident in adipose tissue than in liver, and the gel seems to
confirm this well.
2.4.8.2. SCD primers
The primers for SCD were tested in the same way, and a gel of PCR products
run. Figure 2.4 shows the product bands that were seen.
Liver AT Liver AT Liver AT
ACC ACC FAS 100bp 25bp FAS LPL LPL
100
75
50
102bp
70bp 70bp
92bp
300
200
100
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Figure 2.4 PCR products using primer pairs for SCD
SCD product bands
Product bands
The expected product size was approximately 70 base pairs, and the bands are
level with the 75 base pair marker, so this is likely to be the correct product.
Taqman optimization
2.4.9. Testing of primers and probes for ACC, FAS, LPL and SCD
Probes were synthesised for ACC, FAS, LPL and SCD by Sigma Genosys. The
sequences of the probes are shown in Table 2.15.
Table 2.15 Probes for ACC, FAS, LPL and SCD
Gene Probe sequence Tm (qC)
ACC TCTGTCCAGCCAGCCAGTGTCGA 75.5
FAS TCCGCTACATGGCTCAGGGAAAACA 74.5
LPL AGCCTTGGAGCCCACGCTGCT 75.2
SCD CAGTTGCTCCTGGCTGTGGTGAAGTCT 74.6
A stock solution of hamster cDNA was made as described in section 2.3.14,
and from this standard dilutions were made up to form a standard curve.
Standard curves for ACC, FAS, LPL and SCD were run, to check for linearity.
Figures 2.5-2.8 show the resulting standard curves.
75
Liver Liver 25bp 100bp AT AT 25bp 100bp
75
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Figure 2.5 Standard curve using ACC primers and probe
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Figure 2.6 Standard curve using FAS primers and probe
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Figure 2.7 Standard curve using LPL primers and probe
y = -4.319x + 27.748
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Figure 2.8 Standard curve using SCD primers and probe
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2.4.10. Testing of primers and probe for beta actin
On testing the probe with the primers the standard curve was not linear, so
primers alone and Sybr Green mastermix were used. The standard curve was
still not linear, so primers designed from rat and sheep gene sequences were
tested. These primers worked well and gave a linear standard curve so could be
used for sample analysis, especially using the probes which had been designed
to work with them. Primer and probe matches to the hamster sequence were
examined. The rat primers were conserved between sequences, but the probe
was not so only the primers could be used in any analysis. The sheep primers
and probe were not conserved so these were discarded as an option. The beta
actin primer and probe sequence designed for use with hamster tissue was from
a mouse beta actin sequence so this was aligned with the hamster sequence to
check how conserved the primers were. The reverse primer was not conserved
between species so the hamster sequence was entered into Primer Express. Due
to the constraints imposed by the Taqman method for design of primers and
probes no suitable amplicon could be found, so primers were manually
designed around the existing beta actin probe, keeping within these constraints.
The resultant primers used in the final analysis (Table 2.16) were tested by
running a standard curve (Figure 2.9).
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Table 2.16 Primers designed manually around existing hamster sequence
probe
Sequence Tm (qC)
Forward primer GGCGCTTTTGACTCAGGATTTA 66.1
Probe AACTGGAACGGTGAAGGCGACAGC 74.7
Reverse primer GGGATGTTTGCTCCAACCGA 69.3
Figure 2.9 Standard curve using beta actin primers and probe
y = -3.113x + 23.837
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2.5. STATISTICAL ANALYSIS
Data from the in vitro sheep adipose tissue culture experiments (Chapter 3)
using one variable was subjected to one-way analysis of variance (ANOVA),
blocking for animal (Genstat 6
th
edition, Lawes Agricultural Trust,
Rothamsted). Data from experiments where two different variables were
applied was analysed by two-way ANOVA. Experiments using two different
fatty acids compared to a single control group were analysed by analysis of
variance, with treatments partitioned into the control group versus the rest of
the treatments (control vs rest), type of fat and amount of fat. Results were
deemed significant at p0.05.
Data from the in vivo protected CLA sheep feeding trial (Chapter 4) was
analysed by analysis of variance using Genstat, with variation in treatment
partitioned into the control group versus the rest of the fat treatments (control
vs rest), type of fat and amount of fat. Results were deemed significant at
p0.05.
Data from the in vivo hamster CLA feeding trial (Chapter 5) was analysed by
one-way ANOVA using Genstat, with the exception of the fatty acid
composition data, which was analysed by fitting a regression model to the fatty
acid composition data within an ANOVA analysis. Results were deemed
significant at p0.05.
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3. EFFECT OF CONJUGATED LINOLEICACID ON
LIPID METABOLISM IN OVINEADIPOSE
TISSUE EXPLANTS
3.1. CONTROL OF LIPOGENESIS IN OVINE ADIPOSE
TISSUE
The initial experiments concentrated on verifying that the explant culture
technique was able to detect changes in lipogenesis caused by hormonal
stimulation. Insulin is known to increase the rate of lipogenesis (Vernon, 1979)
in ovine adipose tissue explants, so this was used as a treatment.
Tissue from 10 ±2 month old Mule x Charollais non-lactating ewes fed on a
basal concentrate diet as described in Section 2.2.1.1 was used for all explant
experiments.
3.1.1. Examination of control of lipogenesis by insulin and
dexamethasone
To study the effect of insulin on lipogenesis, adipose tissue explants were
cultured with insulin for 24 hours before being transferred to culture media
containing acetate with the 1
st
carbon labelled with
14
C at a specific activity of
0.02MBq/ml and incubated in a shaking water bath for a further 2 hours.
Tissue was then solubilised and counted using a scintillation counter for
14
C. A
time course experiment measuring acetate incorporation into adipose tissue
was carried out initially to check that incorporation remained linear over the
time period being studied. This was repeated once using a different sheep. The
experiment treating explants with insulin was carried out on subcutaneous
adipose tissue from 4 different sheep and the results shown are data combined
from the four sheep and blocked for individual animal in the analysis of
variance. Experiments were also carried out using insulin and the hormone
dexamethasone (a synthetic glucocorticoid) on 2 different sheep.
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3.1.1.1. Effect of time on lipogenesis
Preliminary studies (Figure 3.1) confirmed that acetate incorporation is linear
over time and can be used as a measure of lipogenesis in explant culture
studies. The pattern of acetate incorporation was best explained when fitted to
a linear regression, with an R
2
value of 0.962 (analysed by ANOVA), therefore
acetate incorporation was concluded to be a suitable marker for the
measurement of lipogenesis in adipose tissue explants. A repeat of the
experiment confirmed these observations.
3.1.1.2. Effect of insulin and dexamethasone on lipogenesis
Insulin at a concentration of 20nM significantly increased acetate incorporation
(Figure 3.2) and therefore lipogenic rate over a 24 hour period in culture. This
is consistent with previous work in this laboratory (Richards, 1997). Treatment
of ovine adipose tissue explants independently with insulin and dexamethasone
(Figure 3.3) resulted in a significant increase and decrease respectively in
lipogenesis (p<0.001). However, when the two hormones were supplied
together levels of lipogenesis increased but not significantly above those of
control levels.
Chapter 3: Effect of CLA on lipid metabolism in ovine adipose tissue explants
88
Figure 3.1 A time course experiment measuring acetate incorporation
into subcutaneous ovine adipose tissue explants incubated in
the absence of insulin in Medium 199
R2 = 0.962
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Data presented are group mean values and is from one experiment. Data was subjected to an
analysis of variance test, and fitted to a linear regression model (R
2
value presented). Error bars
are standard errors of the differences of means.
Figure 3.2 1-[
14
C] acetate incorporation as a measure of lipogenesis in
ovine subcutaneous adipose tissue explants subjected to 24h
pre-incubation, followed by 24h treatment with insulin
(20nM), then 2h incubation with treatments and radio-
labelled acetate.
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Data is from 4 independent experiments using 4 different sheep and was subjected to analysis
of variance, blocking for experiment using Genstat. Error bars are standard errors of the
differences of means of treatment groups. Results were considered significant at p = 0.05.
s.e.d.
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Figure 3.3 1-[
14
C] acetate incorporation as a measure of lipogenesis in
ovine subcutaneous adipose tissue explants subjected to 24h
pre-incubation, followed by 24h incubation with no insulin
(control), 20nM insulin (Ins), 20nM insulin and 10nM
dexamethasone (Ins & Dex) or 10nM dexamethasone (Dex)
alone then 2h incubation with treatments and radio-labelled
acetate.
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Data is from 2 independent experiments using 2 different sheep and was subjected to one-way
analysis of variance, blocking for experiment using Genstat. Error bars are standard errors of
the differences of means of treatment groups. Results were considered significant at p = 0.05.
s.e.d.
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3.1.2. Examination of control of lipogenesis by fatty acids
Having successfully demonstrated that ovine adipose tissue explants in culture
are sensitive to both lipogenic and lipolytic hormones, the effects of fatty acids
on lipogenesis were examined.
3.1.2.1. Effect of different concentrations of fatty acids on lipogenesis
Tissue was treated with an isomeric mixture of 90% pure conjugated linoleic
acid, consisting of approximately equal amounts of the two major isomers cis-
9, trans-11 and trans-10, cis-12 at four different concentrations and compared
to oleic acid at the same concentrations (Table 3.1). There was an interaction
between concentration and type of fatty acid (p<0.001), with explants treated
with 1µM CLA incorporating significantly less acetate than those treated with
oleic acid. Conversely, acetate incorporation in explants treated with 100µM
CLA was significantly higher than those treated with 100µM oleic acid.
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Table 3.1 1-[
14
C] acetate incorporation as a measure of lipogenesis in
ovine subcutaneous adipose tissue explants subjected to 24h
pre-incubation, followed by 24h incubation in insulin-
containing media, with either oleic or conjugated linoleic acid
at different concentrations then 2h incubation with treatments
and radio-labelled acetate.
Acetate incorporation
Control 3.94
1µM oleic acid 8.18
10µM oleic acid 6.58
100µM oleic acid 5.59
1000µM oleic acid 3.79
1µM CLA 5.34
10µM CLA 7.52
100µM CLA 8.47
1000µM CLA 4.24
s.e.d.
Control vs rest 0.577
Type of fatty acid 0.385
Concentration of fatty acid 0.544
Interaction 0.770
P-value
Control vs rest <0.001
Type of fatty acid (F) 0.354
Concentration of fatty acid (C) <0.001
Interaction (F x C) <0.001
Data is expressed as nmol acetate/mg tissue/2h and is from 3 independent experiments using 3
different sheep with 4 plates for each and was subjected to a two-way ANOVA analysis
blocking for experiment using Genstat and comparing control with the rest of the treatments
(Control vs rest). F x C = fatty acid-concentration interaction; F = fatty acid; C = concentration.
Results were considered significant at p = 0.05.
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3.1.2.2. Effect of individual isomers of CLA on lipogenesis
Having established a concentration effect of fatty acids on lipogenesis (Table
3.1), fatty acids were added to cultured explants at a concentration of 10µM. It
was thought that any effect of the different fatty acids would be detected at this
concentration. To further increase rates of lipogenesis, incubation with
treatment fatty acids was increased to 48h, as a result of a time course
experiment showing better responses to insulin with time (data not shown).
There is evidence that different CLA isomers have different effects, so the
effects of the two major isomers (cis-9, trans-11 and trans-10, cis-12 CLA) on
lipogenesis were studied in the presence and absence of insulin, using oleic
acid as a comparative fatty acid and BSA as a control, to take into account any
lipogenic effects of the BSA which the fatty acids were complexed to. There
was much variation in the tissue response between different preparations
(Figure 3.4), with no consistent effect of treatments being seen. When the
results were pooled together and analysed, there was a significant (p<0.001)
interaction between fatty acid and insulin (Table 3.2). When insulin was
present, cis-9, trans-11 and trans-10, cis-12 CLA significantly increased
acetate incorporation, but in the absence of insulin, trans-10, cis-12 CLA
reduced acetate incorporation relative to control incubations, so the inhibitory
effects of trans-10, cis-12 CLA seem to be overcome by the stimulatory effect
of insulin on lipogenesis. Oleic acid reduced acetate incorporation relative to
control values both with and without insulin. However, in light of the variation
between individual experiments and the lack of consistent results it is not
possible to reach a conclusion regarding these results.
Chapter 3: Effect of CLA on lipid metabolism in ovine adipose tissue explants
93
Figure 3.4 Acetate incorporation into subcutaneous ovine adipose tissue
explants subjected to 24h pre-incubation, followed by 48h
incubation with 10µM of treatment fatty acids followed by 2
hours further incubation with radio labelled acetate by
individual experiment
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Fatty acids were oleic acid (OA), cis-9, trans-11 CLA (c9t11) and trans-10, cis-12 CLA
(t10c12) at a concentration of 10µM or with BSA control (Control) at the same concentrations
present in the fatty acid-containing plates. s.e.d. is the standard error of the difference between
the means for fatty acid (FA) treatment. A one-way ANOVA was performed on the data
(Genstat) which is expressed as nmol acetate/mg lipid/2h and is presented as the mean of 3
plates for each treatment.
s.e.d. FA
s.e.d. FA
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c) Experiment 3
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Fatty acids were oleic acid (OA), cis-9, trans-11 CLA (c9t11) and trans-10, cis-12 CLA
(t10c12) at a concentration of 10µM or with BSA control (Control) at the same concentrations
present in the fatty acid-containing plates. s.e.d. is the standard error of the difference between
the means for fatty acid (FA) treatment. A one-way ANOVA was performed on the data
(Genstat) which is expressed as nmol acetate/mg lipid/2h and is presented as the mean of 3
plates for each treatment.
s.e.d. FA
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Table 3.2 Acetate incorporation into subcutaneous ovine adipose tissue
explants subjected to 24h pre-incubation, followed by 48h
incubation with 10µM of treatment fatty acids followed by 2
hours further incubation with radio labelled acetate.
Fatty acid
a
Con OA c9t11 t10c12 Average s.e.d.
b
p-value
c
-Ins 0.65 0.39 0.61 0.19 0.46 f = 0.27 0.002
+Ins 1.10 0.73 2.16 2.82 1.70 i = 0.19 <0.001
Average 0.87 0.56 1.39 1.50 f.i = 0.38 <0.001
a
Fatty acids were oleic acid (OA), cis-9, trans-11 CLA (c9t11) and trans-10, cis-12 CLA
(t10c12) at a concentration of 10µM or with BSA control (Con) at the same concentrations
present in the fatty acid-containing plates.
b
s.e.d. is the standard error of difference of the means of treatment groups.
c
Statistical analyses were performed using a two-way ANOVA (Genstat) to examine
interactions between fatty acid and insulin; f denotes fatty acid effect, i denotes insulin effect.
Data is expressed as nmol acetate/mg lipid/2h and is from 3 independent experiments using 3
different sheep and statistical analysis was carried out blocking for experiment. Results were
considered significant at p = 0.05.
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3.1.3. Effect of fatty acids on acetate incorporation into saturated
and monounsaturated fatty acids
Having examined the effect of CLA and other fatty acids on total lipogenesis,
effects on acetate incorporation into saturated and monounsaturated fatty acids
were studied (Sections 2.3.3, 2.3.6, 2.3.7 & 2.3.8). CLA has been shown to
affect SCD activity, and an indication of enzyme activity can be gained by
studying the formation of monounsaturated fatty acids. The following
experiments were designed to identify if there are any effects of CLA on SCD
activity as measured by the relative synthesis of saturated and monounsaturated
fatty acids. Individual isomers were used as in Section 3.1.2.1 and 3.1.2.2, but
linoleic acid was used as a control fatty acid as it is atomically the same as the
CLAs but lacks the conjugated double bond structure which is characteristic of
these fatty acids. There was no effect of fatty acid on acetate incorporation into
either saturated or monounsaturated fatty acids (Table 3.3), however there was
an indication that trans-10, cis-12 CLA reduced monounsaturated fatty acid
formation, but this was not significant. There was no significant effect of fatty
acid on the ratio of saturated to monounsaturated fatty acids, so it can be
concluded that treatment of explants with any of the fatty acids used here does
not reduce the ratio of formation of saturated and monounsaturated fatty acids.
There was a large amount of variation between tissue preparations’ responses
to fatty acids (Figure 3.5) and inconsistent responses between individual
experiments indicate that there is no detectable effect of fatty acids on saturated
or monounsaturated fatty acid synthesis in ovine adipose tissue.
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Figure 3.5 Acetate incorporation into saturated and monounsaturated
fatty acids of subcutaneous ovine adipose tissue explants
subjected to 24h pre-incubation, followed by 48h incubation
in insulin-containing media with no fatty acid (BSA), and
10µM of either oleic acid, cis-9, trans-11 or trans-10,cis-12
CLA and 4 hours further incubation with radio labelled
acetate by individual experiment
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Fatty acids were linoleic acid (LA), cis-9, trans-11 CLA (c9t11) and trans-10, cis-12 CLA
(t10c12) at a concentration of 10µM or no fatty acid (Control), both with and without insulin.
Each graph is from one experiment. s.e.d. is the standard error of the difference between the
means of treatment groups. A one-way ANOVA was performed on the data (Genstat) which is
expressed as nmol acetate/mg lipid/4h and is presented as the mean of 3 plates for each
treatment.
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c) Experiment 3
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Fatty acids were linoleic acid (LA), cis-9, trans-11 CLA (c9t11) and trans-10, cis-12 CLA
(t10c12) at a concentration of 10µM or no fatty acid (Control), both with and without insulin.
Each graph is from one experiment. s.e.d. is the standard error of the difference between the
means of treatment groups. A one-way ANOVA was performed on the data (Genstat) which is
expressed as nmol acetate/mg lipid/4h and is presented as the mean of 3 plates for each
treatment.
s.e.d. SFA
s.e.d. MUFA
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Table 3.3 Acetate incorporation into saturated and monounsaturated
fatty acids of subcutaneous ovine adipose tissue explants
subjected to 24h pre-incubation, followed by 48h incubation
in insulin-containing media with no fatty acid (BSA), and
10µM of either oleic acid, cis-9, trans-11 or trans-10,cis-12
CLA and 4 hours further incubation with radio labelled
acetate.
Fatty acid
a
Con LA c9t11 T10c12 s.e.d.
b
p-value
c
SFA 3.70 4.04 3.58 3.85 f = 0.71 0.925
MUFA 1.47 1.75 1.39 1.27 f = 0.42 0.701
SFA:MUFA ratio 3.57 3.66 2.84 4.47 f = 0.66 0.130
a
Fatty acids were linoleic acid (LA), cis-9, trans-11 CLA (c9t11) and trans-10, cis-12 CLA
(t10c12) at a concentration of 10µM or no fatty acid (Con), all with insulin.
b
s.e.d. is the standard error of difference of the means of treatment groups.
c
Statistical analyses were performed using a one-way ANOVA (Genstat) to examine effects of
fatty acids on acetate incorporation; f denotes fatty acid effect.
Data is expressed as nmol acetate/mg lipid/4h and is from 3 independent experiments using 3
different sheep and statistical analysis was carried out blocking for experiment. Results were
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3.1.4. Effect of fatty acids on steady-state RNA levels in ovine
adipose tissue
Having concluded from the work studying acetate incorporation into
monounsaturated fatty acids that there was no reproducible effect of CLA on
lipogenic activity in ovine adipose tissue explants cultured in vitro, the key
genes controlling lipogenesis and desaturation in sheep were examined to
determine if CLA had effects at the gene transcription level. Beta actin was
used as a housekeeping gene and did not change significantly with treatment
across all experiments (Figure 3.6). Acetyl-CoA carboxylase is the first
enzyme in the lipogenesis pathway, and is also rate limiting, so this was used
as a marker of lipogenic rate. SCD controls desaturation as previously
mentioned (Section 1.4.3) and was also studied. Preliminary experiments using
the hormones insulin and dexamethasone as in the total lipogenesis
experiments were carried out before using the fatty acids.
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Figure 3.6 Beta actin steady-state mRNA levels in subcutaneous ovine
adipose tissue subjected to 24h pre-incubation, followed by
48h with no insulin (Con), 20nM insulin (Ins), 20nM insulin
and 10nM dexamethasone (Ins & Dex), 10nM dexamethasone
(Dex), 10µM of either oleic acid (OA), cis-9, trans-11 CLA
(c9), trans-10, cis-12 CLA (t10) or linoleic acid (LA)
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Data is from one experiment and was subjected to one way ANOVA using Genstat. The
experiment was repeated twice and the same results obtained. s.e.d. is the standard error of the
difference between the treatment group means which are presented as the mean of 3 plates for
each treatment.
s.e.d.
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There was a significant effect (p<0.001) of treating explants with insulin and
dexamethasone on ACC RNA levels (Figure 3.7). This was the same as seen in
the total lipogenesis studies and indicates that, in the case of ACC, gene
expression is a good indicator of enzyme activity. Treatment with insulin alone
significantly increased ACC mRNA levels, but treatment with dexamethasone
failed to significantly reduce those levels, possibly due to the low levels of
ACC mRNA measured in both control and dexamethasone treated explants.
There was a significant effect (p = <0.001) of both hormones on SCD mRNA
levels (Figure 3.8). Insulin and dexamethasone significantly increased SCD
mRNA levels, as did insulin alone. Dexamethasone alone significantly reduced
SCD mRNA levels. Effects seen on SCD mRNA levels were 4 fold greater
than controls, but those seen on ACC mRNA levels were only 2 fold greater
than controls. This and the effects latterly described were consistent with
Daniel et al, 2004, using ribo-nuclease protection assays. Figures 3.7 and 3.8
demonstrate that steady-state RNA levels as quantified by Taqman real-time
PCR are as reliable as quantification by
32
P ribo-nuclease protection assay.
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Figure 3.7 ACC steady-state mRNA levels in ovine subcutaneous adipose
tissue subjected to 24h pre-incubation, followed by 48h
incubation with no insulin (control), 20nM insulin (Ins), 20nM
insulin and 10nM dexamethasone (Ins & Dex) or 10nM
dexamethasone (Dex) alone
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Figure 3.8 SCD steady-state mRNA levels in ovine subcutaneous adipose
tissue subjected to 24h pre-incubation, followed by 48h
incubation with no insulin (control), 20nM insulin (Ins), 20nM
insulin and 10nM dexamethasone (Ins & Dex) or 10nM
dexamethasone (Dex) alone
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Data is expressed relative to beta actin and is from 3 independent experiments using 3 different
sheep and was subjected to one-way analysis of variance, blocking for experiment using
Genstat. Error bars are standard errors of the difference between treatment group means.
Results were considered significant at p = 0.05.
s.e.d.
s.e.d.
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There was no significant effect of fatty acid (p=0.768 and 0.212 respectively)
on either SCD or ACC RNA levels (Figure 3.10). Linoleic acid increased ACC
RNA levels but the difference relative to control values was not significant.
This is consistent with the total lipogenesis results (Table 3.3). There was
variation between experiments (Figure 3.9) making it difficult to ascertain
whether there was an effect of fatty acid on mRNA levels.
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Figure 3.9 SCD and ACC steady-state RNA levels in subcutaneous ovine
adipose tissue explants subjected to 24h pre-incubation, 48h
incubation in insulin-containing media with no fatty acid
(control), and 10µM of either oleic acid, linoleic acid, cis-9,
trans-11 or trans-10, cis-12 CLA displayed as individual
experiments
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c) Experiment 3
0.0
0.5
1.0
1.5
2.0
Con OA c9t11 t10c12 LA
m
R
N
A
le
v
e
ls
n
o
rm
a
liz
e
d
to
be
ta
a
c
tin
SCD/BA
ACC/BA
Fatty acids are linoleic acid (LA), oleic acid (OA), cis-9, trans-11 CLA (c9t11) and trans-10,
cis-12 CLA (t10c12) at a concentration of 10µM or no fatty acid (control). Each graph is from
one experiment. s.e.d. is the standard error of the difference between the means of treatment
groups. A one-way ANOVA was performed on the data (Genstat) which is expressed as
relative to the housekeeping gene beta actin and is presented as the mean of 3 plates for each
treatment.
s.e.d. ACC
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Figure 3.10 SCD and ACC steady-state RNA levels in subcutaneous ovine
adipose tissue explants subjected to 24h pre-incubation, 48h
incubation in insulin-containing media with no fatty acid
(control), and 10µM of oleic acid, linoleic acid, cis-9, trans-11
or trans-10, cis-12 CLA
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Fatty acids are linoleic acid (LA), oleic acid (OA), cis-9, trans-11 CLA (c9t11) and trans-10,
cis-12 CLA (t10c12) at a concentration of 10µM or no fatty acid (Control).
Data is expressed relative to beta actin and is from 3 independent experiments using 3 different
sheep and was subjected to one-way analysis of variance, blocking for experiment using
Genstat. Error bars are standard errors of the differences between the treatment group means.
Results were considered significant at p = 0.05.
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3.2. DISCUSSION
The aim of these experiments was to determine whether CLA had direct effects
on lipogenesis in sheep adipose tissue and whether these effects were a result
of modulation of expression of mRNA coding for lipogenic genes.
Experiments were performed to specifically look at total lipogenesis and the
synthesis of saturated and monounsaturated fatty acids separately.
3.2.1. Hormonal regulation of lipogenesis
Ovine adipose tissue explant culture is a well established technique for the
study of lipogenesis in response to hormones and the effects of insulin, growth
hormone and the glucocorticoids have been extensively studied in a number of
species. In ruminant animals acetate is the major substrate for lipogenesis
(Smith & Prior, 1986; Vernon, 1979) and therefore acetate and not glucose was
used for the tissue culture work presented here. It has been demonstrated by a
number of researchers that insulin increased lipogenesis in ruminant animals
(Miller et al, 1991; Vernon et al, 1991; Etherton & Evock, 1986; Vernon,
1979), therefore insulin was used as a positive control in all of the adipose
tissue culture experiments to test that the tissue was capable of responding to
hormonal stimuli. Dexamethasone, a synthetic glucocorticoid, was also used,
as this has been shown to reduce lipogenesis (Daniel et al, 2004) in ovine
adipose tissue explants. Initial experiments confirmed that the ovine explants
were responsive to hormones with lipogenesis increasing and decreasing in the
presence of insulin and dexamethasone respectively. However it is of note that
different preparations of adipose tissue explants varied significantly in their
response to insulin with the level of stimulation varying from 61 to over 200%
of controls.
3.2.2. Effect of exogenous fatty acids on lipogenesis
Having established that the explant culture technique was capable of
responding to hormonal stimuli, the effects of fatty acids on lipogenesis were
examined. In initial experiments, in the presence of insulin, the response to
oleic acid was concentration dependent. At low concentrations (1µM) oleic
acid appeared to stimulate lipogenesis. At high concentrations of oleic acid
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lipogenesis appeared to fall and at 1000µM were similar to control levels. It is
possible that the relative reduction at a concentration of 1000µM of fatty acid
may be related to the toxic effect of this high concentration. There was a
similar pattern with the CLA mix with an initial stimulation of lipogenesis on
feeding a CLA mix, up to 100µM and then an apparent decrease at 1000µM.
Contrary to these findings, Dawson & Herbein (1996) reported that bovine
mammary cells cultured with CLA had reduced de novo synthesis of palmitic
acid and that this effect increased as cellular uptake of CLA increased. 3T3-L1
preadipocytes treated with 50 and 200µM CLA presented with significantly
lower triglyceride levels than cells treated with the same concentrations of
linoleic acid (Evans et al, 2000). There was no dose dependent reduction of
triglyceride accumulation with CLA treatment, but linoleic acid increased
triglyceride accumulation in a dose dependent manner. Since there is a large
amount of evidence to suggest that the two major isomers of CLA have
different effects, and it is primarily the trans-10, cis-12 isomer that is
responsible for effects on fat metabolism (Park et al, 1999; Choi et al, 2000),
explants were cultured with individual isomers at a concentration of 10PM
with and without insulin (Table 3.2). Results from these experiments were
somewhat variable but there was little evidence to suggest any major effect of
either isomer on lipogenesis. Brown et al (2001b) cultured 3T3-L1
preadipocytes with individual isomers of CLA in the presence of insulin, and
found that the trans-10, cis-12 isomer reduced the triglyceride content of the
cells, but that treatment with the cis-9, trans-11 isomer increased triglyceride
levels above those seen with linoleic acid. The present results do not confirm
these findings in ovine adipose tissue explants. This may be the result of
species differences in responsiveness to CLA. However it is of note that there
was much variation in basal and insulin stimulated lipogenesis between
different explant preparations. The increase in lipogenesis in response to
treatment with insulin is well documented (Miller et al, 1991; Etherton &
Evock, 1986; Vernon, 1979), and yet in some of the experiments there is a very
small increase in lipogenesis with insulin, while others show larger increases.
Fatty acids seem to stimulate lipogenesis, but effects are highly variable, and
clearly there are differences between tissue preparations evident by these
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variable insulin responses. It is likely that genetic and physiological differences
between animals together with differences in the viability of the final explants
may all contribute to this variation in responsiveness. The availability of fatty
acids to all of the cells within the tissue may also represent a specific problem
when looking for a response. While relatively small, water soluble hormones
may readily diffuse through the tissue to reach cells in the centre of the
explants, this may not be the case for hydrophobic fatty acids, even when
complexed to albumin. It must be concluded that any direct effects of fatty
acids on lipogenesis are not of a magnitude that can be detected using the
adipose tissue explant system.
3.2.3. Effect of fatty acids on saturated and monounsaturated fat
Previous studies in other species have suggested that CLA can markedly affect
the fatty acid composition of tissue by reducing the relative rate of desaturation
of saturated fatty acids to monounsaturated fatty acids through modulating the
activity of SCD. Having failed to demonstrate a clear effect of CLA on total
lipogenesis, effects of CLA treatment on acetate incorporation into different
classes of fatty acids were studied. Previous work from our laboratory showed
that this technique could be used to demonstrate specific effects of insulin and
dexamethasone on the relative synthesis of these fatty acid classes in ovine
adipose tissue explants (Daniel et al, 2004). However in the present
experiments, no consistent effect of this isomer, or any other fatty acid, on the
relative synthesis of saturated fatty acids or MUFA could be demonstrated.
Studies in HepG2 cells treated with trans-10, cis-12 CLA showed an increase
in saturated fatty acids and a concomitant decrease in monounsaturated fatty
acids compared to BSA fatty acid free controls (Choi et al, 2001). There was
no indication that formation of monounsaturated fatty acids was inhibited by
CLA in sheep as has been previously reported in pigs (Demaree et al, 2002;
Smith et al, 2002; Ramsay et al, 2001), rats (Alasnier et al, 2002; Poulos et al,
2001), sheep (Mir et al, 2000). Much of the adipose tissue lipid is comprised of
TAG, and changes in the proportions of saturated and monounsaturated fatty
acids can be used as an indication of SCD activity (Demaree et al, 2002; Smith
et al, 2002). Although fatty acid composition was not measured in these
experiments, it is de novo fatty acid synthesis which is responsible for tissue
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fatty acid composition and therefore measurement of radiolabel incorporated
into fat, or the amount of saturated or monounsaturated fatty acid synthesis
occurring is another method of estimating SCD enzyme activity. Obviously the
lack of any response in the explants may represent a tissue specific difference
in response to CLA isomers. Alternatively, this may reflect a difference in
responsiveness of different species. However, the specific problems associated
with explants, as detailed in Section 3.2.2 may be responsible for the lack of
responsiveness.
3.2.4. Effect of fatty acids on enzyme RNA levels in adipose tissue
Previous work from our laboratory has indicated that ovine adipose tissue
explants can be used to demonstrate the effect of hormones on the mRNA
concentrations for lipogenic enzymes (Daniel et al, 2004; Richards, 1997).
Insulin was shown to increase the levels of both ACC and SCD mRNA while
dexamethasone had the opposite effect (Daniel et al, 2004). Furthermore the
same technique was used to demonstrate the effects of retinoic acid on ACC
and SCD gene expression (Daniel, 2002). It was therefore decided to look at
the effects of different fatty acids, including the two major CLA isomers on
mRNA concentrations for these two enzymes. Initial experiments confirmed
the effects of insulin and dexamethasone and produced similar results to those
previously published (Daniel et al, 2004). However, there was no detectable
change in these mRNA levels with CLA, or any other fatty acid.
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3.2.5. Summary
The present data fails to demonstrate any consistent effect of fatty acid on
lipogenesis, or expression of lipogenic enzymes in ovine adipose tissue
explants. There are many reports of the effects of dietary fat on adipose tissue
lipogenesis in the literature, many of which are conflicting. Variously de novo
lipogenesis was not suppressed (Nelson et al, 1987; Clark et al, 1977) was
suppressed to a greater extent (Waterman et al, 1975; Vernon et al, 1975) or
was less suppressed (Demeyer et al, 1974; Du & Kruger, 1972) by a saturated
fat than a polyunsaturated fat diet. Compounding these findings is the time
scale of experiments which can vary from 48h to 2 weeks. Therefore very
small, insignificant changes in the type and amount of lipid may be seen in this
time which would be significant if observations were made over a period of
months. Effects of CLA on whole body systems may have their effects on a
number of other hormones, transcription factors and metabolites which are not
present in the tissue culture systems. It may be that CLAs have their effects by
acting on factors external to the system, which then have their effects on
lipogenic genes and/or enzymes. In addition, at present there is more evidence
for inhibition of hepatic lipogenesis by fatty acids than adipose tissue, although
an inhibition of lipogenesis with increasing concentrations of fatty acids has
been demonstrated in ovine adipose tissue (Vernon, 1975). It is of interest to
note that no difference in lipogenesis between the 2 treatment fatty acids,
linoleic acid and palmitic acid was seen. The results presented here with
respect to CLA could reflect a lack of responsiveness of mature sheep to the
fat-reducing properties of CLA. However, careful interpretation of in vitro
studies is needed and ideally these should be confirmed during in vivo trials.
For this reason it was decided to undertake the CLA feeding trial described in
the next chapter.
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4. EFFECT OF CONJUGATED LINOLEICACID ON
LIPID METABOLISM IN SHEEP
There have been few studies undertaken to look specifically at the effects of
CLA on ruminant carcass composition and tissue fatty acid composition in the
context of lipogenic enzyme gene expression. The objective of this trial was to
examine the effects of feeding CLA to sheep on carcass composition, tissue
fatty acid composition and ACC and SCD mRNA levels in adipose tissue
depots and liver in order to elucidate how CLA affects fat metabolism at a
transcriptional level. It was predicted that increasing the amount of CLA
available for absorption into tissues would decrease carcass fat by reducing the
mRNA levels of lipogenic enzymes ACC and SCD. This trial was carried out
in conjunction with R. Wynn of the University of Nottingham (see Materials
and Methods). The fatty acid composition data presented here are from the
analyses of Dr. R. Wynn and was presented as part of a PhD thesis (Wynn,
2003).
4.1.1. Experimental design
36 weaned ewe lambs, initial weight 28kg were fed a lamb fattener diet (Table
2.1) as ground meal, supplemented with CLA-80 or Megalac at three levels
for 10 weeks as described in Section 2.2.2. The two fat supplements were
protected against rumen degradation and were broken down in the acidic
conditions of the abomasum. The protected CLA inclusion rates were 25, 50
and 100g/kg diet, equivalent to 4.23, 8.46, 16.92g CLA (with equal amounts of
cis-9, trans-11 and trans-10, cis-12 isomers). Previous studies in this
laboratory (Wynn, 2003) had established that the CLA-80 was 66% protected
against rumen degradation (see Section 2.2.2.2). Megalac is a commercially
available ruminally protected lipid supplement which contains fatty acids
bound to calcium. The calcium salts are protected from degradation in the
rumen, but release the fatty acids for absorption in the duodenum. Megalac was
fed to control for the energy value of the PCLA supplement, which is why the
amounts added to the diet are different from those of CLA. The CLA and
Megalac diets were isoenergetic with each other at each supplementation
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level. A basal lamb fattener diet containing no Megalac or CLA was fed as a
control treatment. Sheep were individually penned with access to water and
mineral licks. Sheep were slaughtered and samples collected as described in
Section 2.2.2.3.
4.1.2. Effect of PCLA on carcass composition
There was no effect of feeding protected CLA or Megalac on the growth rate,
final carcass weight or percentage carcass fat of lambs (Table 4.1). The weights
of perirenal and omental adipose tissue were also unchanged by
supplementation of diets with PCLA or Megalac.
Table 4.1 Animal growth rates, carcass weights, body fat content, fat depot weights and liver weights for lambs fed a basal lamb
fattener diet supplemented with Megalac or protected CLA (PCLA)
Growth rate
(g/d)
Carcass cold weight
(kg)
Body fat content
(% DM)
Perirenal fat weight
(g)
Omental fat weight
(g)
Liver weight
(g)
Control 197.0 20.2 54.8 472.8 643.1 663.5
Low Megalac 204.3 20.7 57.3 534.0 662.5 677.8
Medium Megalac 175.5 19.7 58.6 555.4 663.4 674.3
High Megalac 178.0 19.9 55.8 488.1 594.6 629.3
Low PCLA 186.8 20.3 57.3 491.7 645.4 617.4
Medium PCLA 182.2 20.5 57.1 564.5 662.6 616.3
High PCLA 198.4 20.8 55.9 523.0 705.6 652.1
s.e.d
Control vs rest 10.27 0.55 1.58 69.10 88.70 32.80
Type of fat 11.10 0.59 1.71 74.60 95.80 35.40
Amount of fat 11.86 0.63 1.82 79.70 102.40 37.90
Interaction 13.91 0.77 2.23 97.70 125.50 46.40
P-value
Control vs rest 0.362 0.907 0.185 0.447 0.888 0.569
Type of fat 0.708 0.350 0.697 0.992 0.672 0.244
Amount of fat 0.280 0.840 0.440 0.697 0.989 0.977
Interaction 0.193 0.437 0.856 0.852 0.737 0.366
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4.2. FATTY ACID COMPOSITION OF SHEEP DIETS
Figure 4.1 Fatty acid composition of Megalac supplement
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Figure 4.2 Fatty acid composition of PCLA supplement
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FAME were prepared using 0.5M sodium methoxide/methanol followed by 14% BF3/methanol
as in Section 2.3.7 and analaysed by GC using a BPX 70 60m column under the conditions
described in Section 2.3.9.
Chapter 4: The effect of conjugated linoleic acid on lipid metabolism in sheep
117
4.3. FATTY ACID COMPOSITION OF SHEEP TISSUES
4.3.1. CLA content of adipose tissue depots
Lipid was extracted from subcutaneous, perirenal and omental adipose tissues,
methylated and analysed by gas chromatography to examine incorporation of
cis-9, trans-11 and trans-10, cis-12 CLA as described in Sections 2.3.6, 2.3.7
& 2.3.9. There was a significant effect (p<0.001) of amount and type of fat on
incorporation of both CLA isomers into all adipose tissue depots (Table 4.2
and there was a significant interaction between the two. When the basal lamb
fattener diet was compared against all other treatments there was a highly
significant (p = 0.001) effect of fat treatment on the incorporation of both
isomers into all depots, with the exception of cis-9, trans-11 CLA in the
subcutaneous adipose tissue depot (p = 0.080). The amount of CLA present in
the adipose tissue increased with increasing supplementation. This indicates
that CLA was present in the tissues to potentially affect transcription of the
genes under investigation. The cis-9, trans-11 isomer was present as a greater
proportion of total FAME than trans-10, cis-12 CLA.
Chapter 4: The effect of conjugated linoleic acid on lipid metabolism in sheep
118
4.3.2. CLA content in liver
Lipid was extracted from liver tissue, methylated and analysed by gas
chromatography to examine incorporation of cis-9, trans-11 and trans-10, cis-
12 CLA as described in Sections 2.3.6, 2.3.7 & 2.3.9. There was a significant
(p<0.001) effect of the amount and type of fat fed on incorporation into lamb
liver of both CLA isomers (Table 4.3). The proportion of cis-9, trans-11 is
greater than that of trans-10, cis-12, as seen in the adipose tissue depots (Table
4.2) As supplementation of CLA increases the amount seen in the tissues also
increases, indicating that CLA is incorporated into liver in a dose dependent
manner.
4.3.3. Fatty acid composition of adipose tissue
There was a significant decrease in C16:1 and C18:1 cis-9 with PCLA feeding
(Table 4.4) in subcutaneous adipose tissue (p<0.001). There was a significant
decrease (p<0.001) in C16:1 in perirenal and omental adipose tissue. There was
a significant interaction between type and amount of fat for C18:1 cis-9 (p =
0.002 and 0.015 respectively).
4.3.4. Fatty acid composition of liver
There was a significant decrease in C16:1 with PCLA feeding (Table 4.3;
p=0.046) and a significant interaction between type and amount of fat for
C18:1 cis-9.
4.3.5. Desaturase activity in adipose tissue depots and liver
The lipid extracted from adipose tissue and liver was methylated and subjected
to gas chromatography as described in Section 2.3.9 to identify the individual
fatty acids present in tissues. The ratios of two pairs of fatty acids were
calculated; Palmitoleic acid (C16:1) and palmitic acid (C16:0); and oleic acid
(C18:1 cis-9) and stearic acid (C18:0). This was used as a measure of stearoyl-
CoA desaturase activity, which acts on stearic and palmitic acids to form oleic
and palmitoleic acids (Ntambi, 1999). By comparison of fatty acid composition
in animals fed CLA, specifically of these fatty acids, and RNA levels in tissues,
it is possible to identify whether CLA acts directly on the enzyme complex or
at a transcriptional level. The palmitoleic:palmitic acid desaturase ratio was
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significantly reduced with CLA supplementation in subcutaneous, perirenal
and omental adipose tissue (p = 0.003, <0.001 and 0.002 respectively),
indicating that CLA was reducing the activity of SCD (Table 4.5). The
stearic:oleic acid desaturase ratio was significantly reduced by CLA feeding in
subcutaneous, perirenal and omental adipose tissue depots (p = 0.027, <0.001,
0.008). The results seem to indicate that the subcutaneous adipose tissue depot
is less responsive than the internal depots. There was no significant effect of
increasing dose on either of the desaturase ratios, but there was an interaction
between fat type and amount in perirenal tissue for C16:1/C16:0 and
C18:1/C18:0 (p = 0.084 and 0.042 respectively). Desaturase ratios were also
calculated for liver in the same way as for adipose tissue. There was a
significant effect of amount of fat fed on the palmitoleic:palmitic ratio (Table
4.3; p = 0.028), but no significant effect on the stearic:oleic ratio (p = 0.388).
There was no effect of type of fat on either desaturase ratio, but there were
significant (p = 0.072 and 0.026) interactions between type and amount of fat
fed for both palmitoleic:palmitic and stearic:oleic ratios respectively.
Table 4.2 Proportions (% of FAME) of cis-9, trans-11 and trans-10, cis-12 CLA found in subcutaneous, perirenal and omental adipose
tissue of lambs fed a basal lamb fattener diet supplemented with Megalac or protected CLA (PCLA)
Subcutaneous Perirenal Omental
Cis-9, trans-11 trans-10, cis-12 cis-9, trans-11 Trans-10, cis-12 Cis-9, trans-11 trans-10, cis-12
Control 0.91 0.04 0.46 0.04 0.68 0.05
Low Megalac 0.80 0.02 0.47 0.07 0.73 0.07
Medium Megalac 0.95 0.10 0.50 0.13 0.82 0.08
High Megalac 0.86 0.08 0.52 0.24 0.75 0.10
Low PCLA 1.12 0.19 0.70 0.21 0.98 0.19
Medium PCLA 1.38 0.39 1.03 0.38 1.27 0.37
High PCLA 2.01 0.78 1.66 0.78 1.82 0.77
s.e.d.
Control vs rest 0.150 0.033 0.074 0.048 0.098 0.033
Type of fat 0.162 0.035 0.079 0.052 0.105 0.036
Amount of fat 0.174 0.038 0.085 0.055 0.113 0.038
Interaction 0.213 0.046 0.104 0.068 0.138 0.047
P-value
Control vs rest 0.080 <0.001 <0.001 <0.001 <0.001 <0.001
Type of fat <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Amount of fat 0.015 <0.001 <0.001 <0.001 <0.001 <0.001
Interaction 0.021 <0.001 <0.001 0.001 <0.001 <0.001
FAME were prepared as described in Section 2.3.7 and analysis was carried out by gas chromatography on a 100m CP-Sil 88 column. Data was analysed by ANOVA,
comparing control with the other treatment groups and testing for effects of fat, fat type, fat amount and a type-amount interaction.
Table 4.3 Proportions (% of FAME) of cis-9, trans-11 and trans-10, cis-12 CLA, C16:0, C16:1, C18:0 and C18:1 cis-9 found in the
liver of lambs fed a basal lamb fattener diet supplemented with Megalac or protected CLA (PCLA) and desaturase ratios
Liver Liver Liver Liver
Cis-9, trans-11 trans-10, cis-12 C16:0 C16:1 C18:0 C18:1 cis-9 C16:1/C16:0 C18:1/C18:0
Control 0.39 0.05 15.60 1.43 21.54 16.19 0.091 0.760
Low Megalac 0.40 0.10 14.79 1.20 22.83 16.08 0.080 0.715
Medium Megalac 0.42 0.11 15.67 1.22 22.46 16.97 0.077 0.758
High Megalac 0.54 0.14 15.43 1.67 21.35 20.07 0.106 0.943
Low PCLA 0.76 0.20 15.55 1.21 22.69 17.17 0.078 0.763
Medium PCLA 1.20 0.34 15.87 1.09 22.17 17.86 0.070 0.812
High PCLA 2.32 0.65 14.51 0.89 22.59 16.15 0.061 0.726
s.e.d.
Control vs rest 0.074 0.036 0.446 0.174 0.894 0.776 0.0098 0.0536
Type of fat 0.080 0.039 0.482 0.188 0.966 0.838 0.0106 0.0579
Amount of fat 0.086 0.042 0.515 0.201 1.032 0.896 0.0113 0.0619
Interaction 0.105 0.051 0.631 0.247 1.264 1.097 0.0138 0.0758
P-value
Control vs rest <0.001 <0.001 0.514 0.225 0.373 0.135 0.208 0.628
Type of fat <0.001 <0.001 0.971 0.046 0.714 0.316 0.028 0.388
Amount of fat <0.001 <0.001 0.192 0.777 0.679 0.178 0.583 0.222
Interaction <0.001 <0.001 0.175 0.071 0.648 0.004 0.072 0.026
FAME were prepared as described in Section 2.3.7 and analysis was carried out by gas chromatography on a 100m CP-Sil 88 column. Data was analysed by ANOVA,
comparing control with the other treatment groups and testing for effects of fat, fat type, fat amount and a type-amount interaction.
Table 4.4 Proportions (% of FAME) of fatty acids in subcutaneous, perirenal and omental adipose tissue depots of lambs fed a basal
lamb fattener diet supplemented with Megalac or protected CLA (PCLA)
Subcutaneous Perirenal Omental
C16:0 C16:1 C18:0 C18:1 cis-9 C16:0 C16:1 C18:0 C18:1 cis-9 C16:0 C16:1 C18:0 C18:1 cis-9
Control 24.41 1.48 18.61 31.11 23.72 1.10 27.75 27.72 25.25 1.14 23.91 26.38
Low Megalac 25.05 1.44 19.10 31.22 25.33 1.05 27.63 26.41 26.19 1.12 23.65 26.27
Medium Megalac 25.72 1.47 18.91 30.97 25.79 1.09 27.24 27.24 26.51 1.14 23.23 27.52
High Megalac 24.96 1.40 17.77 31.40 24.64 1.17 25.55 28.61 26.61 1.13 22.82 27.35
Low PCLA 24.27 1.09 22.17 28.49 23.34 0.82 29.73 25.84 25.17 0.95 24.36 26.03
Medium PCLA 24.98 1.08 18.70 28.34 24.27 0.78 28.08 24.08 25.49 0.86 24.68 24.16
High PCLA 24.24 1.00 19.89 25.29 24.11 0.72 28.84 21.81 25.15 0.88 23.58 21.84
s.e.d.
Control vs rest 0.614 0.125 1.476 1.046 0.680 0.064 0.887 0.787 0.552 0.070 1.044 0.843
Type of fat 0.664 0.135 1.594 1.130 0.735 0.069 0.958 0.850 0.597 0.076 1.128 0.910
Amount of fat 0.709 0.144 1.704 1.208 0.785 0.074 1.024 0.908 0.638 0.081 1.206 0.973
Interaction 0.869 0.177 2.087 1.480 0.962 0.091 1.255 1.113 0.781 0.099 1.477 1.192
P-value
Control vs rest 0.456 0.074 0.588 0.092 0.214 0.018 0.992 0.014 0.283 0.078 0.854 0.321
Type of fat 0.149 <0.001 0.180 <0.001 0.022 <0.001 0.015 <0.001 0.015 <0.001 0.265 <0.001
Amount of fat 0.410 0.823 0.378 0.308 0.525 0.969 0.148 0.512 0.844 0.855 0.689 0.167
Interaction 0.999 0.983 0.528 0.186 0.556 0.256 0.574 0.002 0.898 0.725 0.925 0.015
FAME were prepared as described in Section 2.3.7 and analysis was carried out by gas chromatography on a 100m CP-Sil 88 column. Data was analysed by ANOVA,
comparing control with the other treatment groups and testing for effects of fat, fat type, fat amount and a type-amount interaction.
Table 4.5 Desaturase ratios (calculated as the proportions of C16:1/C16:0 and C18:1 cis-9/C18:0) in subcutaneous, perirenal and
omental adipose tissue depots of lambs fed a basal lamb fattener diet supplemented with Megalac or protected CLA
(PCLA)
Subcutaneous Perirenal Omental
C16:1/C16:0 C18:1 cis-9/C18:0 C16:1/C16:0 C18:1 cis-9/C18:0 C16:1/C16:0 C18:1 cis-9/C18:0
Control 0.061 1.72 0.046 1.00 0.045 1.12
Low Megalac 0.058 1.71 0.041 0.97 0.043 1.14
Medium Megalac 0.057 1.64 0.042 1.00 0.043 1.18
High Megalac 0.056 1.77 0.048 1.14 0.043 1.20
Low PCLA 0.045 1.38 0.035 0.88 0.038 1.09
Medium PCLA 0.043 1.53 0.032 0.86 0.034 0.98
High PCLA 0.041 1.33 0.030 0.78 0.035 0.94
s.e.d.
Control vs rest 0.0051 0.1546 0.0025 0.0536 0.0026 0.0736
Type of fat 0.0056 0.1669 0.0027 0.0579 0.0028 0.0795
Amount of fat 0.0059 0.1785 0.0029 0.0619 0.0030 0.0850
Interaction 0.0073 0.2186 0.0036 0.0758 0.0037 0.1041
P-value
Control vs rest 0.055 0.319 0.004 0.236 0.028 0.730
Type of fat 0.003 0.027 <0.001 <0.001 0.002 0.008
Amount of fat 0.875 0.960 0.782 0.798 0.771 0.814
Interaction 0.994 0.581 0.084 0.042 0.698 0.346
FAME were prepared as described in Section 2.3.7 and analysis was carried out by gas chromatography on a 100m CP-Sil 88 column. Data was analysed by ANOVA,
comparing control with the other treatment groups and testing for effects of fat, fat type, fat amount and a type-amount interaction.
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The data displayed previously (Tables 4.3, 4.4 and 4.5) suggested that CLA
was having an effect on SCD and that there was a change in the amount of fatty
acid desaturation occurring. The aim of quantifying the mRNA for SCD and
ACC was to examine whether the effects of CLA on desaturation were due to
reduced transcription or direct inhibition or activation of the enzyme, and if
there was any effect on lipogenesis in terms of gene transcription.
4.4. ACC AND SCD MRNA LEVELS IN SHEEP TISSUES
RNA was extracted from liver tissue and the subcutaneous, perirenal and
omental adipose tissue depots of sheep as described in Section 2.3.10. Section
2.3.11 describes the measurement of tissue mRNA levels in detail. Briefly,
complementary strand DNA was synthesized and sequences were amplified
using Taqman primers and probes. Amplification was measured using the
ABI 7700 ‘Taqman’ machine, which quantifies the amount of RNA present.
Data was expressed relative to the gene beta actin, which was shown not to
change significantly across treatment groups; p = 0.340; 0.358; 0.249; 0.549
for subcutaneous, perirenal, omental adipose tissue and liver respectively
(Figures 4.3-4.6).
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Figure 4.3 Subcutaneous adipose tissue depot beta actin mRNA levels
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Figure 4.4 Perirenal adipose tissue depot beta actin mRNA levels
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Data is presented as the average of treatment groups: CON (control), LP (Low PCLA), MP
(Medium PCLA), HP (High PCLA), LM (Low megalac), MM (Medium megalac), HP (High
megalac). Data was analysed by ANOVA; s.e.d. is he standard error of the differences between
the group means.
s.e.d.
s.e.d.
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Figure 4.5 Omental adipose tissue depot beta actin mRNA levels
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Figure 4.6 Liver beta actin mRNA levels
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Data is presented as the average of treatment groups: CON (control), LP (Low PCLA), MP
(Medium PCLA), HP (High PCLA), LM (Low megalac), MM (Medium megalac), HP (High
megalac). Data was analysed by ANOVA; s.e.d. is he standard error of the differences between
the group means.
s.e.d.
s.e.d.
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4.4.1. ACC mRNA levels in adipose tissue depots and liver
There was no significant effect of feeding protected CLA on ACC mRNA in
subcutaneous and perirenal adipose tissue depots (Table 4.6) , however, there
was a significant interaction between the type and amount of fat in omental
adipose tissue and liver (p = 0.051 and 0.013 respectively). The effect of
amount of fat feeding is different for the two types of fat. Increasing Megalac
supplementation results in an increase in ACC mRNA levels in omental
adipose tissue, while increasing CLA levels reduces ACC mRNA. There is no
pattern to ACC mRNA levels in liver in response to increasing amounts of fat.
4.4.2. SCD mRNA levels in adipose tissue depots and liver
There was a significant effect of fat feeding on SCD mRNA (Table 4.6) in
perirenal adipose tissue and liver (p = 0.026 and 0.024 respectively) and this
resulted in an effect of fat feeding on the ratio of SCD:ACC in the same tissues
(p = 0.026 and 0.005 respectively). Increasing CLA supplementation tended to
reduce SCD mRNA in perirenal adipose tissue, particularly at the highest level
of supplementation. There was no pattern to SCD mRNA levels in liver with
increased fat supplementation, consistent with hepatic ACC.
4.4.3. Ratio of SCD:ACC mRNA levels in adipose tissue and liver
Feeding both Megalac and protected CLA significantly increased (p = 0.005)
the ratio of SCD:ACC in liver (Table 4.6). Conversely, feeding the same
amounts resulted in significant reduction of this ratio in perirenal adipose tissue
(p = 0.026). There was no significant change in ACC mRNA in either of these
tissues. In light of the SCD data, CLA seems to have an effect on SCD only.
Table 4.6 Stearoyl-CoA desaturase and acetyl-CoA carboxylase mRNA levels in liver, subcutaneous, perirenal and omental adipose
tissue depots expressed relative to beta actin mRNA levels
Subcutaneous Perirenal Omental Liver
SCD ACC SCD/ACC SCD ACC SCD/ACC SCD ACC SCD/ACC SCD ACC SCD/ACC
Control 0.651 0.545 1.258 1.263 1.293 0.971 1.361 1.198 1.039 0.609 0.606 0.969
Low Megalac 0.676 0.564 1.239 1.161 1.310 0.890 1.055 0.978 1.085 0.744 0.668 1.127
Medium Megalac 0.724 0.596 1.232 1.038 1.127 0.890 1.110 1.032 0.991 0.733 0.660 1.126
High Megalac 0.613 0.571 1.076 1.072 0.975 0.851 1.274 1.210 1.055 0.710 0.552 1.300
Low PCLA 0.675 0.656 1.037 1.085 1.170 0.859 1.282 1.316 0.972 0.667 0.635 1.055
Medium PCLA 0.637 0.656 1.161 1.063 1.187 0.904 1.188 1.123 1.058 0.624 0.524 1.190
High PCLA 0.608 0.603 1.020 0.997 1.258 0.792 1.117 1.044 1.092 0.738 0.674 1.105
s.e.d.
Control vs rest 0.034 0.0588 0.074 0.082 0.097 0.045 0.110 0.097 0.063 0.039 0.041 0.060
Type of fat 0.028 0.0455 0.060 0.067 0.079 0.037 0.119 0.079 0.051 0.032 0.033 0.049
Amount of fat 0.034 0.0588 0.074 0.082 0.097 0.045 0.127 0.097 0.063 0.039 0.041 0.060
Interaction 0.048 0.0789 0.104 0.116 0.137 0.064 0.156 0.137 0.088 0.055 0.057 0.085
P-value
Control vs rest 0.897 0.271 0.087 0.026 0.221 0.026 0.096 0.413 0.967 0.024 0.758 0.005
Type of fat 0.274 0.193 0.078 0.538 0.397 0.498 0.589 0.278 0.949 0.109 0.644 0.176
Amount of fat 0.089 0.784 0.145 0.529 0.438 0.244 0.914 0.760 0.689 0.511 0.342 0.192
Interaction 0.380 0.863 0.556 0.785 0.112 0.719 0.231 0.051 0.318 0.201 0.013 0.113
FAME were prepared as described in Section 2.3.7 and analysis was carried out by gas chromatography on a 100m CP-Sil 88 column. Data was analysed by ANOVA,
comparing control with the other treatment groups and testing for effects of fat, fat type, fat amount and a type-amount interaction.
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4.5. DISCUSSION
4.5.1. Incorporation of CLA into sheep tissues
Supplementation of lamb diets with protected CLA increased adipose tissue
and liver cis-9, trans-11 and trans-10, cis-12 CLA (Tables 4.2 & 4.3). This is
consistent with incorporation of dietary CLA into adipose and liver tissue and
has been shown in pigs fed CLA (Smith et al, 2002; Ramsay et al, 2001; Bee,
2000) and demonstrates that the CLA is protected against rumen degradation.
The dose dependent increase in CLA incorporation suggests that the presence
of both CLA isomers is due to incorporation of dietary CLA rather than de
novo synthesis in the adipose tissue. CLA content of adipose tissue in pigs fed
different amounts of CLA has been shown to increase with supplementation
level (Ramsay et al, 2001). Previous work has shown no effect of CLA
supplementation on incorporation of isomers into ovine adipose tissue (Mir et
al, 2000), however studies were done with pre-ruminant lambs, before weaning
to a barley-based pelleted diet, and the period of CLA supplementation was
only 3 weeks, so effects may not have been evident within such a short feeding
period. CLA incorporation into liver tissue was slightly lower than that in
adipose tissue. This is probably due to the different proportions of lipid classes
present in liver and adipose tissue. Adipose tissue is made up of 90% TAG,
whereas liver has a much higher proportion of phospholipids. CLA is
incorporated preferentially in TAG (Banni et al, 2001b), and the role of
phospholipids in cell membrane function resists major fatty acid compositional
changes as this affects fluidity and membrane function. The reduction in liver
CLA incorporation is consistent with the lower proportion of TAG present
compared to adipose tissue. There was more cis-9, trans-11 CLA than trans-
10, cis-12 CLA present in tissues (Tables 4.2 & 4.3) of sheep fed CLA. The
diet contained equal amounts of the two major isomers, so the imbalance is
likely to be due to in vivo synthesis, and the action of SCD on vaccenic acid
(Griinari & Bauman, 1999), or preferential metabolism of the trans-10, cis-12
isomer (Alasnier et al, 2002; Martin et al, 2000). These results indicated that
CLA was present within animal tissues and potentially able to affect gene
transcription.
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4.5.2. Effect of CLA on fatty acid composition of sheep tissues
Fatty acid composition of adipose tissue depots and liver was examined, with
particular focus on the amounts of the major saturated and monounsaturated
fatty acids, namely palmitic and stearic (C16:0 and C18:0) and palmitoleic and
oleic (C16:1 and C18:1). The ratio of these pairs (referred to as the desaturase
index) has been shown to be a good indicator of SCD enzyme activity (Choi et
al, 2001), therefore fatty acid composition and ratios of these key
monounsaturated and saturated fatty acids have been used in a number of
species, cell and tissue culture systems to determine whether treatments affect
SCD activity (Choi et al, 2002; Demaree et al, 2002; Smith et al, 2002; Choi et
al, 2001; Corl et al, 2001; Griinari et al, 2000; Park et al, 2000; Bretillon et al,
1999). These ratios and the effects of different fats upon them are discussed in
Section 4.5.3. The fatty acid composition of tissues is first considered in
relation to the fatty acid composition of the treatment diets. There was a
decrease in levels of palmitoleic and oleic acids in adipose tissue and liver
(Tables 4.3 and 4.4) of sheep fed CLA. It is possible that the drop in oleic acid
seen in sheep fed CLA relative to Megalac could be due to the amounts of oleic
acid present in the diets (Figures 4.1 & 4.2). However, there was no difference
in the levels of palmitic acid present in sheep fed PCLA and Megalac, despite
levels of 10% and 50% in PCLA and Megalac preparations respectively.
Additionally, if the fatty acid composition of sheep tissues was due to diet, a
greater amount of stearic acid would have been expected in sheep fed PCLA
than those fed Megalac, due to the amounts of stearic acid in PCLA and
Megalac (Figures 4.1 & 4.2). This was not evident, indicating that there was no
effect of dietary fatty acids on fatty acid composition. Palmitoleic acid was not
present in the diet, and yet levels fell significantly with PCLA feeding
compared to control and Megalac fed animals. There was no significant
difference in levels of palmitoleic acid between control animals and those fed
Megalac (Tables 4.3 and 4.4). Palmitoleic acid can only be present in the
tissues as a result of endogenous synthesis, via the action of SCD on palmitic
acid. These observations indicate that there was inhibition of SCD enzyme
activity with PCLA feeding. The palmitic and palmitoleic acid data suggest
that the drop in tissue levels of oleic acid was due to an inhibition of SCD
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enzyme activity, rather than changes in the relative abundance of this particular
fatty acid in the two diets.
4.5.3. Effect of CLA on SCD enzyme activity
CLA supplementation in growing lambs reduced the desaturase indices for C16
and C18 fatty acids in all adipose tissue depots (Table 4.5); however there was
no further reduction with increased supplementation. This is consistent with
studies in pigs fed CLA where levels of palmitic and stearic acids increased
and oleic acid decreased relative to controls (Smith et al, 2002; Ramsay et al,
2001). CLA also reduced desaturase ratio in pigs fed CLA (Demaree et al,
2002). Abomasal infusion of CLA reduced desaturase activity in the mammary
gland of dairy cows (Chouinard et al, 1999). Increasing amounts of CLA were
infused and this resulted in dose dependent reductions in C16:1 and C18:1
desaturase ratios. However, this group infused 0, 50, 100 and 150g/day of CLA
isomers as CLA-60, and this was directly available for absorption at the level
of the small intestine. Levels of CLA available for absorption at the level of the
small intestine in sheep in this study were between 0 and 5.4g/kg diet, whereas
those in cows were between 0 and 2.3g/kg diet (Chouinard et al, 1999). This
does not explain why there was no dose response effect seen in sheep, but the
method of fat supply may have had an effect. The CLA present for absorption
at the level of the small intestine in sheep is calculated on the basis of the
degree of protection from ruminal degradation, and the actual amount of CLA
absorbed may have been lower than the amount calculated. Therefore the range
of supplementation may have been too limited to show an effect. CLA feeding
significantly reduced the C16 desaturase ratio in liver but had no effect on the
C18 ratio. This is consistent with the reduced incorporation of CLAs into liver
lipids and reflects the lower proportion of TAG and increased long chain fatty
acids present within liver. Liver has a greater proportion of phospholipids,
which are resistant to changes in fatty acid composition, so this could explain
why there was a lesser effect of CLA on desaturase ratios in liver. A number of
other researchers have studied the effects of individual isomers on fatty acid
composition and SCD enzyme activity. Abomasal infusion of trans-10, cis-12
CLA reduced oleic acid and increased stearic acid in mammary tissue from
dairy cows (Baumgard et al, 2002), indicating an effect on SCD enzyme
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activity with this CLA isomer. SCD activity in mouse liver was inhibited with
0.5% dietary CLA (Lee et al, 1998), while in rat liver microsomes treated with
trans-10, cis-12 CLA SCD activity was inhibited (Bretillon et al, 1999), but
this was not the case with cis-9, trans-11 CLA. The degree of inhibition with
trans-10, cis-12 CLA was increased dose dependently (Bretillon et al, 1999).
This is consistent with the changes in desaturase ratios observed in sheep fed
PCLA (Tables 4.3 & 4.5) where the there was a trend towards ratios reducing
with increased supplementation levels, although this was not statistically
significant. Desaturase ratios were reduced in murine 3T3-L1 adipocytes
treated with trans-10, cis-12 CLA and a mixture of CLA isomers (Choi et al,
2000) and in HepG2 cells, where the level of palmitoleic and oleic acids were
reduced and stearic acid was increased (Choi et al, 2001). The results of
enzyme activity studies with both pure and mixed isomers of CLA indicate that
trans-10, cis-12 CLA is responsible for the reduction in SCD activity and that
fatty acid composition can be used to infer changes in enzyme activity.
However, in light of the fatty acid composition of the treatment diets (Section
4.5.2), it suggests that careful consideration of this data, particularly the
oleic:stearic ratio is needed. The palmitoleic:palmitic ratio is more reliable,
because palmitoleic acid can only be made; it cannot come from the diet, and
this did reduce with PCLA feeding, therefore it does indicate that SCD activity
may have been inhibited by PCLA. A better measure to use would have been
the ratio of myristoleic:myristic acid (14:1:14:0) as this can only be synthesised
by the tissues. However, despite these comments, in view of the fatty acid
composition data discussed in Section 4.5.2, it appears that SCD enzyme
activity was directly inhibited in sheep adipose tissue and liver as a result of
PCLA feeding.
4.5.4. Effect of CLA on SCD and ACC mRNA levels
Having determined that there was an effect of CLA on SCD enzyme activity in
terms of effects on fatty acid composition, the effects of CLA on mRNA levels
of SCD and the lipogenic rate limiting enzyme ACC were examined. Changes
in enzyme activity are often correlated to changes in the amount of mRNA
coding for the enzyme, so the next step was to determine if the changes in
enzyme activity were due to an effect of CLA on transcription. There was a
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significant interaction between type and amount of fat for omental adipose
tissue and liver. This is due to different responses to the amount of fat between
Megalac and PCLA. ACC mRNA increases with increasing Megalac feeding
and reduces with increasing PCLA feeding. This is consistent with inhibition of
transcription of the ACC gene as shown in mice fed a mixture of CLA isomers
where ACC mRNA levels were lower than controls (Tsuboyama et al, 2000)
and in dairy cows abomasally infused with both a mixture of CLA isomers and
trans-10, cis-12 CLA alone (Loor & Herbein, 1998; Baumgard et al, 2002).
Trans-10, cis-12 CLA has been shown to be the isomer responsible for the
reduction in milk fat of dairy cows fed CLA (Baumgard et al, 2000) with cis-9,
trans-11 CLA showing no effect. Lipid metabolism in mammary tissue has
been extensively studied, and effects of CLA have formed a large part of this
research. Mammary tissue is extremely metabolically active, and this may be
the reason for the significant reductions in fat synthesis in this tissue. There
was a significant interaction between fat type and amount in liver, but there
was no clear trend to the changes in ACC mRNA with amount or type of fat.
There was no effect of PCLA on levels of ACC mRNA in subcutaneous or
perirenal adipose tissue. Taking the data presented here together with the body
of research in this area, there is no evidence to suggest that lipogenesis as
measured by ACC mRNA levels in adipose tissue or liver in sheep is affected
by dietary CLA. There was a significant effect (p = 0.026 and 0.024) of fat
feeding on SCD mRNA levels in perirenal adipose tissue and liver
respectively. SCD mRNA abundance reduced with fat feeding in perirenal
adipose tissue, but increased slightly in liver. As previously mentioned, there
was no effect of fat feeding on ACC mRNA in perirenal adipose tissue and
liver, and as a result of the changes in SCD mRNA, there was a significant
reduction in the ratio of SCD mRNA/ACC mRNA in perirenal adipose tissue,
and an increase in liver. These different results seem to be due to the relative
changes in ACC mRNA within the tissue (Table 4.6). There was no effect of
CLA feeding specifically on SCD mRNA, but dietary fat had a significant
effect. High fat diets have been shown to have an effect on SCD mRNA levels
(Jones et al, 1996; Sessler et al, 1996). Polyunsaturated fatty acids have been
shown to affect SCD mRNA levels in murine liver (Ntambi et al, 1992),
adipose tissue of Zucker rats and 3T3-L1 adipocytes (Jones et al, 1996; Sessler
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et al, 1996). SCD mRNA is positively regulated by low fat, high carbohydrate
diets (Ntambi, 1992) and negatively regulated by PUFAs. Longer chain PUFA
are more effective in reducing RNA levels; linoleic, linolenic and arachidonic
acids fed as triacylglycerides to mice reduced hepatic SCD mRNA, but there
was no effect of palmitic, stearic or oleic acids (Ntambi, 1992). The effect of
dietary fat on SCD mRNA offers a reason for the significant effect seen in
sheep fed diets supplemented with fat in the current study. There is evidence
that PUFA suppress SCD mRNA dose dependently; this has been demonstrated
in 3T3-L1 adipocytes, together with reductions in palmitoleic acid, which
suggests there was also inhibition of SCD activity (Jones et al, 1996). A
mixture of CLA isomers has been shown to reduce SCD mRNA levels in
murine liver cells, while there was no effect of culturing with purified cis-9,
trans-11 CLA (Lee et al, 1998). The CLA mix of isomers also reduced C16
and C18 desaturase ratios relative to control cultures. There was no significant
effect on ratios with cis-9, trans-11 CLA treatment. Treatment of 3T3-L1 cells
with purified isomers of CLA revealed that there was no effect of cis-9, trans-
11 CLA on SCD mRNA levels, but that trans-10, cis-12 CLA significantly
reduced mRNA levels (Choi et al, 2000). SCD enzyme activity was also
measured and this changed in the same way as the mRNA results, indicating
that trans-10, cis-12 CLA was acting on transcription and not directly on
enzyme activity, as has been suggested by the results presented in the current
study. There was no effect of cis-9, trans-11 CLA on SCD enzyme activity.
Changes in fatty acid composition were studied in response to treatment of cell
cultures with cis-9, trans-11 and trans-10, cis-12 CLA. Trans-10, cis-12 CLA
significantly reduced levels of palmitoleic and oleic acids relative to controls,
while cis-9, trans-11 CLA had no effect (Choi et al, 2000). This is in
agreement with the findings in sheep where the proportions of palmitoleic and
oleic acids reduced and palmitic and stearic increased with CLA feeding.
Taken together with the lack of change in SCD mRNA levels with CLA
feeding, it may be that the effects of CLA are acting directly on the enzyme
complex, possibly by CLA competing with the stearic and palmitic acids for
the active site of the enzyme and reducing the amount of desaturation occurring
in this way. Evidence to support this theory of post-translational regulation of
SCD by direct inhibition of the enzyme activity has come from studies in
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HepG2 cells where trans-10, cis-12 treatment suppressed desaturase activities
without affecting SCD mRNA levels. Clearly trans-10, cis-12 CLA has a
greater inhibitory effect on SCD action than cis-9, trans-11 CLA. Infusion of
purified trans-10, cis-12 into the abomasum of lactating dairy cows resulted in
a suppression of SCD mRNA in mammary tissue (Baumgard et al, 2002). In
conjunction with this, a reduction in the products of SCD activity (palmitoleic
and oleic acids) was also evident, together with an increase in the saturated
fatty acids which are substrates for SCD (Baumgard et al, 2002). The method
of action of CLA in bovine mammary tissue seems to be via transcriptional
changes; however there is no evidence to suggest that this is the case in the
current study in sheep. Previous studies examining the effects of cis-9, trans-11
CLA on milk fatty acid composition confirmed that this isomer had no effect
on desaturation (Baumgard et al, 2000), in agreement with work done in 3T3-
L1 cells (Choi et al, 2000). Taken together with the effects of cis-9, trans-11
CLA on enzyme SCD mRNA levels and activity in 3T3-L1 cells (Choi et al,
2000) and those of trans-10, cis-12 and a mixture of CLA isomers (Baumgard
et al, 2002; Loor & Herbein, 1998) on SCD mRNA levels and enzyme activity
inferred from changes in fatty acid composition, these effects seem to be due to
the trans-10, cis-12 isomer. Only one study has shown an increase in SCD
mRNA with CLA feeding (Peters et al, 2001); it is generally accepted that
CLA treatment reduces SCD mRNA, and indeed the authors suggested that
their results could be due to the different genotype of the mouse strain used in
the study. The mechanism by which some polyunsaturated fatty acids,
including CLA reduce SCD mRNA is at present unknown. Studies in 3T3-L1
adipocytes have suggested a role for a reduction in mRNA stability, via
increased turnover of SCD mRNA (Sessler et al, 1996). This has been seen in
cells treated with linoleic, linolenic and arachidonic acids. It is possible that
CLA has its effects by the same mechanism, and that positional differences in
the two major isomers are responsible for their different effects. The current
study provides no evidence to suggest that CLA is having effects on
transcription of ACC or SCD; however feeding fat per se did affect SCD
mRNA levels.
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4.6. SUMMARY OF RESULTS
Feeding ruminally protected CLA resulted in increased incorporation of both
isomers into adipose tissue depots and liver in a dose dependent manner. The
desaturase ratios for 16:1:16:0 and 18:1 cis-9:18:0 reduced with CLA feeding
in all adipose tissue depots. These changes were not dose-dependent. The
desaturase ratio in the liver was less resistant to change, with only the
16:1:16:0 ratio reducing with increase in CLA supplementation. ACC mRNA
was reduced with CLA feeding, but only significantly in omental adipose
tissue. SCD mRNA was reduced with CLA feeding in perirenal adipose tissue.
There was no clear effect of CLA feeding on SCD or ACC mRNA levels in
liver. In view of these results, there seems to be very little effect of CLA on
messenger RNA levels in either adipose tissue depots or liver in sheep. The
fatty acid composition data provides evidence to suggest a direct inhibitory
effect on SCD activity, resulting in changes in fatty acid composition in ovine
adipose tissue and liver. There is no evidence to suggest that the effects of
CLA on fatty acid composition were mediated through transcriptional
regulation.
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5. EFFECT OF CONJUGATED LINOLEICACID ON
LIPID METABOLISM IN HAMSTERS
5.1. EXPERIMENTAL AIM
The objective of this experiment was to examine the effects of a 90% pure
CLA mixture, consisting of a 50:50 mix of cis-9, trans-11 and trans-10, cis-12
CLA on body weight and composition, plasma cholesterol and triglyceride
levels, adipose tissue depot weights, liver weight, fatty acid composition of
these tissues and mRNA levels for the key lipogenic genes ACC, FAS, LPL
and SCD.
5.1.1. Experimental design
6 week old male Golden Syrian hamsters were fed a 2% fat chow diet as
detailed in Sections 2.1 and 2.2.3.2 supplemented with a further 2% fat as
rapeseed oil and/or CLA at 0.5, 1 and 2% for 11 weeks. CLA was added at the
expense of rapeseed oil, which contains high levels of oleic acid.
Chapter 5: Effect of conjugated linoleic acid on lipid metabolism in hamsters
138
5.1.2. Carcass measurements
A number of measurements were taken at sacrifice as described in Section
2.3.3, including body weight, fat pad and liver weights. Hamster carcasses
were also retained for body composition analysis. There was no effect of CLA
supplementation on feed efficiency, and final bodyweight and feed intake was
not significantly different between groups (Table 5.1). There were no
significant differences in body weights of animals fed differing levels of CLA,
and this was reflected in the fat pad weights from epididymal and perirenal
adipose tissue which also did not change with CLA supplementation (Table
5.2). However, there was a tendency for perirenal fat pad weight to be lower at
0.5%, but this failed to reach significance (Tables 5.2 & 5.3). There was a
significant reduction in intrascapular fat pad with 0.5% and 1% CLA compared
to control, but this was not sustained at 2% CLA supplementation. When the
data was expressed relative to body weight (Table 5.3) there were still no
significant differences between treatments in epididymal and perirenal adipose
tissue. There was a significant difference (p<0.001) between treatments in
intrascapular adipose tissue, with a reduction in the percentage of bodyweight
accounted for by the intrascapular fat pad at 0.5 and 1% CLA. However, this
was not evident at 2% CLA, where there was no difference from control
values. Liver weight significantly increased in animals fed 2% CLA
comparative to controls (Table 5.2), and this was more significant when
expressed as a percentage of final body weight (Table 5.3). There was a trend
towards increased liver weights with increased CLA supplementation, but this
failed to reach significance at 0.5 or 1% CLA. There was a reduction in
hamster carcass fat of 10% when 0.5% CLA was fed (Figure 5.1). This
significant reduction (p = 0.002) was not dose dependent, and increasing
dosage did not cause further reduction in body fat.
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Table 5.1 Body weight and feed consumption in hamsters fed 0, 0.5, 1
and 2% CLA
% CLA
0%
CLA
0.5%
CLA
1%
CLA
2%
CLA
s.e.d. p-value
Initial weight (g) 58.6 58.6 59.5 59.3 1.42 0.901
Final weight (g) 118.2 114.3 113.7 115.2 5.12 0.823
Feed intake (g) 456.6 458.6 443.7 431.7 16.72 0.356
Feed efficiency* 0.1294 0.1198 0.1198 0.1293 0.007 0.288
*Feed efficiency is expressed as body weight gain relative to weight of feed consumed.
6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Data is presented as mean group values as generated by ANOVA statistical analysis (Genstat).
Errors are presented as the standard error of the difference between the means (s.e.d.).
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Table 5.2 Fat pad and liver weights expressed as absolute weights
Body and depot
weights (g)
0%
CLA
0.5%
CLA
1%
CLA
2%
CLA
s.e.d. p-value
EP depot weight 2.40 2.51 2.52 2.69 0.213 0.609
PR depot weight 1.91 1.59 1.86 1.86 0.177 0.263
IS depot weight 0.48 0.37 0.44 0.52 0.034 <0.001
Liver weight 4.16 4.61 4.53 4.96 0.2549 0.030
Table 5.3 Fat pad and liver weights expressed relative to body weight
% of BW
0%
CLA
0.5%
CLA
1%
CLA
2%
CLA
s.e.d. p-value
EP depot 2.03 2.20 2.16 2.32 0.1359 0.23
PR depot 1.62 1.39 1.60 1.59 0.1147 0.20
IS depot 0.42 0.32 0.38 0.45 0.0283 <0.001
Liver 3.52 4.00 3.98 4.30 0.1300 <0.001
*EP = Epididymal fat depot, PR = Perirenal fat depot, IS = Intrascapular fat depot
6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Data is presented as mean group values as generated by ANOVA statistical analysis (Genstat)
as absolute values (Table 5.1) and relative to final bodyweight (Table 5.2). Errors are presented
as the standard error of the difference between the means (s.e.d.).
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Figure 5.1 Hamster carcass fat percentages
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Data is presented as mean group values as generated by ANOVA statistical analysis (Genstat).
Errors are presented as the standard error of the difference between the means (s.e.d.). Level of
significance p = 0.002.
s.e.d.
Chapter 5: Effect of conjugated linoleic acid on lipid metabolism in hamsters
142
5.1.3. Blood cholesterol and triglyceride concentrations
Blood was collected from animals at sacrifice and plasma separated. The
plasma was then analysed for cholesterol and triglyceride as described in
Section 2.3.18.
There was no significant effect (p = 0.241) of CLA on blood cholesterol levels
(Figure 5.2), but there was a trend towards levels increasing with CLA
supplementation. CLA had no significant (p = 0.989) effect on blood
triglyceride levels (Figure 5.3).
Chapter 5: Effect of conjugated linoleic acid on lipid metabolism in hamsters
143
Figure 5.2 Blood cholesterol concentrations
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Figure 5.3 Blood triglyceride concentrations
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Blood samples were taken at sacrifice and plasma prepared for cholesterol and triglyceride
assay. Data is presented as mean group values as generated by ANOVA statistical analysis
(Genstat). Errors are presented as the standard error of the difference between the means
(s.e.d.). Level of significance p = 0.241 and 0.989 for cholesterol and triglyceride respectively.
s.e.d.
s.e.d
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5.1.4. Fatty acid composition of hamster adipose tissue
Fat pads and liver were removed from the hamsters as described in Section
2.3.3, and prepared for gas chromatography analysis as described in Section
3.18 to see if fatty acid composition changed with increasing levels of dietary
CLA. A general analysis of variance test incorporating regression analysis was
performed using the Genstat statistical package to determine the significance
of the results.
Both isomers of CLA were incorporated into the fat in a dose dependent
manner (Figure 5.4). There was more of the cis-9, trans-11 isomer present
compared to the trans-10, cis-12 isomer, as indicated by the steeper slope of
the line for the cis-9, trans-11 CLA isomer. There was a significant difference
(p<0.001) in CLA incorporated into both fat pads between treatment diets, with
levels of 5% and 3% of the cis-9 and the trans-10 isomer respectively present
in animals fed 2% CLA.
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Figure 5.4 Proportions of CLA cis-9, trans-11 and CLA trans-10, cis-12
in hamster fat pad
a) Epididymal fat pad
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b) Perirenal fat pad
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for lipid extraction and methylation of fatty
acids, which were then analysed by gas chromatography. Data is presented as mean group
values as generated by ANOVA statistical analysis (Genstat). Errors are presented as the
standard error of the difference between the means (s.e.d.). EP CLA c9,t11 s.e.d. 0.251; EP
CLA t10,c12 s.e.d. 0.165; Level of significance for EP CLA c9t11 and EP CLA t10c12
p<0.001. PR CLA c9,t11 s.e.d. 0.180; PR CLA t10,c12 s.e.d. 0.124; Level of significance for
PR CLA c9t11 and PR CLA t10c12 p<0.001.
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The proportion of fatty acids present as palmitic acid increased with an
increase in the level of dietary CLA and that of palmitoleic acid decreased in
both adipose tissue depots (Figure 5.5).
Figure 5.5 Proportions of palmitic and palmitoleic acid in hamster fat
pad
a) Epididymal fat pad
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b) Perirenal fat pad
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for lipid extraction and methylation of fatty
acids, which were then analysed by gas chromatography. Data is presented as mean group
values as generated by ANOVA statistical analysis (Genstat). Errors are presented as the
standard error of the difference between the means (s.e.d.). EP C16:0 s.e.d. 0.500; EP C16:1
cis-9 s.e.d. 0.280. Level of significance for EP C16:0 and EP C16:1 cis-9 p<0.001. PR C16:0
s.e.d. 0.400; PR C16:1 cis-9 s.e.d. 0.260. Level of significance for PR C16:0 and PR C16:1 cis-
9 p<0.001.
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A much smaller percentage of fatty acids were found as stearic and oleic acids.
Stearic acid shows a significant increase (p<0.001) with increasing CLA dose
in both adipose tissue depots (Figure 5.6). Conversely, oleic acid levels
decreased (p<0.001) as the dietary CLA dose increases. There is a 10%
reduction in animals fed the 2% CLA diet (p<0.001). Levels of unsaturated
fatty acids in hamster fat pads significantly reduced (p<0.001) with increasing
CLA supplementation (Figure 5.7).
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Figure 5.6 Proportion of stearic and oleic acids in hamster fat pad
a) Epididymal fat pad
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b) Perirenal fat pad
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for lipid extraction and methylation of fatty
acids, which were then analysed by gas chromatography. Data is presented as mean group
values as generated by ANOVA statistical analysis (Genstat). Errors are presented as the
standard error of the difference between the means (s.e.d.). EP C18:0 s.e.d. 0.100; EP C18:1
cis-9 s.e.d. 0.750. Level of significance for EP C18:0 and EP C18:1 cis-9 p<0.001. PR C18:0
s.e.d. 0.100; PR C18:1 cis-9 s.e.d. 0.530. Level of significance for PR C18:0 and PR C18:1 cis-
9 p<0.001.
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Figure 5.7 Proportions of linoleic and linolenic acids in hamster fat pads
a) Epididymal fat pad
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b) Perirenal fat pad
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for lipid extraction and methylation of fatty
acids, which were then analysed by gas chromatography. Data is presented as mean group
values as generated by ANOVA statistical analysis (Genstat). Errors are presented as the
standard error of the difference between the means (s.e.d.). EP C18:2 cis-9, cis-12 s.e.d. 0.559;
EP C18:3 cis-9,cis-12,cis-15 s.e.d. 0.096. Level of significance EP C18:2 cis-9, cis-12 and EP
C18:3 cis-9,cis-12,cis-15 p<0.001. PR C18:2 cis-9, cis-12 s.e.d. 0.555; PR C18:3 cis-9,cis-
12,cis-15 s.e.d. 0.074. Level of significance PR C18:2 cis-9, cis-12 and PR C18:3 cis-9,cis-
12,cis-15 p<0.001.
Chapter 5: Effect of conjugated linoleic acid on lipid metabolism in hamsters
150
The ratio of saturated fatty acids to unsaturated fatty acids significantly reduces
with CLA feeding. (Figure 5.8)
Figure 5.8 16:1 and 18:1 desaturase ratios in hamster adipose tissue
a) 16:1 desaturase ratio in epididymal (EP) and perirenal (PR) adipose
tissue
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b) 18:1 desaturase ratio in epididymal (EP) and perirenal (PR) adipose
tissue
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16:1 desaturase ratio = 16:1 / (16:0 + 16:1); 18:1 desaturase ratio = 18:1 / (18:0 + 18:1).
6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for lipid extraction and methylation of fatty
acids, which were then analysed by gas chromatography. Data is presented as mean group
values as generated by ANOVA statistical analysis (Genstat). Errors are presented as the
standard error of the difference between the means (s.e.d.). 16:1 EP s.e.d. 0.010; 16:1 PR s.e.d.
0.009. Level of significance for 16:1 EP and 16:1 PR p<0.001. 18:1 EP s.e.d. 0.004; 18:1 PR
s.e.d. 0.005. Level of significance for 18:1 EP and 18:1 PR p<0.001.
Chapter 5: Effect of conjugated linoleic acid on lipid metabolism in hamsters
151
5.1.5. Fatty acid composition in hamster liver
There was less CLA incorporation in liver than in adipose tissue, and the
isomers were incorporated in a similar way, with less trans-10, cis-12 CLA
than cis-9, trans-11 (Figure 5.9). The slopes of the lines are also different
(Figure 5.9, footnote), indicating that cis-9, trans-11 is preferentially
incorporated into the tissue over trans-10, cis-12 CLA.
Figure 5.9 Proportions of trans-10, cis-12 and cis-9, trans-11 CLA in
hamster liver
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for lipid extraction and methylation of fatty acids,
which were then analysed by gas chromatography. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). CLA cis-9, trans-11 s.e.d. 0.056; CLA trans-10,
cis-12 s.e.d. 0.040. Level of significance for CLA c9, t11 and CLA 10, c12 p<0.001.
Equations of the lines fitted to the data are: CLA c9,t11 y = 0.7212x + 0.2172 R
2
= 0.9827;
CLA trans-10, cis-12 y = 0.5942x + 0.0308 R
2
= 0.9855
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There was a small but significant decrease in palmitoleic acid levels in hamster
liver and a concomitant increase in palmitic acid (Figure 5.10). These changes
are not as pronounced as in adipose tissue.
Figure 5.10 Proportions of palmitic and palmitoleic acid in hamster liver
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for lipid extraction and methylation of fatty acids,
which were then analysed by gas chromatography. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). C16:0 s.e.d. 0.526; C16:1 cis-9 s.e.d. 0.164.
Levels of significance for C16:0 and C16:1 cis-9 p = 0.024 and <0.001 respectively.
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There was a significant increase in stearic acid with CLA feeding (Figure
5.11), although the change with levels of dietary CLA was not equivalent to
that seen in adipose tissue. The decrease in levels of oleic acid with CLA
feeding was also significant, but this was not as great as the change seen in
adipose tissue.
Figure 5.11 Proportion of stearic and oleic acids in hamster liver
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for lipid extraction and methylation of fatty acids,
which were then analysed by gas chromatography. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). C18:0 s.e.d. 0.563; C18:1 cis-9 s.e.d. 0.895.
Levels of significance for C18:0 and C18:1 cis-9 p = 0.045 and 0.026 respectively.
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Linoleic acid levels remained relatively constant with increasing dietary CLA
(Figure 5.12), while levels of linolenic acid reduced with increasing dietary
CLA. These changes are likely to be a reflection of the amount present in the
diet as animals cannot make this particular fatty acid. The level and changes in
linolenic acid concentrations was very small, and probably reflected the low
amounts present in the diet and therefore the small changes which were seen.
Figure 5.12 Proportion of linoleic and linolenic acids in hamster liver
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for lipid extraction and methylation of fatty acids,
which were then analysed by gas chromatography. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). C18:2, cis-9, cis-12 s.e.d. 0.296; C18:3, cis-9,cis-
12,cis-15 s.e.d. 0.031. Levels of significance for C18:2 cis-9, cis-12 and C18:3 cis-9, cis-12,
cis-15 p = 0.010 and <0.001 respectively.
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There was a significant decrease in levels of both 20:1 and 20:5 with CLA
feeding (Figure 5.13). Levels of 20:3 increased with CLA feeding.
Figure 5.13 Proportions of long chain fatty acids 20:1, 20:3 and 20:5 in
hamster liver
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for lipid extraction and methylation of fatty acids,
which were then analysed by gas chromatography. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). 20:1 s.e.d. 0.012; 20:3 s.e.d. 0.066; 20:5 s.e.d.
0.026. Levels of significance for C20:1, C20:3 and C20:5 p<0.001, 0.001 and <0.001
respectively.
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The desaturase ratio was also reduced in hamster liver (Figure 5.14), but was
lower than that in adipose tissue.
Figure 5.14 Desaturase ratios in hamster liver
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for lipid extraction and methylation of fatty acids,
which were then analysed by gas chromatography. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). 16:1 desaturase ratio s.e.d. 0.008; 18:1 desaturase
ratio s.e.d. 0.036. Levels of significance for 16:1 and 18:1 are p<0.001 and 0.001 respectively.
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5.1.6. Steady-state mRNA levels in hamster tissues
Much work has focused on the effects of fatty acids at a transcriptional level.
Gene expression was measured using real time PCR and expressed relative to a
constant housekeeping gene, beta actin. There was no change in beta actin
mRNA levels in epididymal, perirenal adipose tissues or liver with CLA
feeding (Figure 5.15). Beta actin was therefore suitable for use as a
housekeeping gene and all other genes of interest were expressed relative to
beta actin values. Expression of data relative to beta actin did not change the
pattern of the bars, but reduced the errors associated with the data (Figure
5.16).
Figure 5.15 Beta actin steady-state mRNA levels in hamster tissues
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue and liver were taken at sacrifice for RNA extraction and cDNA
synthesis, which was then quantified by real-time PCR. Data is presented as mean group values
as generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard
error of the difference between the means (s.e.d.). Levels of significance for EP p = 0.720; PR
p = 0.750; Liver p = 0.234.
EP s.e.d.
PR s.e.d.
Liver s.e.d.
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5.1.6.1. Adipose tissue depots
Levels of ACC, FAS, LPL and SCD mRNA were quantified in adipose tissue
depots and corrected for beta actin, which did not change with treatment (Table
5.16).
Figure 5.16 ACC steady-state mRNA levels in hamster perirenal adipose
tissue expressed as absolute values and relative to beta actin
a) Absolute values
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for RNA extraction and cDNA synthesis,
which was then quantified by real-time PCR. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). Level of significance ACC uncorrected for beta
actin p = 0.529. Level of significance ACC corrected for beta actin p<0.001.
s.e.d.
s.e.d
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ACC gene expression was increased with CLA supplementation at the 0.5%
level (Figure 5.16b), but increasing doses do not sustain this effect, with 2%
CLA returning expression levels to those of control animals. FAS gene
expression was increased in epididymal and perirenal adipose tissue with CLA
supplementation (Figure 5.17). There was not a dose response relationship, but
0.5% dietary CLA significantly raises expression levels above those of control
animals and increasing doses of CLA maintained this expression level.
Figure 5.17 FAS gene expression in hamster adipose tissue
a) Epididymal adipose tissue
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for RNA extraction and cDNA synthesis,
which was then quantified by real-time PCR. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). Level of significance p = 0.004.
s.e.d.
s.e.d.
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SREBP-1c gene expression was kindly measured by Dr. Scott Cooper of the
University of Nottingham, using a ribonuclease protection assay. SREBP-1c
mRNA in perirenal adipose tissue significantly increased with CLA feeding
(Figure 5.18), but was not dose dependent as the highest level of mRNA was
seen at 0.5% supplementation.
Figure 5.18 SREBP-1c gene expression in hamster perirenal adipose tissue
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for RNA extraction and ribo-nuclease
protection assay. Data is presented as mean group values as generated by ANOVA statistical
analysis (Genstat). Errors are presented as the standard error of the difference between the
means (s.e.d.). Level of significance for perirenal adipose tissue p = 0.01. n.d. = not determined
s.e.d.
n.d.
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SCD mRNA levels remained the same independent of doses of CLA in
epididymal and perirenal adipose tissue (Figure 5.19).
Figure 5.19 SCD mRNA levels in hamster adipose tissue
a) Epididymal adipose tissue
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for RNA extraction and cDNA synthesis,
which was then quantified by real-time PCR. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). Level of significance for EP p = 0.757; PR p =
0.317.
s.e.d.
s.e.d.
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CLA supplementation did not change LPL mRNA levels in any of the fat
depots (Figure 5.20).
Figure 5.20 LPL gene expression in hamster adipose tissue
a) Epididymal adipose tissue
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of adipose tissue were taken at sacrifice for RNA extraction and cDNA synthesis,
which was then quantified by real-time PCR. Data is presented as mean group values as
generated by ANOVA statistical analysis (Genstat). Errors are presented as the standard error
of the difference between the means (s.e.d.). EP s.e.d. 0.290; PR s.e.d. 0.2039. Level of
significance for EP and PR p = 0.087 and 0.287 respectively.
s.e.d.
s.e.d.
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5.1.6.2. Liver
There was no effect of dietary CLA on ACC, FAS, LPL or SCD mRNA levels
in hamster liver (Table 5.4). The general analysis of variance test performed
tested for a linear relationship, but no evidence of a dose-response relationship
was found. There was no effect of CLA feeding on SREBP-1c mRNA levels
measured by ribonuclease protection assay in liver (Figure 5.21).
Table 5.4 Gene expression in hamster liver
CLA%
0%
CLA
0.5%
CLA
1%
CLA
2%
CLA
s.e.d. p-value
ACC 0.882 1.014 0.835 0.871 0.1817 0.773
FAS 0.944 0.900 1.046 0.901 0.2430 0.923
LPL 0.324 0.602 0.474 0.765 0.1989 0.180
SCD 0.968 0.932 1.030 0.935 0.1489 0.904
6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for RNA extraction and cDNA synthesis, which was
then quantified by real-time PCR. Data is presented as mean group values as generated by
ANOVA statistical analysis (Genstat). Errors are presented as the standard error of the
difference between the means (s.e.d.).
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Figure 5.21 SREBP-1c gene expression in liver
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6 week old male Golden Syrian hamsters were fed 2% diets supplemented with 0.5, 1 and 2%
CLA for 11 weeks. Total fat fed was constant for all diets. CLA was replaced by rapeseed oil.
Samples of liver were taken at sacrifice for RNA extraction and ribo-nuclease protection assay.
Data is presented as mean group values as generated by ANOVA statistical analysis (Genstat).
Errors are presented as the standard error of the difference between the means (s.e.d.). Level of
significance for liver p = 0.954.
s.e.d.
n.d.
Chapter 5: Effect of conjugated linoleic acid on lipid metabolism in hamsters
165
5.2. DISCUSSION
5.2.1. Background to the study
There was no evidence of a reduction in fat deposition in sheep fed CLA
(Wynn et al, 2004) or an effect of CLA on total lipogenesis or lipogenic
enzymes (Chapter 3). The aim of the experiment was to identify possible
mechanisms of action of CLA in an animal which has been shown to respond
to CLA treatment. Many studies have been done in the mouse both with
individual CLA isomers and mixtures of isomers, and these have demonstrated
a huge response compared to other animals, suggesting that this particular
species responds much better to CLA treatment. Studies in pigs, rats and
hamsters show a much more conservative response to CLA treatment (Table
5.5). Previous work in the hamster has shown reduced body fat with CLA
feeding (Bouthegourd et al, 2002; Kim et al, 2002; Gavino et al, 2000) but no
effect on body weight or body weight gain except in two studies where
hamsters fed a mixture of CLA isomers showed reduced body weight gain
(Gavino et al, 2000) and reduced perirenal fat pad weights (Sher et al, 2003).
One study has failed to demonstrate an effect of CLA feeding on fat pad weight
(de Deckere et al, 1999). Trans-10, cis-12 CLA and a mixture of CLA isomers
have been shown to increase plasma triglyceride concentrations (de Deckere et
al, 1999), indicating an effect on LPL activity, and reduce plasma cholesterol
with up to 4 weeks of CLA treatment. More prolonged treatment did not
significantly affect cholesterol concentrations. However in hamsters fed a high
PUFA diet, supplemented with a CLA mix for 12 weeks, there was no effect on
plasma triglyceride or cholesterol (Sher et al, 2003). These studies would tend
to suggest an acute response to CLA in terms of plasma cholesterol and
triglyceride which is normalised after 4 weeks of treatment. In hamsters fed an
atherogenic diet, feeding a CLA mix dramatically reduced plasma triglycerides
and cholesterol (Gavino et al, 2000) compared to animals fed cis-9, trans-11
CLA and LA and this effect was seen at 2 and 6 weeks of feeding. Tissue fatty
acid composition has been less well studied in the hamster in response to CLA
feeding. In different groups of hamsters fed cis-9, trans-11 CLA, trans-10, cis-
12 CLA and an isomeric mix, hamsters fed trans-10, cis-12 CLA had
significantly lower levels of linoleic acid in fat pad TAG than those fed an
isomeric mix of cis-9, trans-11 CLA. Levels of linolenic acid were also
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reduced in hamsters fed the CLA mix or trans-10, cis-12 CLA. Liver TAG was
much more resistant to change, with no effect of CLA being seen on levels of
linoleic or linolenic acids (de Deckere et al, 1999). There was no effect of CLA
feeding on levels of oleic acid in liver or fat TAG. To date, there have been no
studies investigating gene expression in the hamster and effects of CLA on
lipid metabolism in terms of gene expression have been inferred from fat pad
and liver weights and evidence from studies in other rodent species. The effect
of CLA on fatty acid oxidation in the liver has been examined, by measuring
the activity of carnitine palmitoyl transferase-1 (CPT-1) the rate limiting
enzyme in fatty acid oxidation. Enzyme activity was significantly elevated in
hamsters fed cis-9, trans-11 CLA or an isomeric mix (Bouthegourd et al,
2002), suggesting that the fat reducing effect of CLA may be due to increased
hepatic fatty acid oxidation, although in this study, there was no effect of CLA
on white adipose tissue weights. Trans-10, cis-12 CLA and a CLA mix
increased liver weight (de Deckere et al, 1999) in hamsters fed for 8 weeks, but
a CLA mix failed to change liver weights in hamsters fed for 12 weeks (Sher et
al, 2003). A previous study in mice had suggested that the increased liver
weight seen was due to lipid filling (West et al, 1998), but liver lipid was not
measured so this could not be determined. Belury et al (1997) found CLA
feeding increased hepatic lipids and suggested that peroxisome proliferation,
causing hypertrophy of the liver may occur. There was no effect on key
enzymes involved in peroxisome proliferation (de Deckere et al, 1999), so it is
not likely that this is the mechanism by which liver weight is increasing. This
is the first study to examine fatty acid composition and lipogenic gene
expression in response to CLA feeding.
Chapter 5: Effect of conjugated linoleic acid on lipid metabolism in hamsters
167
5.3. MAJOR FINDINGS FROM THIS STUDY
There was no effect on body weight or food intake and no change in plasma
lipids. A 10% decrease in body fat was seen, with variable results in different
adipose tissue depots. There was no effect on hepatic gene expression, but an
increase in ACC and FAS mRNA in adipose tissue, associated with an increase
in SREBP-1c was seen. SCD enzyme activity decreased but there was no
change in gene expression. The following section discusses these results.
5.3.1. Body fat, weight gain and feed efficiency
There was no change in final body weights with CLA feeding. This has been
shown in a number of studies with rats (Yamasaki, 2003; Sisk et al, 2001;
Azain, 2000; Stangl, 2000), mice (Park et al, 1997), hamsters (see Section
5.2.1) and pigs (Weber et al, 2001). There are few studies in mice that have
failed to demonstrate an effect of CLA on body weight; indeed many studies
have shown a reduction in response to CLA feeding (Park et al, 1999; West et
al, 1998). There was no change in feed intake in hamsters fed different levels
of CLA, and this is supported by the majority of studies done in rats (Terpstra
et al, 2002; Sisk et al, 2001; Azain et al, 2000), hamsters (Bouthegourd et al,
2002; Kim et al, 2002) and pigs (Weber et al, 2001; Ostrowska et al, 1999).
Consequently, there was no significant effect of CLA on feed conversion
efficiency in hamsters. This has also been demonstrated in rats (Yamasaki et al,
2003; Sisk et al, 2001; Azain et al, 2000), and one hamster study claimed that
feed intake and body weight was not changed in animals fed CLA
(Bouthegourd et al, 2002). In contrast to the hamster, pigs seem to be more
responsive to CLA in terms of feed efficiency, with CLA feeding increasing
feed efficiency in a number of studies (Wiegand et al, 2001; Ostrowska et al,
1999; Dugan et al, 1997). The proportion of carcass fat was reduced by 10% in
hamsters fed CLA. This is in line with findings in mice (Terpstra et al, 2002;
Peters et al, 2001; Park et al, 1999; 1997; West et al, 1998), rats (Azain et al,
2002; Stangl, 2000), pigs (Ostrowska et al, 1999; Dugan et al, 1997) and other
studies in hamsters (Bouthegourd et al, 2002; Kim et al, 2002; Gavino et al,
2000). It is clear from previous studies (see Section 1.7.2 for a review) that the
trans-10, cis-12 isomer is likely to be responsible for the effects on body
composition because reductions in body weight have been seen in mice fed
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trans-10, cis-12 CLA and feed intake has been lower when mice were fed
either trans-10, cis-12 CLA or a CLA mixture (Park et al, 1999) and when rats
fed a CLA mixture were shown to have reduced weight gains relative to those
fed a CLA mixture (Gavino et al, 2000). Therefore it seems that hamsters do
not respond well in terms of body weight, feed intake and feed conversion
efficiency to CLA feeding. The 10% decrease in carcass fat with CLA feeding,
however, indicates that CLA may change body composition via fat reduction at
the expense of some other body component. Mice fed trans-10, cis-12 CLA
showed a reduction in body fat and a simultaneous increase in liver weight
(Degrace et al, 2003). This is further evidence that the reduction in fat
proportion seen in the current trial may be at the expense of fat partitioned into
the liver. Although a mixture of both major CLA isomers was used in the
current trial, it is likely from the literature reviewed that the trans-10, cis-12
isomer is responsible for the changes in body fat between treatment groups and
that there is no effect of the cis-9, trans-11 isomer comparative to controls.
5.3.2. Adipose tissue depot weights
There was no significant difference in epididymal or perirenal fat pad weights
from hamsters fed up to 2% CLA compared to control animals. There was a
tendency for CLA to reduce perirenal fat pad weight, which was not
statistically significant, but has been seen in hamsters fed CLA (Sher et al,
2003). This agrees partially with work done in rats (Yamasaki et al, 2003),
where CLA had no effect on epididymal adipose tissue weight, but reduced
perirenal adipose tissue depot weight; but the majority of work in rats
demonstrates reductions in fat depot weights in response to CLA (Yamasaki et
al, 2003; Kim et al, 2002; Sisk et al, 2001; Azain et al, 2000) where large
reductions in fat depot weights have been seen. Peters et al (2001) showed that
in mice fed 0.5% CLA, epididymal fat depots were significantly reduced
compared to those of control animals, while in a study in rats conducted by
Kim et al (2002) where CLA was added to high and low fat diets,
retroperitoneal and omental fat was significantly reduced in animals fed the
low fat diet, but only peritoneal fat was significantly reduced in animals fed the
high fat diet. Azain et al (2000) showed that in female rats fed CLA at 0.25%
and 0.5%, retroperitoneal and parametrial fat pad weight was significantly
reduced compared to rats fed control diets containing soybean oil. These were
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different fat pads to the ones measured in the current study, so this may reflect
differential regulation between depots rather than a completely different
response to CLA. It is interesting to note that one study (Kim et al, 2002)
compared the responsiveness to CLA of rats and hamsters, and concluded, in
terms of fat reduction, hamsters were the most responsive to CLA, and
suggested that this was the best species to study effects of CLA on after the
mouse.
Table 5.5 The effect of CLA on body fat in hamsters, rats and pigs
Author Species Treatment Measurements Conclusion
Alasnier et al,
2002
Rats 150mg cis-9, trans-11, trans-9,
trans-11, trans-10, cis-12 or
trans-10, trans-12 CLA fed as
part of a 5% fat diet
Body weight, carcass lipid
content, fatty acid content
of liver, muscle and
perirenal adipose tissue
No effect of CLA on body weight or lipid content. Most
incorporation of CLA in adipose tissue – mainly incorporated in
TAG. No effect of cis or trans-9 isomers on FAC. t10,c12
reduced C16:1 and C18:1 in muscle. Double bonds at position 12
seem to be key to inhibit SCD activity. Wistar rats respond poorly
to CLA diets in terms of lipogenic activities.
Bouthegourd et
al, 2002
Hamster 9 week old hamsters fed control
diet, control supp. with cis-9,
trans-11 CLA and control supp.
with a CLA mixture
Whole body triglyceride,
BMR, CPT-1, carcass
parameters
No effect of CLA on food intake, body weight gain, white
adipose tissue weight or carcass weights. CPT-1 activity in liver
higher in c9, t11 CLA and CLA mix groups. Body triglyceride
greater in c9, t11 CLA group. Plasma insulin higher with CLA
mix feeding.
Kim et al,
2002
Hamster
and rat
20% and 5% fat diet
supplemented with 0.5 or 1%
CLA at the expense of corn oil
fed for 9 weeks
Body weight, fat pads and
carcass composition
Significant reduction in % body fat in hamsters fed low fat (5%)
diets; reduction in % body fat in hamsters fed 20% fat diets. Rat
retroperitoneal and omental fat pad weights reduced in animals
fed 5% fat; peritoneal fat pad weight reduced in rats fed 20% fat.
Azain et al,
2000
Rat Diets supplemented with 0, 0.25
and 0.5% CLA fed for 5 weeks
Body weight, fat pad and
liver weight, food intake,
adipocyte size, plasma
triglyceride and
cholesterol
CLA feeding did not affect plasma triglyceride or cholesterol
concentrations, food intake or body and liver weight. CLA at
0.5% reduced parametrial and retroperitoneal fat pad weights,
suggesting a specific effect on fatty acid metabolism. CLA
feeding reduced average adipocyte diameter suggesting that CLA
inhibits lipid filling during growth of adipose tissue depots.
De Deckere et
al, 1999
Hamster 11 week old hamsters fed
control, CLA mix, c9, t11 and
t10, c12 CLA-containing diets
for 8 weeks
Plasma cholesterol, food
intake, body weights,
Liver and fat pad weights
and FAC
Liver weights increased and epididymal fat pad weight reduced in
t10, c12 fed group. Significantly lower plasma cholesterol and
higher TAG in CLA mix and t10, c12 fed groups. T10, c12 fed
groups stimulated C18 PUFA oxidation compared to other
groups.
Gavino et al,
1999
Hamster Mild atherogenic diet
supplemented with 1% CLA as
mixture of isomers, 0.2% cis-9,
trans-11 CLA and 0.2% LA
Plasma cholesterol and
triglyceride, body weight,
gain and food
disappearance
Food disappearance greater in 1% CLA group. Mix of isomers
reduced plasma triglycerides, body weight and fat despite
hamsters eating more.
Ostrowska et
al, 1999
Pig Diets supplemented with 0, 1.25,
2.5, 5.0, 7.5 and 10.0 mg CLA-
55 for 8 weeks
Feed intake, backfat
thickness, body
composition
CLA feeding significantly reduced carcass percentage fat but
there was no significant effect on carcass protein. Reductions in
backfat and increases in feed efficiency with CLA feeding seen
after 3 wk.
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5.3.3. Liver weight
There was a significant increase in liver weight with CLA feeding. This has
been observed in a number of other studies in mice (Degrace et al, 2004;
Clement et al, 2002; Terpstra et al, 2002; West et al, 1998) and in obese
Zucker rats fed CLA (Sisk et al, 2001). Significant increases in liver weight in
addition to reductions in body fat were seen in mice fed 0.5% CLA (Peters et
al, 2001), and CLA was shown to increase liver weight when high (45%) and
low (15%) fat diets were fed (West et al, 1998). Studies with individual
isomers demonstrated that the trans-10, cis-12 isomer was responsible for the
increase in liver weight in mice (Degrace et al, 2004; Clement et al, 2002), and
furthermore, that this was accompanied by a massive increase in hepatic TAG
(Degrace et al, 2004) and lipid (Clement et al, 2002). It was suggested that the
weight increase was due to hepatic lipid accumulation. CLA feeding increased
liver weight by 30% in mice (Terpstra et al 2002). Loss of body fat and
incidence of fatty liver is accompanied by hyperinsulinemia (Clement et al
2002). This is a health concern which has received little attention to date, set
against the favourable effects of CLA on body fat. This study used mice fed
both trans-10, cis-12 CLA and cis-9, trans-11 CLA and found that mice fed the
trans-10, cis-12 isomer displayed significantly heavier and paler livers,
symptomatic of increased lipid storage. In addition, dramatic reductions in
body fat were also observed. Hepatic steatosis has been shown to occur when
there is an increase in lipogenesis above oxidation and secretion (Araya et al
2004). Although it is tempting to conclude that this is the method by which
liver weight increased in the hamster with CLA feeding, this is unlikely to be
the case in view of the mRNA data for ACC and FAS. Clement et al (2002)
demonstrated that both isomers of CLA were equally efficient at activating
peroxisome proliferator activated receptors D,E and J, but only mice fed trans-
10,cis-12 CLA were hyperinsulinemic and had fatty livers. This led to the
conclusion that the effect of trans-10, cis-12 CLA is not likely to directly
involve these nuclear receptors, but may act by inducing hyperinsulinemia
which in turn induces fatty acid uptake and lipogenesis by stimulation of
insulin sensitive genes such as ACC and FAS. However, there is evidence that
there are species differences in terms of the liver response to CLA feeding.
Mice fed CLA-supplemented die
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lipid accumulation (Tsuboyama-Kasaoka et al, 2000; Belury & Kempa-Stecko,
1997), but hamsters fed CLA developed hepatic hypertrophy, resulting in
enlarged hepatocytes. This was shown to be independent of lipid accumulation
(de Deckere, 1999). Clearly further work needs to be done, and awareness of
species differences is needed in elucidating the effects of CLA on the liver. In
support of the results presented here, a recent study by Kang et al (2004)
showed that in mice fed 0.2% trans-10, cis-12 CLA liver weight was increased
but hepatic lipid content was not compared to control animals. Kang et al
(2004) speculate that trans-10, cis-12 CLA may be increasing energy
expenditure as shown by West et al (2000) and Ryder et al (2001). It may be
that the increase in liver weight can be explained by a repartitioning effect, and
that the reduction in carcass fat seen in hamsters fed 2% CLA may have
actually been repartitioned and present in the liver. However, as hepatic lipid
content was not determined in this study, this remains speculative.
5.3.4. Blood cholesterol and triglyceride concentrations
There was no significant change in plasma cholesterol concentrations in
hamsters fed varying amounts of CLA. A similar study, feeding 8% fat diets
and 2% CLA to rats for 12 weeks showed that plasma cholesterol did not
change (Yamasaki et al, 2000). There was a trend towards cholesterol
increasing in hamsters fed 2% CLA but this was not significant. De Deckere et
al (1999) fed 0.6% CLA to hamsters and found that plasma total cholesterol
decreased in animals fed a 50/50 mix of both major isomers for 4 weeks, but
that after 8 weeks there was no significant difference between treatment
groups. However, unlike the current study hamsters were fasted for 16h before
blood collection, which will have reduced lipoprotein formation and
circulation. Plasma cholesterol levels in hamsters involved in the current trial
were all between 3 and 4mmol/L, which is normal for hamsters (de Deckere et
al 1993), so there is no evidence that CLA had any effect. There is evidence of
a drop in plasma total cholesterol in hamsters fed CLA mixtures (Nicolosi et al,
1997, Lee et al, 1994), but the hamster model used had abnormally high
plasma total cholesterol levels of 16mmol/L (Lee et al, 1994) so it may be that
CLA is more efficacious at high concentrations of cholesterol. Sher et al (2003)
fed hamsters 1% CLA for 7 weeks with and without 0.3% cholesterol and
measured plasma total cholesterol and triglyceride. There was no effect of CLA
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on total cholesterol in animals fed a cholesterol-free diet, in agreement with the
current study, but CLA decreased cholesterol in hamsters fed 0.3% cholesterol.
This has been seen in recent work done in our laboratory (unpublished results)
where hamsters were fed a high cholesterol diet and butter enriched with cis-9,
trans-11 CLA. Plasma cholesterol concentrations were reduced in animals fed
CLA compared to control animals. It has been suggested (Sher et al, 2003) that
CLA did not affect plasma cholesterol in the absence of dietary cholesterol
because the supposed impairment of cholesterol transport by CLA was not
detectable under the analysis used. This study, combined with those of Nicolosi
et al (1997) and Lee et al (1994) increases the evidence for an effect of CLA
on plasma total cholesterol only when animals are fed diets high in cholesterol
or who have high levels of circulating cholesterol. The beneficial effect of CLA
on cholesterol therefore seems to require an abnormally high intake of
cholesterol, the consumption of which has implications for other aspects of
health, and the dose of CLA at which effects are seen is surplus to that which
can be obtained from a natural food source. Hamsters fed up to 2% dietary
CLA showed no change in plasma triglyceride concentrations; this is in line
with observations in other studies (Sher et al, 2003). There was no effect of 1%
(Sher et al, 2003) or 2% (Yamasaki, 2000) CLA feeding on circulating
triglyceride levels in hamsters and rats. Feeding of the pure trans-10, cis-12
CLA isomer and a CLA mixture increased plasma triglyceride concentrations,
but cis-9, trans-11 CLA failed to have an effect (de Deckere et al, 1999).
Hamster livers were significantly larger in animals fed trans-10, cis-12 CLA
and the CLA mixture, so this may explain the higher plasma triglyceride
concentrations, but increased free fatty acid levels in the CLA mix group (a
major source of fatty acids for hepatic triglyceride synthesis under fasting
conditions) were seen, making this unlikely. Plasma triglyceride levels can be
affected by LPL activity; effects have been seen in adipocytes where CLA
reduced LPL activity (Park et al, 1997). Paradoxically, Tsutsumi et al (1997)
have found the opposite in hamsters; however the current results presented in
this chapter show no effect of CLA on LPL mRNA. LPL is responsible for
cleaving triglyceride-rich lipoproteins circulating in the blood, liberating fatty
acids for esterification into adipocytes. From the results presented here it is
unlikely that CLA is affecting LPL activity.
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5.3.5. Fatty acid composition of hamster tissues
Analysis by gas chromatography identified the major fatty acids present in
adipose tissue and liver. Analysis of the adipose tissue and liver showed that
both isomers of CLA were present in detectable quantities and increased with
the supplementation levels. There was slightly more cis-9, trans-11 CLA than
trans-10, cis-12 which differed from the diet where approximately equal
amounts were present. However it has been hypothesised that lower levels of
the trans-10, cis-12 isomer in both liver and adipose tissue could be due to
more efficient metabolism of this isomer relative to its cis-9, trans-11
counterpart (Alasnier et al 2002). In support of this Martin et al (2000)
observed that the trans-10, cis-12 isomer was preferentially driven through the
beta-oxidation pathway over the cis-9, trans-11 isomer due to its geometric and
positional structure allowing it to escape four enzymatic steps that could be rate
limiting. The cis-9, trans-11 CLA isomer would only miss two, allowing
accumulation in the tissues. In addition to this cis-9, trans-11 CLA is the major
isomer found in many tissues (Sehat et al, 1998; Parodi, 1997; Chin et al,
1992; Ha et al, 1989), so the abundance of this could merely be due to in vivo
synthesis and not an imbalance between trans-10, cis-12 and cis-9, trans-11 in
the diet. This has also been observed in cattle (Parodi, 1977). There was a dose
dependent increase in levels of palmitic and stearic acids in both adipose tissue
and liver with CLA feeding. SCD catalyses the desaturation of palmitic and
stearic acids to form palmitoleic and oleic acids (Enoch et al, 1976), and levels
of palmitoleic and oleic acids dropped with increasing CLA levels in a dose
dependent manner. Taken together, these changes suggest that there is
inhibition of SCD activity. The inhibitory effect was greater in adipose tissue
than liver, with oleic acid dropping by 10% and 4% and palmitoleic acid
dropping by 5% and 2% in adipose tissue and liver respectively, suggesting
that there is a greater effect of CLA on sites of major fatty acid metabolism and
storage. These decreases in monounsaturated fatty acids, coupled with the
increases in the saturated fatty acids palmitic and stearic suggest that CLA may
be having an effect on stearoyl-CoA desaturase (SCD) and that it is either
acting at a transcriptional level by suppressing the SCD gene or directly
inhibiting SCD enzyme activity. There was a dramatic reduction in oleic acid,
making a strong case for the inhibition of SCD by CLA since its preferred
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substrate is stearic acid (Enoch et al, 1976). Further evidence for an inhibition
of desaturase is seen in the reduced desaturase ratios (C16:1/C16:0+C16:1 or
C18:1/C18:0+C18:1) in both liver and adipose tissue, which reduced further
with the degree of CLA supplementation. Both the increase in saturated fatty
acids and the reduction in desaturase ratio with CLA feeding were seen in the
adipose tissue of pigs fed CLA (Smith et al, 2002; Ramsay, 2001). These
effects were most efficacious at 1-2% supplementation and were also dose
dependent as shown in the current study. The dose dependent relationship
suggests that CLA may be competitively inhibiting SCD as seen with sulphur-
containing fatty acids, or sterculic acid (Hovik et al, 1997). Studies show that a
cis-12 double bond is needed to inhibit SCD activity (Park et al, 2000) and
especially so when present with a trans-10 double bond. The effect on fatty
acid composition and SCD activity is likely to be due to the trans-10, cis-12
isomer, as has been demonstrated in cell lines. SCD activity in MCF-7 cells
treated for 48 hours with CLA isomers was significantly lower than in albumin
treated control cells (Choi et al 2002). Studies using microsomal fractions from
HepG2 cells treated with trans-10, cis-12 and cis-9, trans-11 CLA showed an
inhibition of SCD activity of 60% with trans-10, cis-12 CLA treatment, but not
with cis-9, trans-11 CLA (Choi et al, 2001). The effect on SCD activity was
evident, indicating that CLA was directly acting on the enzyme and not via
transcription of the gene. CLA added to hepatic microsomal fractions reduced
incorporation of [1-
14
C] palmitic acid into palmitoleic acid within 15 minutes
(Park et al, 2000). The enzyme assay was backed up by fatty acid composition
work which showed that levels of MUFAs were significantly lower in cells
treated with the trans-10, cis-12 isomer and that mRNA and protein levels were
not affected by CLA treatment (Choi et al, 2002; Choi et al, 2001). Taken
together, these studies show that CLA acts directly on the enzyme complex,
rather than through transcription. There was an increase in levels of stearic and
palmitic acids in adipose tissue and liver, but as with the monounsaturated fatty
acids this change was not as pronounced in liver. This reflects the differences
in composition of adipose tissue lipids and liver lipids. Liver contains more
long chain fatty acids than adipose tissue, whereas adipose tissue contains 90%
of its lipids as triglycerides, and of that 90%, 58% is present as oleic or
palmitoleic acid (Kasturi & Joshi, 1982). Generally there is an increase in
levels of long chain fatty acids in the liver tissue compared to those present in
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adipose tissue. This is likely to be due to the extensive metabolism of
cholesterol and lipoproteins which occurs in the liver. Conversely, a recent
paper suggests that the effects of CLA are independent of effects on SCD gene
expression and activity (Kang et al 2004). 2% CLA was fed in a high fat (20%
provided as corn oil) diet to normal wild type mice and SCD1-null mice which
possess a targeted disruption in the SCD1 gene (SCD-/-). Dietary trans-10, cis-
12 CLA feeding significantly reduced the 16:1/16:0 ratio in adipose tissue of
wild type mice without changing SCD1 mRNA expression and this would
seem to point to an inhibition of SCD activity; but the key finding of the study
was that SCD1-null mice and wild type mice responded similarly to trans-10,
cis-12 CLA feeding. It is possible that the corn oil could have had an effect on
SCD, with the high levels masking any effect of trans-10, cis-12 CLA. Corn oil
contains high levels of linoleic acid, oleic acid and other PUFAs (Chow, 1992)
which are known to inhibit SCD in liver and adipocytes, casting doubt on the
assertion that the anti-obesity effect of CLA is mediated through SCD1 gene
expression and/or enzyme activity. However, with 4 SCD isoforms discovered
to date in the mouse (Miyazaki et al, 2003), the possibility that CLA may have
effects on the others cannot be ruled out. Ramsay et al (2001) fed CLA to pigs,
and found that linoleic acid in tissues was reduced. They suggested that this
may be due to a reduction in available linoleic acid in the diet as a result of
replacement of corn oil with CLA. A reduction in levels of linoleic and
linolenic acids was seen in hamster adipose tissue and liver; this may have been
due to a lack of available linoleic acid in the diet due to replacement of linoleic
acid-rich rapeseed oil with increased CLA supplementation. It is not possible
for the desaturation steps from linoleic to linolenic to happen in animals, as the
enzyme responsible for the conversion is only present in plants; therefore levels
of linolenic acid in tissues are representative of dietary intake and will not be
affected by endogenous CLA. The level and changes of linolenic acid
concentrations were also very small and probably reflected the low amounts
present in the diet. CLA can be metabolised to conjugated diene (CD)
metabolites eg. CD18:3, CD20:3, so it is possible that the increase seen in these
long chain fatty acids was due to metabolism of the dietary CLA rather than
effects on a specific pathway. It is not possible from this analysis to tell which
isomers have been formed and therefore by which pathway, so effects of CLA
on specific enzymes remain speculative. However an increase in 22:6 was seen,
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which is a metabolite of linolenic acid, and formed by beta oxidation. This may
point to an activation of beta oxidation by CLA, which has already been
suggested in rats as a potential body fat reducing mechanism (Sakano et al
1999) and also demonstrated using CLA isomers in 3T3-L1 adipocytes Evans
et al (2002). Whether all of these effects are as a result of dietary fatty acid
changes as mentioned by Ramsay et al (2001) or directly linked to CLA
remains to be elucidated.
5.3.6. Steady-state mRNA levels in hamster tissues
5.3.6.1. ACC and FAS mRNA levels
Levels of ACC and FAS mRNA increased in adipose tissue of hamsters fed
CLA. Studies have indicated that CLA may exert its effects on body
composition through actions on lipogenic enzymes like ACC and FAS. There
is no evidence that down-regulation of lipogenic gene expression is occurring
in either adipose tissue or liver of hamsters fed CLA, so the reduction in
carcass fat is not as a result of this. The lack of effect of CLA on fat pad
weights is inconsistent with previous rodent studies (Table 5.5) which have
shown reduced fat in animals fed CLA. Paradoxically the increase in adipose
tissue ACC and FAS mRNA indicates that lipogenesis is being up-regulated,
and yet there is no increase in fat pad weight as would be expected as a result
of this. However, up-regulation of adipose tissue FAS has been seen in mice
fed trans-10, cis-12 CLA; but this was combined with a reduction in fat pad
weight and an up-regulation of UCP-2, which increases energy consumption
(Kang et al, 2004) and was cited as the reason for the change in fat pad
weights. There was a significant reduction in intrascapular fat pad weight with
0.5% CLA feeding, but this effect was not sustained at 2% CLA, and mRNA
levels for ACC and FAS showed the same pattern as for the other adipose
tissue depots. The difficulties associated with dissection of white adipose tissue
from the intrascapular fat pad and separation from the brown adipose tissue
present may explain these results. Mice fed trans-10, cis-12 CLA were found
to have reduced FAS mRNA levels in white adipose tissue (Clement et al,
2002), but this was accompanied by an increase in hepatic FAS mRNA. FAS
mRNA has been shown to increase in adipose tissue from wild type mice fed
trans-10, cis-12 CLA (Kang et al, 2004), supporting the idea that the effects
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seen in the hamster are mediated through the actions of this isomer. There is
also the possibility that the increase in lipogenic gene expression is a
compensatory effect and that the adipose tissue is trying to respond to a drop in
fat levels in the body by up-regulating ACC and FAS in the adipocytes. CLA
feeding has been shown to increase hepatic FAS mRNA in wild type mice
(Peters et al 2001). The current study showed no change in hepatic ACC or
FAS mRNA in hamsters fed CLA, indicating that the effects on body
composition were not mediated through genes expressed in the liver. Mice fed
CLA were also shown to have levels of circulating insulin up to 10 times those
seen in control mice. Clement et al (2002) suggest that CLA may affect FAS
expression by causing hyperinsulinemia in animals fed CLA, via an up-
regulation of SREBP-1c, present in adipose tissue, which then, combined with
glucose and insulin, acts on the insulin responsive element in the FAS
complex, causing up-regulation of the gene and increasing rates of fatty acid
synthesis. This is consistent with the current study, which showed an increase
in adipose tissue SREBP-1c with CLA feeding. In support of this, higher levels
of insulin have also been seen in mice fed CLA (Tsuboyama-Kasaoka et al,
2000). Increased mRNA levels do not always mean that there will be increased
transcription or activity of the enzymes for which they code (Peters et al,
2001), as there may be post-translational inhibition of the ACC and FAS
enzyme complexes, resulting in reduced lipid synthesis, or simply reduced
translation of the gene. Evans et al (2002a) demonstrated in 3T3-L1 cells that
trans-10, cis-12 CLA resulted in an increase in glucose and oleic acid
incorporation into lipid, indicating that lipogenesis was being stimulated.
However, treatment of the cells with trans-10, cis-12 CLA resulted in increased
oxidation of oleic acid, and combined with the suggestion made by Martin et al
(2000) that trans-10, cis-12 CLA is more efficiently oxidised by beta oxidation
enzymes it suggests that CLA may stimulate lipogenic enzymes but also up-
regulate those of the beta oxidation pathway. Although the activity of the rate
limiting enzyme of beta oxidation, carnitine palmitoyl transferase-1 was not
measured in this hamster study, Martin et al (2000) showed an increase in rats
fed CLA, linking the effects of CLA with increased fatty acid oxidation. There
is also evidence for an increase in energy expenditure with CLA feeding;
metabolic rates in mice were significantly increased with CLA feeding,
changing respiratory quotient and indicating an increase in lipid oxidation
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(West et al, 1998). Saturated fatty acyl-CoAs are known to allosterically inhibit
ACC, which reduces levels of malonyl CoA, which is required for fatty acid
biosynthesis. It also has an inhibitory effect on the carnitine palmitoyl
transferase shuttle system, which is the rate limiting step in mitochondrial
import and oxidation of fatty acids. A reduction in intracellular malonyl-CoA
leads to increased fatty acid transport into mitochondria for oxidation
(Miyazaki & Ntambi, 2003) and may be the mechanism by which CLA
increases energy expenditure. It has been reported that n-3 PUFAs reduce
lipogenic gene expression (Jump et al, 1994) and stimulate beta oxidation. The
increase in lipogenic enzymes seen both in this study and in cell lines fails to
satisfy the hypothesis that CLA has its effects via an inhibition of lipogenesis
and provides further evidence for a mild stimulatory effect of CLA on fatty
acid synthesis and a larger stimulation of fatty acid oxidation. The current
study provides no evidence to show that there is down-regulation of lipogenic
gene expression in adipose tissue or liver as a result of CLA feeding, so the
reduction in carcass fat cannot be explained by this mechanism. In contrast to
the fatty acid data, none of the effects on ACC and FAS mRNA levels are dose
dependent, and the largest effects are seen at the lowest dose. As
supplementation increases ACC and FAS mRNA levels fall back to those seen
in control animals. There may be an interaction between the two isomers which
is concentration dependent; at low concentrations cis-9, trans-11 CLA may act
to increase lipogenesis via transcriptional up-regulation of ACC and FAS. The
effect of CLA on SCD activity was dose dependent, with the most inhibition at
the highest level of CLA, and this has been attributed to the trans-10, cis-12
isomer. At higher concentrations therefore the inhibitory effect of trans-10, cis-
12 on SCD may become evident, reducing levels of oleic and palmitoleic acid.
It has been shown that endogenously synthesised MUFAs are required for TAG
synthesis (Miyazaki et al, 2001), and that if these are not present, levels of
TAG are reduced by inhibition of ACC and FAS. This antagonistic effect of
the two major isomers present in the CLA supplement could explain the change
in lipogenic enzyme mRNA levels with different doses of CLA.
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5.3.6.2. SCD mRNA levels and enzyme activity
The current study shows that there is no change in SCD gene expression in
adipose tissue depots or liver of hamsters fed CLA. This has been shown in
adipose tissue from mice fed trans-10, cis-12 CLA (Kang et al 2004). This
study also showed an increase in adipose tissue FAS mRNA levels as seen in
the current study. There have been few studies where CLA has been fed to
rodents and gene expression has been examined in adipose tissue; however a
number of researchers have evaluated this in the 3T3-L1 adipocyte cell line.
Choi et al (2000) treated 3T3-L1 pre-adipocytes with trans-10, cis-12 CLA and
examined levels of RNA during the differentiation period. SCD1 mRNA was
shown to reduce in cells treated with trans-10, cis-12 CLA in a dose dependent
manner. SCD1 protein levels also followed this pattern and SCD1 activity was
reduced by 15% and 60% in cells treated with cis-9, trans-11 CLA and trans-
10, cis-12 CLA respectively. Levels of palmitoleic and oleic acids were also
reduced, as seen in the current study, and this was consistent with the gene
transcription, activity and protein results. Trans-10, cis-12 reduced lipid within
adipocytes; this may be due to an inhibitory effect on the SCD1 complex,
because 16:1 and 18:1 make up 58% of the fatty acids in intracellular lipid
droplets (Lee et al, 1995). The fatty acid composition data for hamster adipose
tissue depots indicate that SCD activity is being inhibited as a result of CLA
feeding, due to the drop in 16:1 and 18:1 and relative increase in 16:0 and 18:0.
The lack of effect of CLA on SCD mRNA levels indicates that the inhibition of
SCD is not at a transcriptional level and taken together with the fatty acid
composition data suggests that CLA is reduces SCD enzyme activity. There is
evidence that CLA, particularly the trans-10, cis-12 isomer can inhibit
adipogenesis in cultures of 3T3-L1 preadipocytes (Evans et al, 2000). The
reducing effect of CLA on levels of 16:1 and 18:1 and increase in 16:0 and
18:0 may have increased fatty acid oxidation, by affecting intracellular
intermediary factors.
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5.3.6.3. LPL mRNA levels and enzyme activity
It is known that LPL is expressed differentially between tissues, and the
findings from this study that LPL gene expression in liver was generally lower
than that in epididymal and perirenal adipose tissue support this. There was no
significant difference in expression of LPL with CLA feeding in all tissues
studied. This is consistent with the plasma data which showed no changes in
circulating cholesterol or triglycerides, which LPL removes from the
circulation for esterification and storage in adipocytes. This is consistent with
work done by Degrace et al (2003) who fed individual CLA isomers to mice at
1% in the diet and used RT-PCR techniques to measure hepatic LPL gene
expression. There was no effect of CLA feeding on LPL gene expression in
mice. In addition, mice were found to have significantly enlarged livers as in
the current hamster study. Degrace et al (2003) studied very low density
lipoprotein (VLDL) secretion by liver in CLA fed mice injected with 10%
Triton to inhibit LPL activity, preventing cell breakdown and uptake of VLDL.
Plasma concentrations of VLDL-apolipoproteinB-100 were therefore
proportional to their secretion rates. Livers from mice fed CLA trans-10, cis-12
showed a 20% increase per gram of tissue in the rate of VLDL clearance.
These findings show that the liver triglyceride accumulation in mice fed trans-
10, cis-12 CLA was not due to a decrease in the VLDL secretion, despite
overproduction because there was an increased influx of fatty acids entering the
lipoprotein assembly process (Degrace et al, 2003). Lower plasma LDL
concentrations and higher plasma TAG were observed in hamsters fed CLA (de
Deckere et al, 2003); this is associated with inhibition of LPL activity (Park et
al, 1997). In non-fasted animals LPL is active in white adipose tissue, resulting
in a flux of fatty acids to the adipose tissue where their fate is esterification and
storage. Therefore in the current trial where animals were in the fed state, LPL
expression was expected to be high in adipose tissue, thus allowing possible
effects of CLA to be seen clearly. However, many of the studies have fed high
fat diets resulting in an increase in circulating chylomicrons and increased LPL
activity to extract triglyceride from the lipoproteins. The current study fed a
relatively low fat diet with 4% total fat, so LPL expression may have been low
due to low circulating levels of triglyceride-rich lipoproteins. Degrace et al
(2003) also only fed 5% fat in total in the study in mice, so this may be the
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reason that no effects of CLA were observed. Kang et al (2003) fed a 20% fat
diet inclusive of 5% CLA to mice and measured LPL gene expression. CLA
was shown to reduce LPL gene expression in adipose tissue although there was
no effect on circulating triglyceride. Few studies have examined the effect of
CLA on LPL gene expression in animals, although a number of researchers
have evaluated expression and enzyme activity in 3T3-L1 cells. 3T3-L1 cells
are from a pre-adipocyte cell line and are grown to confluence in culture.
However, only relatively short term studies (6-7 days post-differentiation) are
possible as when the cells mature they lose their adhesion to the plate, so
effects on mature cells are difficult to study. In addition, 100% differentiation
is never achieved, so some reported effects will be due to reductions or
increases in adipogenesis. Lin et al (2001a) treated 3T3-L1 cells with cis-9,
trans-11 CLA, trans-10, cis-12 CLA and linoleic acid at concentrations up to
1000µmol/L. Intracellular LPL activity was increased with all treatments up to
a concentration of 30µmol/L but then dropped back to initial levels. Park et al
(1997) also noted that on addition of 5µmol/L CLA to cell cultures an increase
in LPL activity was seen prior to a reduction above this concentration. Whether
this is due to the initial increase in supply of fatty acids is not clear and requires
further investigation. Heparin-releasable LPL (LPL secreted from adipocytes
and anchored to the luminal surface of capillary endothelial cells) activity was
reduced at all concentrations by trans-10, cis-12 CLA, but increased with cis-9,
trans-11 CLA and linoleic acid treatment at concentrations up to 100µmol/L
(Park et al, 1997). Activity declined again with concentrations greater than
100µmol/L. Park et al (1999, 1997) also saw this in isolated rat adipocytes. Lin
et al (2001a) introduce the idea that trans-10, cis-12 CLA may interfere with
the transport of intracellular LPL to the cell membrane and therefore its
attachment to the endothelial cell surface. The current study in hamsters
measured total LPL gene expression however, and the only indication of
activity measured was the plasma triglyceride assay. A drop in circulating
triglyceride would indicate an increase in the activity of LPL. There was no
effect of CLA feeding on plasma triglyceride in hamsters, therefore this argues
against an effect of CLA on either LPL gene expression or activity and does
not support the hypothesis of interference of trans-10, cis-12 CLA with LPL
transport to the cell membrane (Lin et al, 2001a). As mentioned previously
though, it may be that there was a change in activity and/or gene expression
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which was too small to be detected, due to the low flux of fatty acids through
the lipid metabolism pathways as a result of the low fat diet. It is not clear what
is happening in the current study as CLA did not change gene expression, and
there was no change in plasma triglyceride levels, which tends to rule out an
effect on LPL enzyme activity. However the effect on LPL with CLA may only
be seen with high fat diets. Certainly much of the previous work seems to point
towards a CLA-mediated effect on LPL enzyme activity rather than
transcriptional change, but more work will be needed to clarify this. The
current study suggests than LPL is not responsible for the change in carcass fat
of these animals. Another possible mechanism for fat reduction is via an
increase in lipolysis.
5.4. SUMMARY
Both isomers of CLA were incorporated into the adipose and liver tissues dose
dependently, with less trans-10, cis-12 CLA compared to cis-9, trans-11 CLA;
this is likely to be due to preferential metabolism of the former. There is no
evidence that CLA supplementation has any effect on body weight, feed intake
or feed efficiency in hamsters fed low fat diets. Epididymal and perirenal fat
pad weights were not affected with CLA feeding, although a reduction in
intrascapular fat pad weight was seen with low levels of CLA feeding, in spite
of an increase in ACC and FAS mRNA levels in adipose tissue. This was not
dose dependent and was greatest at the lowest level of CLA supplementation
suggesting a dose dependent interaction between the two isomers with the
effects of cis-9, trans-11 CLA prevailing at low concentrations and those of
trans-10, cis-12 CLA prevailing at high concentrations. 0.5% CLA
supplementation reduced carcass fat by 10%, but there was no further effect
with 1 and 2% supplementation, as with the ACC and FAS mRNA levels,
raising the possibility that lipogenic gene expression in adipose tissue was
stimulated in response to a reduction in overall body fat. Liver weight was
increased with CLA feeding; this may be due to lipid filling as there is no
evidence to suggest that CLA acts on liver gene expression. It is likely that the
effects of CLA are mediated through the adipose tissue. There is no evidence
of an effect of CLA on LPL mRNA levels, or plasma total cholesterol and
triglyceride data, which was not different with treatments and was
physiologically normal. CLA inhibits SCD activity dose dependently,
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evidenced by the reduction in MUFAs and increase in SFAs, and the reduction
in the SCD index. There was no effect of CLA on SCD gene expression,
indicating that CLA acts directly on the enzyme complex rather than through
transcription. This study indicates that CLA has different effects at different
concentrations and that the SCD inhibition and fat reducing effects that have
been attributed to trans-10, cis-12 CLA, are more evident at high
concentrations, with the anti-carcinogenic effects of cis-9, trans-11 CLA
having a greater effect at lower concentrations. The two isomers may act
antagonistically, with effects of the two isomers becoming evident at different
concentrations. Clearly this has consequences for the control of lipid
metabolism in response to CLA.
5.4.1. Conclusions
There is no evidence that the reduction in body fat is associated with decreased
lipogenesis as both epididymal and perirenal depots were examined and did not
change significantly.
There is a potentially adverse effect of CLA on fatty acid composition; this is
likely to be due to inhibition of SCD activity rather than SCD expression.
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6. CONCLUSIONS
Lamb consumption has shown a downward trend for a number of years (see
Sections 1.1 and 1.2), at least partly due to the high levels of saturated fat
associated with the meat, in conjunction with government advice to reduce
intakes of this type of fat. In addition, obesity and associated medical
conditions are on the increase. CLA has been shown to reduce fat deposition in
a number of animals; however the mechanisms are as yet unclear. This project
initially investigated fat synthesis in the sheep in response to CLA in an
attempt to determine the factors in the process affected by CLA. Although
there has been much work done on the effects of CLA in small animals, the
effects of CLA on sheep have not been well investigated and much of the work
done to date in ruminant animals has centred on dairy cows and the effects of
CLA on milk fat synthesis. Work in small animal models has demonstrated that
CLA seems to consistently act on the liver, the major site of fatty acid
biosynthesis in rodents. The major site of fatty acid biosynthesis in ruminants
is the adipose tissue, and the adipose tissue explant technique was used to study
this as it was anticipated that CLA may also target this tissue. In the absence of
an effect of CLA on lipogenesis or lipogenic gene expression in the sheep (both
in explants and in vivo), feeding studies were performed in the hamster, a
monogastric species previously shown to reduce body fat in response to CLA.
6.1. TISSUE CLA CONTENT
Feeding CLA to both sheep and hamsters resulted in an increase in the
proportions of cis-9, trans-11 and trans-10, cis-12 CLA incorporated into
adipose tissue and liver (Chapters 4 & 5). This demonstrated that it was
possible to protect dietary CLA from hydrogenation in the rumen of the sheep.
The CLA fed to sheep was approximately 66% protected (Wynn, 2003), and
was clearly present in the small intestine for absorption into tissues. In both
species and tissues studied, the proportion of trans-10, cis-12 CLA was lower
than that of cis-9, trans-11 CLA, even when accounting for endogenous
synthesis seen in sheep fed the control diet. This is consistent with a number of
other studies (Sehat et al, 1998; Parodi, 1997; Chin et al, 1992; Ha et al, 1989)
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There has been some support for the idea that the trans-10, cis-12 isomer is
metabolised in preference to cis-9, trans-11 CLA (Alasnier et al, 2002; Martin
et al, 2000), however it was not possible from the present studies to say
whether this was the case.
6.2. EFFECTS OF CLA ON LIPOGENESIS
Studies in mice, rats and hamsters had demonstrated that CLA had favourable
effects on body composition, with animals showing significant reductions in fat
mass and more modest increases in lean tissue mass (Kim et al, 2002; Azain et
al, 2000; Gavino et al, 1999; Park et al, 1999 Park et al, 1997). Studies on
lipogenesis in ovine adipose tissue explants treated with CLA and other fatty
acids (Chapter 3) showed variability between tissue preparations, evident by
the different responses to insulin and dexamethasone treatment. Insulin is
known to increase lipogenesis in ruminant adipose tissue (Chilliard &
Faulconnier, 1995; Faulconnier et al, 1994; Miller et al, 1991; Etherton &
Evock, 1986; Vernon, 1979), so increased lipogenesis with inclusion of this
hormone indicated that the tissue was metabolically active and capable of
responding to stimuli. Dexamethasone, a synthetic glucocorticoid has been
shown to reduce lipogenesis in ruminant adipose tissue (Daniel et al, 2004;
Faulconnier et al, 1997; Chilliard & Faulconnier, 1995; Vernon et al, 1991;
Plested et al, 1987). Maximal stimulation of lipogenesis and de novo fatty acid
synthesis with insulin and inhibition with dexamethasone demonstrated that the
tissue was responsive to treatments. In addition, insulin maintains tissue
viability in culture (Vernon, 1979), making it possible to study responses to
treatments over several days. There was no consistent effect of CLA on
lipogenesis in ovine adipose tissue explants, but as insulin was included in the
culture there was the possibility that the potential inhibitory effect of the fatty
acid could not overcome the stimulatory effect of insulin, as seen in rat adipose
tissue explants cultured with fatty acid and insulin (Vernon, 1975). However,
studies in ovine adipose tissue explants treated with fatty acids with and
without insulin showed that insulin could not overcome the fatty acid induced
inhibition of lipogenesis (Vernon, 1975). There was no evidence for a dose
dependent inhibition of lipogenesis with oleic acid or CLA in the studies
reported here; although there was a decrease in lipogenesis with the highest
concentrations of fatty acids this may have been due to the cytotoxic effects of
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the fatty acid. The availability of fatty acids to all of the cells within the tissue
may also have been impaired. Small water soluble hormones may diffuse easily
through the tissue to reach cells in the centre of the explants, but this may not
be the case for hydrophobic fatty acids, even when complexed to albumin. Any
direct effects of fatty acids on lipogenesis seem not to be of a magnitude that
can be detected using the adipose tissue explant system.
6.2.1. ACC mRNA levels in response to CLA treatment
In adipose tissue of hamsters CLA seemed to stimulate lipogenesis, measured
by increases in ACC and FAS mRNA. There was no evidence to suggest that
CLA had any effect on lipogenesis in sheep in explants or in vivo. It was noted
that in the hamster levels of ACC and FAS mRNA did not differ from controls
with levels of CLA above 1% in the diet. There was no significant effect of
CLA on ACC mRNA levels in sheep fed PCLA. The hamster showed a 10%
reduction in body fat with CLA feeding, despite the increase in adipose tissue
lipogenic mRNA levels at 0.5% CLA. Taking all these results together, it is
significant that the highest level of mRNA for both ACC and FAS was seen in
conjunction with the drop in body fat and a non-significant drop in perirenal
adipose tissue weight. This was all seen at the lowest level of supplementation
and suggests that there is increased oxidation of fat as well as increased
lipogenesis. The two major isomers present in the CLA mix used for both the
explant and hamster studies contained 90% CLA, with approximately 98% of
this being either cis-9, trans-11 or trans-10, cis-12 CLA, in equal proportions.
It has been demonstrated that trans-10, cis-12 CLA is the isomer responsible
for the changes in body composition (Baumgard et al, 2002; Brown et al, 2001;
Park et al, 1999), but there are no reports of effects of the two isomers at
different concentrations. It is possible that the effects of the individual isomers
are manifested at different concentrations; cis-9, trans-11 CLA may increase
ACC and FAS mRNA levels at low concentrations, while trans-10, cis-12
CLA may reduce or prevent further increase in gene transcription at higher
concentrations, resulting in a reduction in lipogenesis. However, studies in
ovine adipose tissue explants with individual isomers showed no effect of cis-
9, trans-11 CLA on ACC mRNA levels; it would be interesting to see whether
this is the case in hamsters fed different levels of individual isomers. There was
no effect of CLA feeding on ACC mRNA levels in liver of sheep or hamsters,
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suggesting that there is more effect of dietary fat on the adipose tissue, which is
the predominant site of lipid metabolism.
6.3. EFFECTS OF CLA ON SCD
There was no apparent effect of CLA on synthesis of saturated and
monounsaturated fatty acids in ovine adipose tissue explants. However this was
measured by incorporation of acetate into the tissue, and not by fatty acid
composition, as in hamsters and sheep fed CLA. It would have been interesting
to look at fatty acid composition of the tissue in addition to fatty acid formation
to see if acetate incorporation was a good indicator of fatty acid composition.
However, this would be difficult to study in the time frame used in these
experiments, as the tissue would not turn over rapidly enough for any changes
to be measured. Additionally, there are problems associated with long term
culture of explants. Conversely, in sheep and hamsters fed CLA there were
significant differences in fatty acid composition, with lower levels of
palmitoleic and oleic acids in animals fed CLA than those fed control diets.
The type of fat fed significantly affected desaturase ratios in sheep, but there
was no significant dose effect, only a trend towards lower values with
increased CLA. Conversely, the effect of CLA on hamster desaturase activity
was dose dependent with the greatest degree of SCD inhibition being seen at
the highest level of CLA. CLA treatment had most effect on adipose tissue
SCD, with liver SCD activity changing very little in both sheep and hamsters
relative to CLA dose. This is likely to be due to the different constitutions of
adipose tissue and liver. Liver contains a larger proportion of phospholipids
than adipose tissue, which is mainly made up of triacylglyceride. Phospholipids
appear to be highly resistant to changes in their fatty acid composition (Ip &
Scimeca, 1997); this is consistent with the results seen in sheep and hamsters.
There was no effect of CLA treatment on SCD mRNA levels in ovine adipose
tissue explants, ovine adipose tissue or hamster adipose tissue. Taken together
with the fatty acid composition data, this strongly indicates that CLA inhibits
SCD enzyme activity and does not have any effect on transcription of the SCD
gene.
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6.4. EFFECTS OF CLA ON HAMSTERS AND SHEEP
In the present studies, the hamster was more responsive to CLA feeding than
the sheep in terms of reductions in body fat, SCD activity and lipogenesis
(indicated by ACC and FAS mRNA levels) and changes in these with different
levels of CLA feeding. Clearly there are difficulties in the ruminant due to the
hydrogenation of fats in the rumen, necessitating the protection of supplements
from breakdown by the rumen micro-organisms. Feeding a fat supplement to
the monogastric like the hamster is simpler in that there are few micro-
organisms present in the digestive tract until after the small intestine, the site of
fat absorption. However, protection of the CLA was achieved sufficiently to
allow changes in fatty acid composition to be seen. In an attempt to explain a
difference in the responses of the two species, the amounts of CLA available
for absorption at the level of the small intestines of the sheep and the hamster
were calculated, and compared with the amounts of both CLA isomers in
perirenal adipose tissue depots. There was significantly more CLA reaching the
adipose tissue of hamsters than sheep (Figure 6.1). This was the case even
when there was more CLA available for absorption at the level of the
duodenum. However, the calculation of the amount of CLA available for
absorption was based on the proportions of the supplements present as cis-9,
trans-11 and trans-10, cis-12 CLA, and was not confirmed by levels of CLA
present in the digestive tract of the hamster. CLA present in the abomasum of
sheep was shown to increase with supplementation levels (Wynn, 2003) in the
same way, but without looking at flow rates, absolute values for an amount of
supplement could not be determined. However, looking at the levels of CLA
available for absorption it appears that the greater responses seen in hamsters
may be due to the increased availability of CLA for absorption at the level of
the small intestine. There my not have been enough CLA to elicit an effect on
the parameters measured, however there were similar amounts of both CLA
isomers in tissues of sheep (Figure 6.1) fed the highest amount of CLA
(100g/kg) and hamsters fed the lowest amount of CLA (50g/kg) so this seems
unlikely. Additionally, Ostrowska et al (1999) fed pigs 10g CLA/kg diet and
observed significant reductions in back fat, indicative of reduced lipogenesis.
Taken together, these observations suggest that the sheep does not respond to
dietary CLA. It may be that levels of CLA available at the duodenum in
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practice were much lower than those calculated despite feeding larger amounts
of CLA. There was no effect of CLA on hepatic ACC or SCD mRNA in
hamsters or sheep fed CLA. While there is little lipogenesis occurring in the
liver of ruminants, with the majority of fatty acid synthesis occurring in the
adipose tissue, lipogenesis is split between the liver and adipose tissue in
hamsters. The results suggest that CLA targets adipose tissue, rather than liver
in the instigation of its effects.
Figure 6.1 Proportions of CLA isomers in perirenal adipose tissue from
hamsters and sheep fed different levels of CLA
a) Cis-9, trans-11 CLA
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6.5. FUTUREWORK
Although there was no effect on lipogenesis in ruminants fed a mixture of cis-
9, trans-11 and trans-10, cis-12 CLA at the levels of supplementation used in
the present study, it would be interesting to examine if supplementation of diets
with pure cis-9, trans-11 and trans-10, cis-12 CLA affected the lipogenic
enzymes and fatty acid composition studied here. Another line of investigation
could focus on the effects of feeding CLA to breeding ewes and the effects on
the lambs in terms of fat deposition, enzyme activities and fatty acid
composition. There is already evidence to suggest that feeding CLA during
gestation to rats and pigs has long term effects on the offspring in terms of
body weight, body composition and tissue fatty acid composition (Poulos et al,
2001; Bee, 2000). Production of lambs with less fat would appeal to the health-
conscious consumer and may have commercial relevance. Ruminant mammary
tissue clearly responds to trans-10, cis-12 CLA in terms of a reduction in milk
fat synthesis (Baumgard et al, 2002; Baumgard et al, 2000) and CLA has been
shown to reduce milk fat in lactating sheep (Sinclair, personal communication).
Comparative studies examining the effect of CLA on mammary and adipose
tissues would be interesting to investigate whether the effect of CLA on
ruminant mammary tissue is tissue specific. The studies in hamsters fed CLA
revealed that the effects of CLA were different with different levels of CLA
feeding. This suggested an antagonistic role for the two isomers, with the
possibility that the effects of cis-9, trans-11 CLA predominate over those of
trans-10, cis-12 CLA at a low concentration and trans-10, cis-12 becomes
dominant at high concentrations. Future studies feeding individual isomer
supplements would help to determine whether this is the case, and further
studies are still required to explain the decrease in carcass fat seen with CLA
feeding.
Investigation of the effects of the individual isomers of CLA on aspects of lipid
metabolism, the concentrations at which they are effective, the tissues that they
target and the degree of efficacy will be a key aim for future work.
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6.6. CONCLUSION
The effects of CLA on lipid metabolism have been investigated in sheep and
hamsters. This is the first report on the effects of CLA on ovine adipose tissue
lipogenesis. There was no effect of CLA on total lipogenesis, but an inhibitory
effect of increasing concentrations of fatty acids. CLA had no effect on
proportions of saturated and monounsaturated fatty acids formed in ovine
adipose tissue, suggesting that CLA failed to alter fatty acid composition via
inhibition of SCD. Finally, the effect of CLA on ACC and SCD mRNA was
measured. There was no effect of CLA on either ACC or SCD mRNA levels
consistent with the previous experiments on total lipogenesis and fatty acid
formation. The use of tissue culture models is limiting, however, due to the
absence of many hormones and processes present in the whole body, therefore
the work with CLA in adipose tissue was followed by a feeding trial in sheep.
Protection of the CLA from ruminal degradation was essential, to ensure that it
was available for absorption at the level of the small intestine, and this was
achieved successfully, with the CLA being 66% protected and significant
quantities of both isomers being found in the adipose tissue depots and liver to
demonstrate this. The decrease in monounsaturated fatty acids with CLA
feeding was indicative of an inhibition of SCD enzyme activity; this is likely to
be due to direct action of CLA on the SCD enzyme complex and not to be
mediated through transcription of the SCD gene, as levels of SCD mRNA were
shown not to be affected by CLA feeding. The results presented in this thesis
show that sheep do not respond to CLA in terms of a reduction in body fat in
the same way as other species such as rodents and pigs.
A CLA feeding trial in hamsters demonstrated changes in fatty acid
composition indicative of inhibition of SCD activity, but again no change in
SCD mRNA levels. This is consistent with the sheep, and suggests the
inhibition of SCD activity by CLA is an effect common across species.
However, the hamster seems to respond differently in that adipose tissue ACC
and FAS mRNA was increased with CLA feeding, but there was no increase in
fat pad weights suggesting that fat oxidation was also increased. Carcass fat
was decreased by 10% with CLA feeding; however there was an increase in
liver weight, so it is possible that the fat was being mobilised from the carcass
and stored in the liver in response to CLA feeding. There was no effect of CLA
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on liver ACC or FAS mRNA, ruling out the possibility of increased hepatic
lipogenesis being responsible for the increase in liver weight. Adipose tissue
SREBP-1c mRNA is increased by CLA feeding, suggesting that ACC and FAS
are not directly affected by CLA but up-regulated by the increase in availability
of this transcription factor.
This thesis demonstrates that CLA has no effect on ovine lipogenesis, so is
unlikely to be useful as a method of reducing fat associated with lamb, and has
unfavourable effects on the fatty acid profile, due to the inhibition of SCD
enzyme activity. The amount of CLA in the tissues is not increased to any large
degree, therefore to significantly increase dietary intake of CLA it would be
necessary to take in more saturated fatty acid, present as a consequence of CLA
enrichment, which from a health point of view is not desirable. Taken together
with the negligible repartitioning effects seen in growing sheep (Wynn, 2003);
there is no commercial reason for feeding CLA to meat producing animals.
On the other hand, work in the hamster, a species shown to respond to CLA
demonstrates that the effects of CLA act on SREBP-1c, a transcription factor
responsible for the up-regulation of many lipogenic genes, including ACC and
FAS. This may be activated in response to the drop in total carcass fat seen
with CLA feeding. The reason for the lack of effect of CLA on fat pad weights
is more perplexing; it may be that CLA increases fatty acid oxidation, and the
resultant decrease in body fat stores activates SREBP-1c. The mechanism by
which CLA works is far from elucidated, and the results in this thesis and in
the literature demonstrate that it has variable effects both within and between
species, and that results require careful interpretation in an attempt to verify
how CLA has its effects on lipid metabolism. However, in neither species was
there any evidence to suggest that CLA works through inhibiting lipogenesis.
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